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Abstract  
Late gestation and labour is associated with inflammatory changes in the myometrium that include an increase 
in neutrophil and monocyte numbers. The mechanisms regulating altered leukocyte dynamics in pregnancy are 
not well understood, but may be critical in identifying novel targets for the prevention of preterm labour (PTL). 
PTL is defined as the onset of labour prior to 37 weeks gestation and often results in preterm birth (PTB). Here 
we investigated local and systemic leukocyte trafficking during late gestation and labour, focussing on the pro-
inflammatory Ly-6Chigh monocyte subpopulation in mouse models of normal, preterm and delayed labour.  
Using flow cytometry and in vivo cell labelling methods, we demonstrated for the first time that blood-derived 
Ly-6Chigh monocyte densities increase in the myometrium prior to labour onset. Increases were also observed in 
the pools of intravascular, lung-marginated Ly-6Chigh monocytes and neutrophils during late gestation, which 
although not mirrored in the circulation is indicative of a systemic inflammatory response. Using exogenous 
progesterone supplementation and a progesterone receptor antagonist, we demonstrated that progesterone 
controls Ly-6Chigh monocyte cell densities within the myometrium, with rapid increases following its functional 
withdrawal.  In a mouse model of infection-induced PTL by laparotomy and intrauterine LPS injection, we 
unexpectedly found that inflammatory leukocyte migration to the myometrium was low pre- labour.  Levels of 
cytokines and chemokines, including the monocyte chemoattractant CCL2, were high in the myometrium, but 
also systemically in plasma and organ tissue, indicating a significant systemic inflammatory response. In the 
surgical controls, in which labour was delayed, there were substantial increases in Ly-6Chigh monocytes in the 
myometrium, which were shown using knockout mice to be CCR2-dependent.  
Taken together, our data indicate that both local and systemic inflammation play important roles in labour. 
Despite consistent observations of Ly-6Chigh monocyte infiltration into the myometrium, there was a lack of clear 
evidence supporting their role in labour, suggesting their late-gestation myometrium infiltration is more relevant 
to post-partum uterine repair and remodelling. 
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Siglec-1  CD169, Sialoadhesin, MOMA-1 
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Pregnancy describes the process from fertilization through to parturition that typically lasts for 40 
weeks in humans. Preterm birth (PTB) is defined as delivery prior to 37 weeks gestation and globally 
is the leading cause of neonatal mortality and morbidity1. The rates of PTB are increasing in developed 
countries and pose a significant clinical problem as currently the exact mechanisms responsible for 
preterm labour (PTL) are not fully understood2. Currently therapeutics are targeted at preventing 
contractions once labour has started. However, tocolytic administration such as calcium channel 
blockers or prostaglandin synthetase inhibitors used to inhibit uterine contractions have not been 
shown to improve neonatal outcomes3. Currently progesterone (P4) is the only prophylactic available 
to women who are at risk of PTL and P4 supplementation does not benefit all women4. Understanding 
the mechanisms of normal labour as well as PTL is essential in the development of effective 
therapeutics. 
1.1 The immune response during pregnancy 
Pregnancy is a unique physiological and immunological state. The adaption of the maternal immune 
system to pregnancy is a compromise between the need for tolerance of the developing semi-allograft 
foeto-placental unit and the ability to mount an effective response to an infectious agent.  The 
imperfect nature of this compromise is shown on the one hand by well-recognised increased mortality 
rates seen in pregnant women during flu-epidemics, malaria infection and sepsis5. While on the other 
hand, excessive activation of the maternal innate response to infection can be directly harmful to the 
foetus resulting in neurodevelopmental disabilities or indirectly, as a result of preterm labour. 
1.1.1 Adaptive immunity 
Pregnancy represents a complex state of maternal-foetal immunological interaction in which the 
mechanisms designed to protect the mother from infection have the potential to reject the semi-
allogeneic foetus. An important site where specific immune recognition of foetal antigen can occur is 
at the placenta. Hemochorial placentation describes a structure where the chorion of the foetus is in 
direct contact with the maternal blood allowing optimal exchange of nutrients and metabolic waste 
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products, this type of placentation is found in primates, rabbits, rats and mice6. The degree of invasion 
into maternal tissues varies between species, with humans exhibiting the most invasive structure7. 
Humans have a hemomonochorial placenta with one single layer of syncytiotrophoblast cells while 
mice have three layers of trophoblast cells described as a hemotrichorial placenta.  In humans the 
chorionic villi extend into the maternal blood space to form a blood-syncytiotrophoblast interface 
while in mice the labyrinth trophoblast structure is in direct contact with maternal blood.  
The close interaction between foetal-derived cells and the maternal circulation at the placenta 
requires that the mother’s adaptive immune response acquires tolerance to the foetus. This is 
achieved through several mechanisms acting at different stages of pregnancy at both the local and 
systemic level. 
The trophoblast cells of the foetus are responsible for the successful attachment of the embryo to the 
uterine wall. Trophoblast cells invade the decidua and myometrium during early pregnancy to expose 
the developing foetus to the maternal blood supply. The foetal-derived syncytiotrophoblast cell layer 
forms the direct interface between the foetus and maternal blood in humans. The decidual tissue is 
an important location of maternal-foetal immune interaction. It has been hypothesised that the early 
systemic exposure of maternal immune system to cells of foetal origin is a primary mechanism 
involved in the development of immune tolerance. Cells of the syncytiotrophoblast layer are shed 
throughout pregnancy8, these cells are then cleared from the maternal circulation and this process 
has been demonstrated to contribute to the maintenance of maternal tolerance9, 10.  Placental 
shedding has been shown to be exacerbated in women diagnosed with pre-eclampsia. Pre-eclampsia 
is a disease diagnosed by the onset of hypertension and proteinuria during pregnancy11. Trophoblast 
invasion of the uterus is impaired in women with pre-eclampsia, this in turn reduces blood flow 
through the placenta inhibiting foetal growth12. The excessive inflammatory responses characterised 
by endothelial dysfunction and leukocyte activation in women with pre-eclampsia are hypothesised 
to be as a direct result of the increased placental shedding caused by poor placentation12-16. A central 
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mechanism of systemic exposure to foetal antigen and development of immune tolerance appears to 
be via the budding and release of membrane microvesicles from the syncytiotrophoblast which can 
reduce pro-inflammatory Th1 responses by inhibiting lymphocyte proliferation17 and inducing 
apoptosis18  as demonstrated in vitro. The excessive syncytiotrophoblast microvesicle release during 
pre-eclampsia stimulates monocytes to increase Th1 responses via an increase in the production of IL-
12 and TNF-α15. 
A key mechanism for recognition of self is through the expression of major histocompatibility 
complexes (MHC) on the surface of antigen presenting cells19. In both human and murine pregnancy 
the trophoblast cells do not present MHC alloantigens20-22, these findings suggested that paternal 
antigens were hidden from the maternal immune system. However there is indirect evidence that T 
cells do mediate their responses to paternal alloantigens during pregnancy. This is supported by a 
study that found expression of paternal MHC class I molecules have not been found to reduce 
pregnancy rates 23. Support for a heightened immune tolerance throughout pregnancy is supported 
by the finding that women diagnosed with the immune disorders such as Rheumatoid Arthritis and 
Multiple Sclerosis experience an amelioration of symptoms for the length of gestation24.  In one study 
pregnant mice transplanted with allogeneic tumours originating from the sires of their pregnancy 
accepted the tumour and had reduced T cell responses for the length of gestation. This immune 
recognition did not extend post-partum or when tumours from a second male were transplanted25.  
It is hypothesised that at term the adaptive immune responses are influenced to assist with the onset 
of labour and the tolerance to the foetus is reduced. This is thought to be due to a combination of, 
increases in T cells within the decidua which express inflammatory cytokines associated with labour, 
and by a reduction in the suppressive activity of Tregs26. 
Antigen presenting cells (APCs) link the innate and adaptive immune response. APCs such as dendritic 
cells and monocytes use a combination of MHC and co-signalling molecules to activate or inhibit T 
cells27, 28. Pregnancy is associated with high levels of Progesterone (P4) and P4 has been shown to inhibit 
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DC- stimulated proliferation of T cells 29 and directly suppresses T cell activation during pregnancy30. 
This suppression has been proposed as a mechanism for increased susceptibility to viral infections 
during pregnancy31, 32.  
1.1.2 Innate immunity 
A localised or systemic infection during pregnancy can result in miscarriage, intrauterine death or 
preterm labour. Therefore the innate immune response is required to coordinate an effective 
response to pathogens during pregnancy without causing excessive inflammation which would be 
harmful to the developing foetus.  
The main cells that are involved in innate immune responses are leukocytes, and also endothelial and 
epithelial cells. Leukocytes are the primary effectors of innate responses and consist of monocytes, 
macrophages, neutrophils, eosinophils, basophils, dendritic cells, mast cells, nuocytes, and natural 
killer (NK) cells. These cells are required to assist with successful implantation of the blastocyst into 
the decidual tissue of the uterus. This implantation phase of pregnancy is associated with 
inflammation within the uterus as the invasive nature of the blastocyst involves damage to the 
endometrial tissue33 and leukocytes are required to regulate this process. Uterine NK cells (uNK) are 
the most abundant leukocyte in early pregnancy making up ~70% of all decidual leukocytes34. uNKs 
are associated with the regulation of trophoblast invasion and successful spiral artery formation which 
is essential for supplying the placenta with an adequate blood supply35, 36. By term, numbers of uNK 
cells have reduced suggesting a diminished importance at parturition37.  
Macrophages constitute 20-30% of all decidual cells at the site of implantation and in contrast to uNK 
cells their numbers in the decidua remain relatively high throughout gestation38-41. Decidual 
macrophages perform a crucial role in removing apoptotic cells from the foeto-maternal interface. 
Abrahams et al. hypothesised that engulfment of apoptotic cells was essential to prevent the release 
of pro-inflammatory and pro-immunogenic intracellular molecules from necrotic trophoblast cells42. 
Macrophages are also likely to be crucial to assist the ongoing growth of the foetus by promoting 
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effective remodelling of the decidua throughout pregnancy43. Similarly uterine macrophages are 
known to protect against infection and have a role in immunosuppression in the pregnant uterus, they 
also contribute to the production of cytokines44. Uterine macrophages have been demonstrated to 
protect against infection due to their phagocytic properties45, 46. 
Dendritic cells (DCs) within the decidual tissue perform the dual roles of initiating a primary innate 
immune responses and also mediating immunological tolerance47. In addition to their role as 
mediators of T cell responses, DCs are also critical in the successful implantation and remodelling of 
the decidual tissue during pregnancy. Ablation of DCs in the murine uterus impaired implantation as 
angiogenesis and tissue remodelling was diminished48. Later in gestation the predominant DC subset 
in the uterus (CD8α−) has been shown to display an anti-inflammatory phenotype with increased 
expression of the anti-inflammatory cytokine IL-1049. 
From studies investigating phenotype and activation of leukocytes during pregnancy, a contrast has 
been identified between the enhanced immune response in the maternal circulation and a reduced 
inflammatory phenotype in the decidual tissues. NK cells within the decidua display a CD56bright 
phenotype while peripheral blood NK cells are predominantly CD56dim, comparative transcriptional 
expression revealed dendritic NK cells were a distinct subset from peripheral blood NK cells50. 
Cytotoxic activity of the decidual NK cell population was shown to be reduced compared to peripheral 
blood NK cells and also NK cells found within the non-pregnant uterus50-52. 
Circulating peripheral blood leukocytes have been shown to have increased activity throughout 
gestation compared to non-pregnant controls. Granulocytes and monocytes in the circulation of 
women in their third trimester have been demonstrated to express higher levels of CD11b, CD14, and 
CD64 and increased intracellular reactive oxygen species compared to non-pregnant women14, 53. 
While the proportion of monocytes in the circulation of pregnant women were not shown to increase, 
activation was shown to increase throughout gestation as demonstrated by an increase in the 
expression of surface markers CD11a, CD11b, CD54, and CD64 combined with increases in IL-12 and 
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IL-1β production53, 54. Although the proportion of monocytes and granulocytes have not been shown 
to increase during pregnancy Sacks et al. reported that their numbers increase in maternal circulation 
during pregnancy55. The systemic response is thought to be enhanced during pregnancy and adapts 
over the course of gestation. Systemic monocytes are primed to produce more TNF-α throughout 
gestation, while more IL-12p70  is produced in the first and second trimesters and IL-18 increases in 
the first trimester only56.  
Throughout pregnancy the maternal immune system is constantly exposed to cells of foetal origin and 
their shed microvesicles. During the third trimester approximately 3g of apoptotic syncytiotrophoblast 
cells are released daily into the maternal circulation8, 57. The priming of monocytes to display an 
enhanced inflammatory phenotype during pregnancy is hypothesised to be as a result of the 
increasing exposure of systemic monocytes to these and other placental products55. 
The Shwartzman reaction is a lethal shock syndrome induced by the administration of first a small 
dose of LPS called the priming dose followed by a larger dose 24 hours later which results in mortality 
not seen with the large dose alone58. Priming with IL-12 or IFN-γ also induces a lethal reaction in mice59. 
Pregnant animals show increased mortality in response to a single dose of LPS compared to non-
pregnant controls and it is hypothesised that factors associated with pregnancy promote an excessive 
activation of the innate immune response55, 60,61. 
These studies highlight the differences in the innate and adaptive immune adaptation to pregnancy. 
In the 1970s pregnancy was considered a state of immunosuppression62-64, more recently the complex 
interaction between the suppressive effects of the adaptive immune response and an enhanced 
innate immune response have been acknowledged55, 65. These adaptations however mean that 
pregnant women are more susceptible to viral infections and in response to systemic infection can 
mount an exaggerated systemic inflammatory response which can result in sepsis.  
1.2 Parturition 
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Parturition is defined as the act or process of giving birth. In humans the average length of time 
between conception and parturition is 40 weeks. During pregnancy the uterus is in a state of 
quiescence and spontaneous labour at term requires physiological changes that transform the uterus 
into a contractile organ in order to expel the foetus and placenta. Simultaneously, the cervix must 
undergo cervical ripening whereby the cervix fully effaces and dilates.  
The exact molecular mechanisms involved in the initiation of human parturition are largely unknown 
however it is thought to involve a combination of maternal and foetal factors, such as uterine 
mechanical stretch-induced signalling, prostaglandin synthesis, a loss of uterine quiescence by the 
reduction in nitric oxide (NO) levels, immune responses and endocrine dynamics. The importance of 
understanding the complex interplay between these processes and how they are coordinated is 
highlighted by the high mortality and morbidity associated with preterm labour (PTL) and birth (PTB).  
1.2.1 Term labour 
Myometrial stretch has a central role in the regulation of the onset of parturition. Twin pregnancies 
have an increased incidence of PTL and it is thought that the increase stretch exerted on the uterus 
contributes to the early onset of labour66. Evidence for this comes from studies where the uterus is 
distended in women at term and macaques at mid-gestation with the use of inflatable balloons and 
labour onset is triggered67, 68. The effects of stretch on myometrial smooth muscle cells have been 
shown to initiate the activation of many signalling pathways involved in the onset of labour.  
The mitogen-activated protein kinase (MAPK) pathway consists of a signalling cascade which is 
initiated by an extracellular stimulus such as pro-inflammatory cytokines, growth factors or oxidative 
stress69. Once the MAPK pathway has been activated, downstream processes result in the mediation 
of gene transcription to regulate processes such as differentiation, proliferation and cell death70. The 
MAPK pathways have been shown to be activated in the myometrium as a result of stretch both in 
vivo and in vitro71-74. The activation of various MAPK cascades in the uterus has been demonstrated to 
increase CXCL8 and COX-2 expression72, 75 while also increasing c-fos expression71, 73. Through these 
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pathways stretch has been demonstrated to directly promote Cx43 expression, Cx43 is a pro-
contractile protein thought to be required for sustained and coordinated contractions of the 
myometrial myocytes via its actions on intercellular communication 71, 73, 76, 77. 
As well as stretch it is hypothesised that the foetus can stimulate the initiation of the inflammatory 
responses in the uterus at term to promote labour onset. Corticotrophin-releasing hormone (CRH) is 
a hormone produced by the foetal adrenal glands which is found in increasing amounts in late 
gestation in maternal plasma78. CRH has been shown to be necessary for the production of foetal lung 
surfactant proteins which enter the amniotic fluid from the lungs of the foetus and activate the 
transcription factor NFκβ which is both directly and indirectly responsible for promoting uterine 
contractility by the production of pro-labour factors such as Cx43 and COX-279.  
1.3 Inflammatory mediators 
1.3.1 Cytokines 
Cytokines are a class of  small soluble signalling proteins expressed by all nucleated cells which affect 
nearly every biological process80. Cytokines can be categorised into separate classes depending on 
their function. Functional classes include but are not limited to; pro or anti-inflammatory cytokines, 
chemotactic cytokines and lymphocyte growth factors81. Cytokine action is often not specific to one 
cell type, furthermore the net effect of their pro and anti-inflammatory actions can be difficult to 
quantify. Pregnancy and labour as with nearly every biological process, requires cytokines to regulate 
each phase from ovulation to parturition82-84.    
Pro-inflammatory cytokines include IL‐1, IL‐6 and TNF‐α all of which have been shown to increase in 
the uterus and foetal tissues during human parturition resulting in prostaglandin synthesis which 
promotes the onset of myometrial contractions85-88. Immunohistochemical analysis has determined 
that the majority of pro-inflammatory chemokines are localised to the leukocyte populations present 
in the uterine tissues and foetal membranes, however, some cytokine expression was also found in 
the stromal and trophoblast cells86.  
25 
 
Increased stretch and pro-inflammatory stimuli such as IL-1β and LPS stimulate MAPK pathways in the 
uterus to increase the expression of prostaglandins, chemokines, pro-inflammatory cytokines, matrix 
metalloproteinases and  pro-contractile genes  which are all associated with labour onset 75, 89.  
Therefore, physiological or pathophysiological inflammatory processes have the potential to regulate 
or perturb the normal labour process. 
These responses are tightly regulated, for example the anti-inflammatory cytokine IL-10 is thought to 
act as an immunosuppressant during pregnancy90. In both humans and mice, levels of IL-10 are 
variably expressed in the myometrium, decidua and placental tissues depending on the stage of 
gestation91-93. Prior to and during labour, foetal tissues show a decreased expression of IL-1094, 95 while 
circulating levels have been shown to increase during labour96. A reduction in localised IL-10 
expression may be necessary to allow for the inflammatory process at labour to be initiated.  
1.3.2 Leukocytes 
Cells of the myeloid lineage are derived from hematopoietic stem cells (HSCs) and include 
granulocytes (neutrophils, eosinophils, and basophils), monocytes, macrophages, erythrocytes, 
megakaryocytes, and mast cells. Myeloid derived leukocytes can be identified by their expression of 
the cluster differentiation factor 11b (CD11b) which regulates leukocyte adhesion and migration. The 
investigation of myeloid-derived leukocytes, particularly monocytes, macrophages, neutrophils and 
dendritic cells in the onset of parturition has been a focus of study since Thomson et al. described 
leukocyte infiltration at labour as part of an inflammatory process26, 97. Many groups have since 
demonstrated an increased amount of leukocytes in the myometrium, decidua, cervix and foetal 
membranes around the time of labour in both humans and in animal models98-100. The close 
association between the increase in infiltrating leukocyte populations in the uterine tissues around 
the time of labour has been suggested to be indicative of their causative role in labour onset and/or 
progression97, 99-105. However, currently it is not known if the infiltration of leukocytes into the uterus 
and foetal tissues contribute to the induction of labour or is as a result of labour itself.  Resident and 
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infiltrating leukocytes in the uterus are a key source of cytokines and matrix metalloproteinases which 
are implicated in the onset of parturition26. While myometrial macrophages produce NO which is 
involved in uterine quiescence and also secretory products that promote contractions26. The role of 
leukocytes in parturition requires further investigation. 
1.3.2.1 Monocytes and Macrophages 
The mononuclear phagocyte system (MPS) is a term used to describe a subgroup of leukocytes that 
are present in the circulation as monocytes then migrate into tissues as macrophages during normal 
conditions or in response to inflammation106.  
The mouse has been extensively used to model the dynamics of monocyte development and 
heterogeneity. At least two phenotypically and functionally distinct monocyte subsets have been 
identified in the mouse originally this was based of the levels of CCR2 expression107 and more recently 
the surface marker Ly-6C has been used to distinguish the subsets108, 109. Pluripotent stem cells develop 
through multipotent progenitor stages in the bone marrow through the action of M-CSF/Csf-1110. 
Blood monocytes that have recently been generated in the bone marrow are Ly-6Chigh and CCR2+109, 
111. Sunderkötter et al. demonstrated that Ly-6C expression levels indicate the stage of maturation the 
monocyte is at, with the Ly-6Chigh bone marrow derived blood monocyte maturing over the course of 
3 days to the Ly-6Clow monocyte subset112. The Ly-6Chigh subset has been shown in various infection 
and inflammation models to be preferentially recruited to inflamed sites and so are termed the 
inflammatory monocyte subset113-115. This process appears to be regulated primarily by the higher 
expression of the chemokine receptor CCR2 on Ly-6Chigh monocytes, which regulates both their egress 
from their bone marrow and their extravasation into tissue116-118.  The Ly-6Clow subset counterpart has 
been termed the resident subset due to its principle role of replenishing the tissue resident 
macrophages although there is evidence of its early transient recruitment to inflammatory sites119-121.  
In humans the equivalent to murine Ly-6Chigh monocytes is the classical CD14high CD16 – CX3CR1low 
CCR2+  subset while the murine Ly-6Clow subset corresponds to the non-classical CD14low, CD16high, 
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CX3CR1highCCR2- human monocyte subset122. These monocyte subsets have only recently been 
investigated in the context of pregnancy. The percentage of the non-classical monocyte subset in the 
circulation of humans and rats during pregnancy was shown to increase and this was interpreted as 
exemplifying pregnancy as a pro-inflammatory state123. Tagliani et al. demonstrated that the uterus 
actively recruits the ‘inflammatory’ Ly-6Chigh rather than the ‘resident’ Ly-6Clow subset during 
gestational development124. However these monocyte subset populations have not be identified in 
the human or murine uterus around the time of labour.  
Macrophages perform specific functions depending on their microenvironment. Like the monocytes 
they are derived from they have a large degree of heterogeneity between organs and can also be 
heterogeneous within the same organ110. Macrophages could be important in tissue remodelling of 
the uterus throughout pregnancy due to their ability to produce collagenase and elastase, and also 
may be required in maintaining myometrial quiescence during pregnancy due to their NO producing 
capabilities44, 125-127.   
The uterine macrophage population has been found to increase during murine pregnancy128. M-CSF is 
a pleiotropic growth factor involved in regulating monocyte development and macrophage 
proliferation and differentiation. M-CSF production is up regulated in pregnancy, furthermore  in the 
uterus a thousand  fold increase in M-CSF concentration from fertilisation to term is observed129. 
Tagliani and colleagues demonstrated how uterine macrophage densities were regulated by M-CSF in 
early gestation130. They found that high levels of M-CSF activity induced the expression of CCR2 ligands 
by uterine macrophages which maintained a high rate of Ly-6Chigh monocyte subset extravasation into 
the growing myometrium. The high levels of M-CSF activity also were found to increase macrophage 
proliferation in the growing mouse uteri.  
M-CSF is not the only factor influencing monocyte recruitment to the uterus as demonstrated in 
osteoporotic mice (op/op) which have a defective M-CSF gene. These mice have very low levels of 
blood monocytes and tissue macrophages however at mid gestation these mice have approximately 
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50% of uterine macrophages present as those seen in M-CSF competent mice131. Suggesting either, 
factors other than M-CSF are involved in maintaining the myometrial macrophage population, or some 
compensatory mechanisms have evolved in the pregnant osteoporotic mouse. 
The view of the uterine/myometrial macrophage population as belonging to the same homogenous 
cell type may limit progress in the field of parturition. The diverse and often opposing roles of 
infiltrating monocytes and macrophages throughout gestation through to parturition could have 
significant clinical relevance in order to develop effective therapeutics. Infiltrating populations of 
monocytes may serve as important modulators of the myometrial macrophage population to regulate 
processes such as uterine quiescence and the onset of labour.  
1.3.2.2 Granulocytes 
Granulocytes comprise neutrophils, eosinophils, basophils and mast cells. The role of neutrophils in 
term and preterm parturition has been the focus of many studies. Neutrophils are hypothesised to 
participate in the process of labour via the release of pro-inflammatory cytokines and the secretion of 
matrix metalloproteinases necessary for cervical remodelling132 and foetal membrane rupture133. Cell 
counts and activation of neutrophils in the circulation of both humans and animals have been shown 
to gradually increase prior to term; this coincides with increased levels of neutrophils in the 
myometrium, decidua, cervix and foetal membranes during labour14, 53, 97, 102, 105, 134. However, labour 
onset was unaffected when circulating neutrophils were depleted in pregnant mice from mid-
gestation using Gr1 and Ly-6G antibodies135, 136. This suggests neutrophil infiltration into the uterus 
and cervix is not essential to the onset and progression of labour in the mouse. Importantly, Gr1 
antibodies also bind to Ly-6C molecules and so these studies may have also indirectly depleted Ly-
6Chigh monocytes as well as neutrophils. 
1.3.3 Chemokines 
Chemotaxis is the process in which cells move in response to a chemical gradient generated by 
chemokines. Chemokines are a class of mostly small chemotactic cytokines involved in directing the 
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migration of cells such as leukocytes. Just under 50 chemokines have been identified which interact 
with at least one of ~23 chemokine receptors. The majority of chemokine receptors are located on the 
cell surface of leukocytes and are G Protein Coupled Receptors (GPCR) that bind chemokines to trigger 
intracellular pathways that affect the adhesive properties of the cell and mediate chemotaxis137. 
Currently four different classes of chemokines have been identified based on the position of the 
cysteine residues within the ligand138. The four classes belong to either the two major (CC and CXC) or 
the two minor (CX3C and C) families of chemokines139. C denotes cysteine and X or X3 refers to one or 
three non-cysteine amino acids. The receptor nomenclature refers to the class of chemokine it binds, 
for example the chemokine ligand CCL2, binds with high affinity to the chemokine receptor CCR2. 
While CCR2 has a high affinity for CCL2, the ligands CCL7, 8, 13, in humans, and CCL7 and CCL12 in 
mice also bind to this receptor. Table 1.1 shows chemokine and chemokine receptor interactions for 
each of the four classes and the chemokines expressed exclusively in humans and mice.  
 
 
 
 
Class Chemokine Receptor Chemokine Ligands 
Human Mouse 
 
 
 
 
CC 
CCR1 CCL3, CCL4, CCL5, CCL7, 
CCL8, CCL13, CCL14, 
CCL153,  CCL16 and 
CCL232 
CCL3, CCL5, CCL62, CCL7, 
CCL9/103, CCL15 and 
CCL23 
CCR2 CCL2, CCL7, CCL5, CCL8, 
CCL13 and CCL16 
CCL2, CCL7 AND CCL12 
CCR3 CCL4, CCL5, CCL7, CCL11, 
CCL13, CCL153, CCL24, 
CCL26 and CCL28 
CCL5, CCL7, CCL9/103, 
CCL11, CCL15 and CCL24 
CCR4 CCL17 and CCL22 CCL17 and CCL22 
CCR5 CCL3, CCL4, CCL5, CCL7, 
CCL14, CCL16 
CCL3, CCL4 and CCL5 
CCR6 CCL20 CCL20 
CCR7 CCL19 and CCL21 CCL19 and CCL21 
CCR8 CCL1 and CCL16 CCL1 and CCL8 
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CCR9 CCL25 CCL25 
CCR10 CCL27 and CCL28 CCL27 and CCL28 
 
 
CXC 
CXCR1 CXCL51, CXCL6 and CXCL8 CXCL51, CXCL6 AND 
CXCL7 
CXCR2 CXCL14, CXCL2, CXCL34, 
CXCL51, CXCL6, CXCL7 
and CXCL8 
CXCL14, CXCL2, CXCL34, 
CXCL51, CXCL6 and 
CXCL7 
CXCR3 CXCL9, CXCL10 and 
CXCL11 
CXCL9, CXCL10 and 
CXCL11 
CXCR4 CXCL12 CXCL12 
CXCR5 CXCL13 CXCL13 
CXCR6 CXCL16 CXCL16 
CX3C CX3CR1 CX3CL1, CCL26 CX3CL1 
C XCR1 XCL1 and XCL2 XCL1 
Chemokines in bold highlight species specificity 
Human specific chemokines Mouse specific chemokines 
XCL2 
CCL3L1 & 3 
CCL4L1 & 2 
CCL8 
CCL13 
CCL14 
CCL16 
CCL18 
CCL26 
CXCL4 
CXCL5 
CXCL8 
CCL8 
CCL12 
CXCL15 
Exceptions: 
1 Human CXCL5 has no mouse equivalent however CXCL5 in the mouse is similar to human CXCL6 
2 Human CCL23 is the equivalent of mouse CCL6 
3 Human CCL15 is the equivalent of mouse CCL9/10 
4 Human CXCL1 is the equivalent of mouse CXCL3 while human CXCL3 is the equivalent of CXCL1 
Table 1.1. Chemokine receptors and their ligands. 
 
Human neutrophils express the chemokine receptors CXCR1 and CXCR2 while murine neutrophils only 
express CXCR2. Human and murine monocytes express CCR2 and CX3CR1 in varying levels depending 
on the subset, however this is by no means fixed and neutrophils and monocytes have been shown to 
increase or decrease a range of chemokine receptors depending on their environment140-142. Dendritic 
cells have a similar chemokine receptor expression pattern as monocytes; they express CCR1, CCR2, 
CCR5, CCR6 and CXCR2. The internalisation of foreign antigen acts as a maturation stimuli to increase 
the expression of CCR7 on dendritic cells and encourage migration to the lymphoid organs143, 144. 
Pregnancy is a unique immune environment and the trafficking of leukocytes to the decidua, 
myometrium and cervix is hypothesised to be an important factor in the regulation of pregnancy and 
parturition26, 145. The expression of chemokines CCL2, CCL4, CCL5, CCL20, CXCL3, CXCL5, CXCL8 and 
CXCL10 have all been demonstrated to increase during term labour in the uterine tissues102, 146, 147. 
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However a decline in chemokine receptor expression of CCR2, CXCR1 and CXCR2 has been observed 
in human term labouring myometrial samples from the upper segment of the uterus but not the lower 
segment148. This is consistent with the finding that leukocyte infiltration predominantly occurs in the 
lower segment of the uterus at labour97 suggesting distinct processes occurring throughout the uterus 
at labour.  
Chronic inflammatory diseases such as atherosclerosis, rheumatoid arthritis and multiple sclerosis   are 
associated with high levels of leukocyte infiltration to sites of inflammation149-151. Therefore treatment 
with chemokine receptor antagonists offers the possibility of reducing excessive leukocyte migration 
to ameliorate inflammation. Currently only two chemokine receptor antagonists are licensed for use 
as therapeutics and they are Maraviroc a CCR5 antagonist for the treatment of HIV and Plerixafor a 
CXCR4 antagonist/partial agonist also used in the treatment for HIV and also for use in cancer patients 
to promote stem cell mobilisation152. The difficulty in targeting a specific chemokine receptor to treat 
disease is that the promiscuous nature of chemokines means that the target can ultimately be 
redundant153. For example monocyte trafficking can be regulated by multiple CC, CXC and CX3C 
chemokines via an array of chemokine receptors. The redundancy theory suggests that multiple 
chemokines can bind to multiple receptors resulting in one functional outcome154. The theory was that 
this would ensure a robust system in which if one component, either agonist or receptor was depleted, 
trafficking was not abolished completely. However since the discovery of biased signalling the theory 
of redundancy is an outdated one. Experimental data has demonstrated that biased signalling occurs 
in three ways155. Firstly by different ligands mediating their actions on the same receptor, secondly by 
one ligand acting at multiple receptors and finally chemokine and receptor interactions can be tissue 
or species dependant. 
1.4 Preterm labour 
Preterm birth (PTB) is defined as delivery prior to 37 weeks gestation. The World Health Organization 
published a report in 2012 titled Born Too Soon in which it was estimated that annually 15 million 
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babies are born preterm, globally that equates to 1 in 10 births 1. In England and Wales in 2012, 7.3% 
of live births were preterm156. The mortality rate of foetuses born preterm in 2012 was 23.6 for every 
1,000 live births, however, for the infants that do survive only 20% do not experience any type of 
disability156, 157. Compared to infants born at term, children born preterm have increased rates of 
cerebral palsy, learning disabilities, respiratory illnesses, sensory deficits, gastrointestinal and 
immunologic problems.  
In approximately 30-35% of PTBs, delivery was as a result of obstetric intervention due to 
complications associated with the pregnancy such as pre-eclampsia or foetal distress, but  for the 
other 60-65% of PTBs, delivery is as a result of spontaneous PTL or the premature rupture of 
membranes (PPROM)158.  In up to 40% of spontaneous PTBs labour is associated with the presence of 
infection, however, for a large percentage the exact cause is unknown158, 159.   
1.4.1 Spontaneous PTL 
Several factors such as smoking, drug abuse, stress, uterine anomalies and a previous preterm labour 
or birth are associated with an increased risk of PTL in singleton pregnancies, but for many 
spontaneous PTBs the exact cause is unknown160. Once PTL has begun, tocolytics such as calcium 
channel blockers are given, which in some cases can delay delivery and improve neonatal outcomes161. 
For women who have experienced a previous idiopathic PTL, P4 is prescribed as a prophylactic 
treatment, however, P4 treatment has only been shown to reduce the incidence of PTL by a third4.   
1.4.1.2 Progesterone (P4) 
P4 is essential for the maintenance of pregnancy.  High P4 levels throughout pregnancy promote 
uterine quiescence through multiple mechanisms that include the down regulation of receptors 
involved in uterine contractility, dampening electrical excitability of myocytes and reducing 
myometrial responsiveness to cytokines162, 163.  In humans, plasma levels of P4 remain high throughout 
gestation and labour, but it is thought that there is a functional P4 withdrawal at term which promotes 
the onset of contractions labour164-166. There are four main hypotheses of a functional P4 withdrawal 
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in humans167. The first is the paracrine hypothesis that suggests ratios of P4 and oestrogen (E2) 
produced locally in the uterus in the decidua and foetal membranes are altered at parturition. These 
changes at the local level are hypothesised to regulate contractility. The second hypothesis is that the 
dominance of the P4 receptor (PR) isoform B is reduced around labour and PR isoform A, which has 
opposing effects to PRB, increases in ratio.  The third hypothesis is that P4 is metabolised locally in the 
uterus by the placenta, foetal membranes and decidual tissue prior to labour. The final hypothesis is 
that P4 activity is regulated at the post receptor level at term.  
The functional P4 withdrawal hypothesis supports the continued use of animal models to investigate 
the mechanisms on labour onset following a systemic P4 withdrawal. In rats168, mice169, 170 and 
rabbits171 a decrease in circulating P4 levels have been demonstrated prior to parturition. P4 
withdrawal during pregnancy in rodents results in PTL: ovariectomy of the rodent partway through 
pregnancy induces PTL which is prevented by the administration of exogenous P4172.   
RU486/mifepristone is a progesterone and glucocorticoid receptor antagonist which is widely used in 
rodent models to model non-infection induced PTL. RU486 is also used as an abortive agent in 
combination with prostaglandins for human use prior to 7 weeks gestation highlighting how crucial P4 
is in the regulation and maintenance of pregnancy173. 
1.4.2 Infection induced PTL 
Current treatment for PTL involves the use of tocolytics to delay delivery by preventing uterine 
contractions; however, long-term neonatal outcomes are not greatly improved174. Up to 40% of 
spontaneous PTBs may be due to intrauterine infection and prolonging gestation in an inflammatory 
environment may cause greater harm to the neonate 175. This figure is regularly cited however the 
statement originates from a prospective study of 50 patients published in 1993176 and the true 
percentage of infection induced PTL is unknown. It is important that the molecular mechanisms 
preceding infection-induced labour onset are characterised in order to effectively identify and treat 
the syndrome. 
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As outlined above, normal labour is an inflammatory process associated with increased levels of 
leukocytes infiltrating the uterus and foetal membranes at the time of labour85, 97, 101.  It is well 
documented that inflammation instigated by infection induces labour. In humans a high incidence of 
PTL is associated with evidence of microbial colonisation of the amniotic fluid, subclinical intrauterine 
infection, pyelonephritis, pneumonia and periodontal disease159, 177. Furthermore in animal models, 
the administration of microbes or microbial products consistently induces PTL178-181.  
Infection regardless of the route of exposure is closely association with PTL, a systemic or localised 
(intrauterine or intraamniotic) infection can activate pathways which ultimately result in the preterm 
delivery of the foetus159. Toll-like receptors (TLRs) are type I transmembrane proteins which when 
activated during pregnancy by pathogen-associated molecular patterns (PAMPs) result in the 
activation of inflammatory cascades which initiate transcription factor mediated release of cytokines, 
chemokines, prostaglandins and pro-labour genes (Fig.1.1.)89, 182-184. In non-infected women, 
expression of TLR-2 and TLR-4 mRNA has been shown to be significantly higher in term myometrial 
samples compared to those collected from earlier on in gestation and mRNA expression is further 
upregulated in term labouring samples185. Likewise, levels of IL-1, IL-6 and TNF-α were found to be 
increased in the amniotic fluid of women in PTL with evidence of an intraamniotic infection, 
furthermore levels of each of these cytokines were increased during term labour as opposed to term 
not in labour samples186-191. These observations together strongly suggest that infection-induced PTL 
could be as a result of premature activation of the normal inflammatory cascades activated at term.  
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Figure 1.1. The infection induced PTL pathway. PAMPS act through multiple TLRs to initiate inflammatory 
signalling cascades regulated by transcriptions factors which result in the up regulation of genes encoding 
cytokines and other pro-labour factors89, 192-194. 
 
1.4.2.1 Animal models of inflammation-induced PTB 
Animal models are used to pin-point specific mechanisms involved in the premature onset of 
parturition. The onset of contractions in animals is difficult to determine therefore in studies 
investigating PTL in animal models, time to delivery is used to evaluate if an agent successfully induces 
PTL. Live bacteria or bacterial wall components such as lipopolysaccharide (LPS) are used as 
standardised methods to mimic infection induced PTB.  There are two main models of infection-
induced PTL, systemic and local, and these are based on the route of administration of the infectious 
agent. The systemic model of infection is produced by intraperitoneal or intravascular administration 
of LPS, live bacteria or the gram-positive bacterial component lipoteichoic acid (LTA). These models 
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are used to mimic clinical incidences of sepsis or bacteraemia which are associated with pneumonia195 
or pyelonephritis196 during pregnancy. There is considerable variability between systemic doses of 
inflammatory agents needed to induce PTB between species, strains of animals and between groups 
performing the experiments178.  Different variations of these routes and types of inflammatory stimuli 
result in PTB in rats, mice, sheep, rabbits and Rhesus monkeys178.  Currently the intraperitoneal route 
is the most widely used and can reliably induce PTB within 24 hours, while the intravenous route of 
administration is less well defined178.  
For the local model of infection-induced PTL, injection of microbial agents is via the intrauterine, 
intraminiotic or intracervical routes.  One of the most commonly used and potent methods for 
inducing PTL is the localised method of intrauterine administration of LPS. Hirsch and colleagues first 
developed a model of intrauterine infection by the administration of Escherichia coli into the uterine 
horn which consistently resulted in PTB197. This method was later adapted by Elovitz et al. with the 
use of LPS and involved performing a laparotomy, excising the uterine horn and injecting with 250µg 
LPS which resulted in 100% PTB within 24 hours179. Girardi and colleagues have demonstrated that 
250µg of LPS given via an intravaginal infusion also results in PTB within 36 hours198.   
The importance of the TLR4-chemokine system is demonstrated by the failure of gram negative 
bacteria to consistently induce PTB in TLR-4 functionally deficient mice and in wild type mice after 
blocking chemokine receptors with a broad spectrum chemokine inhibitor,BN83470 a peptide based 
on the sequence of CCL2 which was reported to act by blocking CCR2 and CCR5 199, 200. Downstream 
from TLR activation direct stimulation with the pro-inflammatory cytokines IL-1 and TNF-α can induce 
PTB201, 202 while the anti-inflammatory cytokines IL-10 has been shown to prevent LPS induced PTB93, 
203, 204.  
Delaying infection induced PTB with the use of knockout mice, cytokine inhibitors, prostaglandin 
synthesis inhibitors or with the administration of anti-inflammatory cytokines gives a useful insight 
into the mechanisms involved in the onset of parturition. In an attempt to inhibit the inflammatory 
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pathways associated with infection induced PTL anti-microbial therapy has been used as a possible 
treatment for women at risk of premature labour. When anti-microbial therapy has been used to treat 
patients that are already presenting with signs of labour it is mostly ineffective in preventing PTB205, 
206. The futility is likely to be because the processes involved in the onset of parturition cannot be 
reversed once initiated. Recently it has been proposed that anti-microbial therapy could be used in 
combination with cytokine suppressive anti-inflammatory drugs (CSAIDs) such as TAK1 or IKK complex 
inhibitors which target the signalling molecules involved in the p38 MAPK and NF-κβ signalling 
pathways193. The challenge with CSAIDs is to avoid off-target side effects which could have far reaching 
consequences for both the mother and the foetus. 
1.5 Conclusions 
There is a very large body of data implicating Ly-6Chigh monocytes in the induction and resolution of 
sterile tissue inflammation207 but their role in pregnancy has only recently begun to emerge130. A 
central mechanism regulating their recruitment is based on their expression of CCR2, which results in 
preferential recruitment of this so called ‘inflammatory’ monocyte subset to injured or infected 
tissues.  Importantly, expression levels of the mRNA encoding CCL2, increase in the myometrium prior 
to and during labour and this has been demonstrated to be positively regulated by increasing stretch 
in the myometrium and negatively by the actions of P4208. Shynlova et al. hypothesised the action of 
CCL2 integrated the mechanical and endocrine signals to induce monocyte migration to the 
myometrium which contributes to inflammation and is therefore associated with labour onset208, 209. 
Conversely CCR2 deficient mice deliver healthy pups at term despite evidence that 
monocyte/macrophage cell densities in the myometrium are reduced at labour compared to wild-type 
mice210. It is important to consider that in chronic knockout mouse models compensatory mechanisms 
often develop211-213. So in this study we aimed to determine leukocyte trafficking dynamics locally to 
the uterus and systemically. We specifically investigated the period around preterm and term labour 
in the mouse to determine the role of leukocytes in the onset or progression of labour. The aim of this 
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study was to address these uncertainties and the unclear role of leukocyte infiltration of the 
myometrium in regulating labour onset. We set out to perform a systematic analysis of leukocyte 
trafficking locally to the uterus, and systemically within the blood and different vascular beds, prior to 
and around term and preterm labour in the mouse. Our particular focus was on the Ly-6Chigh monocyte 
subset, as its systemic and local trafficking has not yet been fully elucidated in pregnancy. To obtain a 
fuller picture of its function and that of other migrating and resident inflammatory leukocytes, we 
compared cell kinetics with inflammatory mediator production.  To establish a causal relationship 
between Ly-6Chigh monocyte infiltration and labour, we assessed the effect of both CCR2 genetic 
ablation and pharmacological blockade on normal and early labour onset times.  
 
 
 
 
1.6 Hypotheses 
1) The pro-inflammatory Ly-6Chigh monocyte subset is recruited to the uterus during late 
gestation in mice and plays an important regulatory role in inducing onset of labour. 
2) Enhanced trafficking of Ly-6Chigh monocytes to the uterus leads to a state of systemic 
inflammatory priming in pregnancy. 
3) Progesterone regulates Ly-6Chigh monocyte trafficking to the myometrium in a CCR2-
dependent fashion. 
4) In the localised i.u. LPS model of infection-induced PTL, Ly-6Chigh monocyte infiltration into the 
myometrium contributes to early labour onset. 
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1.7 Aims 
1) To quantify leukocyte subsets kinetics within the uterus, blood and systemic vascular beds 
during late gestation in the CD-1 mouse.  
2) In parallel to cell trafficking analysis, evaluate the local and systemic chemokine and cytokine 
levels in late gestation. 
3) Investigate the hormonal regulation of the myeloid leukocyte populations using P4 
supplementation and withdrawal during late gestation in CD-1 mice. 
4) Evaluate the myeloid leukocyte kinetics in the myometrium, blood and systemic vascular beds 
in i.u. LPS-induced PTL.   
5) Determine whether CCR2 regulates Ly-6Chigh monocyte trafficking to the myometrium in 
spontaneous, P4 withdrawal-induced and i.u. LPS induced PTL. 
 
 
 
 
 
 
 
 
Chapter 2  
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Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
2.1 Animals 
All animal work was performed under the UK Home Office Licences 70/7518 or 70/6906. Studies were 
performed in accordance with the Animals (Scientific Procedures) Act 1986, United Kingdom and had 
previously been reviewed and approved by the Home Office. Animals were housed in open cages at 
21 ± 1°C, on a 12:12 light/dark cycle, and were given ad libitum access to food and water. 
2.1.1 Mice 
CD-1 outbred mice were purchased from Charles River (Margate, UK) at 6-8 weeks of age and left to 
acclimatise for a minimum of 7 days before undergoing any regulated procedure or mating.  
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2.1.2 Knockout Mice  
Female CCR2 KO mice on a C57BL/6 background were purchased from the Jackson Laboratory 
(Margate, UK). To develop the KO mouse model on a CD-1 background, female KO mice (F0 
generation) were mated with CD-1 outbred males. Heterozygous pups (F1 generation) from different 
litters were mated together, producing a heterogeneous generation (F2 generation) (25% KO 50% 
heterozygous and 25% wild type litters). Genotyping was performed using ear clippings from the F2 
generation to identify the KO mice which were then interbred to expand the colony. 
2.1.3 Timed-Mating 
Female mice (CD-1 or CCR2 -/-) were mated overnight with CD-1 males and the day a copulatory plug 
was observed was designated embryonic day 0 (E0). CD-1 pregnant dams will usually deliver from the 
afternoon of E18 until the early hours of E19 if untreated. Post natal collections were all within 24 
hours of delivery.  
 
 
2.2 Mouse models of LPS induced PTB 
2.2.1 Intrauterine Injection (i.u.) of LPS  
A model of intrauterine infection was first developed by Hirsch et al. in 1995 197 this was later modified 
by Elovitz et al. using LPS 179. This model was established for use within our group 214 and further 
adapted for these studies. On E16, morphine analgesia (2.5mg/kg) was administered subcutaneously 
30 minutes prior to surgery and anaesthesia was induced and maintained using isoflurane.  The shaved 
abdomen was swabbed with providone iodine (Ecolab, St Paul, USA) and a 1.5cm incision was made 
in the lower abdomen and the uterine horns exteriorised and kept moist with sterile PBS (Sigma, St. 
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Louis, USA). Intrauterine injections were performed on the right uterine horn between the first and 
second upper foetus with care not to enter either amniotic cavity. A 10µg dose of Escherichia coli LPS 
serotype 0111:B4 (Sigma) in volume of 25µl or sterile PBS (25 µl) were injected to form a bleb. The 
number of live foetuses per horn was noted. The peritoneal wall was closed with a continuous suture 
and a simple interrupted suture used to close the skin incision (MidMeds, Broxbourne, UK). Mice 
recovered from surgery in a heating chamber set at 30°C for 30 minutes before being individually 
housed in separate cages. Labour was determined by the delivery of at least one pup. Preterm labour 
was defined by delivery of at least one pup up to 24 hours after LPS administration. 
2.2.2 Intraperitoneal Injection (i.p.) of LPS 
For all injection procedures mice were anaesthetised briefly with isoflurane so that an intraperitoneal 
injection could be performed without risk of injecting the uterus and for greater accuracy in the 
subcutaneous injections due to the viscous nature of the peanut oil vehicle used for P4 administration. 
On E16 pregnant dams were injected i.p. with 10µg of E. coli LPS serotype 0111:B4 in a total volume 
of 100µl sterile PBS of or sterile PBS (100 µl) alone. 
2.3 Pharmacological treatments 
Progesterone (P4) supplementation, a 2mg dose of P4 (Sigma) was administered by injection of 40µl of 
50mg/ml P4 dissolved in peanut oil (Sigma) or peanut oil alone injected subcutaneously from E14 and 
continued daily until the day of tissue collection.  To simulate P4 withdrawal a 150µg dose of 
mifepristone/RU486 (Sigma) was administered by injection of 20µl of 7.5mg/ml RU486 in DMSO 
(Sigma) or DMSO alone injected subcutaneously on E16. CCR2 antagonist administration 10mg of the 
highly selective CCR2 antagonist RS504393 (Abcam, Cambridge, UK) was dissolved in DMSO at a 
concentration of 4mg/ml (10mM). To obtain a final concentration of 2mg/kg for in vivo administration 
the 4mg/ml stock was diluted 1:20 with PBS so that DMSO concentration was reduced to 5%. 
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RS504393 was administered via an oral gavage, this dose and was selected based on CCR2 blockade 
experiments by Furuichi et al. and Kitagawa et al215, 216.  
2.4 In vivo leukocyte trafficking  
For labelling of intravascular leukocytes, anti-CD45 antibody conjugated with phycoerythrin (PE) 
fluorophore (Biolegend, San Diego, USA) (2µg in 200l) was injected intravenously (i.v.), the mouse 
was left for 5 minutes before terminal anaesthesia, exsanguination by cardiac puncture and tissue 
collection (see below).  To label dividing cells in vivo, a BrdU i.p. injection of 100µl 10mg/ml BrdU in 
sterile 1x DPBS was given (BD Pharmingen, New Jersey, USA). BrdU was injected at approximately 24 
hours prior to collection of tissues. In brief tissues and blood were fixed and permeabilised. Cell 
suspensions were incubated with DNAse to expose incorporated BrdU, then stained with leukocyte 
identifying antibodies including APC-antiBrdU clone 3D4 before FACS analysis. 
2.5 Mouse tissue collection and processing 
Mice were culled via terminal anaesthesia and exsanguination by cardiac puncture. Whole blood for 
FACS analysis was immediately mixed with 5mM EDTA after cardiac puncture and stored at 4°C until 
analysis within 12 hours. For plasma collection, whole blood was centrifuged immediately at 1000x g 
for 10 minutes and snap frozen on dry ice. For serum collection whole blood was allowed to clot for 
30 minutes at room temperature and centrifuged at 2000 x g for 20 minutes and snap frozen on dry 
ice. 
The mouse uterus consists of two lateral uterine horns, as opposed a single uterine fundus in humans 
(Fig.2.1.). Each uterine horn was cut longitudinally and foetuses, amniotic sacs and placentas were 
removed from the decidua basalis. A longitudinal strip containing the decidua was cut from the 
myometrium, the individual decidual plaques were cut from this strip. Longitudinal strips from each 
uterine horn were combined for FACS analysis. Placentas were cut in half and combined with other 
segments from a range of foetuses. The lungs and sections of liver were briefly blotted on tissue paper 
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to remove excess blood, samples were either flash frozen for PCR, Western blotting or chemokine and 
cytokine assays or processed immediately for FACS analysis. 
Figure 2.1. Diagram of the bicornuate structure of the pregnant mouse uterus with a second diagram depicting 
the traverse section of one uterine horn. 
 
 
 
 
 
2.5.1 Preparation of single cell suspensions for flow cytometry 
Samples of lung, liver, myometrium, placenta and decidua were weighed immediately after collection. 
Approximately 0.2g of tissue was processed for FACS using an adapted method previously published 
by our group217. Tissue samples were finely minced with scissors and added to a gentleMACS M tube 
(Miltenyi Biotec Ltd, Cologne, Germany) containing 1ml of IC fixation buffer (eBioscience, San Diego, 
USA) and homogenised for 1 minute on the spleen 01 setting. 5ml of FACS Wash Buffer (FWB) (1x 
PBS,FCS 2% Sodium Azide 0.1% 2mM EDTA) was then added to the tube to stop fixation and the 
homogenate was then passed through a 40µm nylon cell strainer (BD Falcon, Bedford, USA), and  the 
cell suspension was then centrifuged at 400xg for 5 minutes. Cells were then washed twice and 
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resuspended in FWB for transportation between laboratory sites. Prior to cell staining protocol, cell 
suspensions were centrifuged at 400xg for 5 minutes and the cell pellet was resuspended in  400µl 
permeabilising wash buffer (PWB) (1x PBS, 0.1% Sodium Azide, 0.5% BSA and 0.2% Saponin).  The 
volume of the cell suspension was measured using a pipette and noted. 
2.5.1.1 Enzymatic Tissue Digestion using Liberase 
Liberase (Roche, Basel, Switzerland) is a mixture of collagenase and protease enzymes used to digest 
the collagen fibres in tissue. Comparing cell yields using collagenase type IV (Sigma) alone or liberase 
treatments, Liberase was found to give the highest cell recoveries. Liberase and DNAse (Roche) were 
made up to a concentration of 100µg/ml and 200µg/ml (respectively) of PBS + 0.1g/l MgCl2 + 0.133g/l 
CaCl2 (Sigma). In 5ml of Liberase mix, up to 0.2g of tissue was weighed and the weight noted. The 
tissue was then chopped using two scalpel blades (Swann Morton, Sheffield, UK) and added to the 
liberase mix to be incubated at 37°C on a rotator for a maximum of 1 hour. At 15 minute intervals the 
tissue suspension was rigorously shaken. 5ml of FWB was added to stop the action of the enzymes 
and the cell suspension was then strained through a 40µm nylon cell strainer (BD Falcon), and 
centrifuged at 400xg for 5 minutes. Cells were then washed twice and resuspended in 400µl FWB.  
 
2.5.1.2 Apoptotic cell staining in cell suspensions  
For identification and analysis of apoptotic cells in tissues I used the APO-BrdU TUNEL Assay Kit 
(Invitrogen, Carlsbad, USA). Approximately 0.2g of myometrium and decidua were finely chopped 
using scissors and added to a gentleMACS M tube containing 1ml of IC fixation buffer and 
homogenised 2 x on the spleen 01 setting for a total fixation time of 5 minutes. Cells were washed and 
transported as above. Cells were incubated with antibody panel 9 prior to permeablisation with 
ethanol. This allows the BrdUTP to access and label the 3´hydroxyl ends of DNA strands that have been 
cleaved or nicked by nucleases during apoptosis. BrdU is incorporated into the DNA and detected 
using an anti-BrdU antibody and analysed using flow cytometry. 
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2.6 Antibody staining of cell suspensions for flow cytometry  
Volumes of 50µl of either whole blood or washed cell suspensions were incubated with 50µl of 
antibody cocktail (in FWB for unfixed samples or PWB for fixed samples) at twice the working dilution. 
Samples were vortexed gently and incubated at 4°C in the dark for 30 min. After staining, cells were 
washed in either FWB (unfixed samples) or PWB (fixed samples). Whole blood and Liberase prepared 
cell suspensions were treated with FACS lysing solution (BD Biosciences, San Jose, USA) to lyse 
erythrocytes and fix cells.  Cell counts were determined by adding 20µl of AccuCheck counting beads 
(Invitrogen) to each FACS tube. Samples were run using CyAn ADP Beckman Coulter flow cytometer 
and Cell Quest 3.3 software. Data was analysed using FlowJo version 7.6.5 (FlowJo LLC, Ashland, USA). 
2.6.1 Antibody staining panels for flow cytometry 
The tables below show information on the combinations of antibodies used for FACS analysis of blood 
and tissue samples. Panels 1-5 show the antibody combinations used to calculate cell counts. Panel 6 
was used for CD45 compartment staining to identify intravascular leukocyte populations. Panel 7 was 
used to identify apoptotic monocytes/macrophages in the myometrium.  
Table 2.1. Antibody staining panels 1-3 
Channel Antibody Panel 
 
1. FITC Ly-6C (HK1.4) (BioLegend cat#128021) 1,2,3 
 2.PE IgG2a K Isotype Control (eBR2a) (eBioscience cat#12-
4321) 
 
COX-2 (M-19) (Santa Cruz Biotechnology, Dallas, USA 
cat#sc-1747) 
 
CD86 (B7-2) (eBioscience cat#120862) 
1 
 
2 
 
3 
4.PerCp Gr1 (RB6-8C5) (BioLegend cat#108426) 1,2,3 
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5.PeCy7 CD45(30-F11) (BioLegend cat#103110) 1,2,3 
8.APC/Ax647 F4/80 (BM8)  (eBioscience cat#123116) 1,2,3 
9. Ax780 CD11b (M1/70) (eBioscience cat#47-0112) 1,2,3 
 
Table 2.2. Antibody staining panel 4 
Channel Antibody 
1. FITC Ly-6C (HK1.4) (BioLegend) 
 2.PE F4/80 (BM8) (BioLegend cat#123110) 
 
4.PerCp Gr1 (RB6-8C5) (BioLegend) 
5.PeCy7 NK1.1 (PK136) (BioLegend cat#108714) 
8.APC/Ax647 MHCII (AMS-32.1) (eBioscience cat# 17-5323-82) 
9. Ax780 CD11b (M1/70) (eBioscience) 
 
Table 2.3. Antibody staining panel 5 
Channel Antibody 
1. FITC Ly-6C (HK1.4) (BioLegend) 
 2.PE F4/80 (CI:A3-1)  (BioLegend) 
 
 3.PE-CF594 CD11b (M1/70) (BD biosciences cat#553311) 
4.PerCp Gr1 (RB6-8C5) (BioLegend ) 
5.PeCy7 NK1.1 (PK136) (BioLegend) 
8.APC/Ax647 MHCII (AMS-32.1) (eBioscience) 
9. Ax780 CD11c (N418) (eBioscience cat#25-0114) 
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Table 2.4. Antibody staining panel 6  
Channel Antibody 
1. FITC Ly-6C (HK1.4) (BioLegend ) 
 2.PE i.v. injection of CD45 (30F11) (eBioscience cat#12-
0451-81) 
4.PerCp Gr1 (RB6-8C5) (BioLegend) 
5.PeCy7 F4/80 (BM8) (Biolegend) 
8.APC/Ax647 MHCII (AMS-32.1) (eBioscience) 
9. Ax780 CD11b (M1/70) (eBioscience) 
 
Table 2.5. Antibody staining panel 7  
8.APC/Ax647 F4/80 (BM8)  (eBioscience) 
9. Ax780 CD11b (M1/70) (eBioscience) 
2.6.2 Leukocyte identification by flow cytometry 
Cell counts were determined by flow cytometry with the addition of Accucheck microsphere counting 
beads (Invitrogen). Using FlowJo version 7.6.5 events with very low forward and side scatter levels 
were excluded from the analysis. To determine the geometric mean of COX-2 and CD86 expression by 
leukocyte populations, cells were stained in duplicate one using an isotype control (IC) antibody or 
either COX-2 or CD86 antibody. The geometric mean emitted by IC control cells was subtracted from 
COX-2 or CD86 stained cells. The treatment of all tissue samples involved permeabilising the cells, 
therefore expression of the cell markers will represent both intracellular and extracellular staining. 
This may mean that cells identified as Ly-6Chigh may not be expressing this antigen on the cell surface. 
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Table 2.6.  Leukocyte population gating strategy in each tissue 
 Blood Lungs Liver Myometrium Placenta Decidua 
Ly-6Chigh 
Monocytes 
SSlow 
CD11b+ 
Ly-6G- 
NK1.1- 
F4/80- 
Ly-6Chigh 
and 
MHCIIlow 
CD11b+, Ly-
6G-, NK1.1-, 
F4/80-, Ly-
6Chigh and 
MHCIIlow 
CD11b+, 
Ly-6G-, 
NK1.1-, 
F4/80 
med/neg Ly-
6Chigh and 
MHCIIlo 
CD11b+ Ly-
6G- F4/80med 
Ly-6Chigh 
SSlow, 
CD11b+, 
Ly-6G-, 
NK1.1-, 
F4/80 
med/neg Ly-
6Chigh  
CD11b+ 
Ly-6G- 
F4/80med 
Ly-6Chigh 
 
 
 
Ly-6Clow 
Monocytes 
SSlow 
CD11b+ 
Ly-6G- 
NK1.1- 
F4/80- 
Ly-6Clow 
and 
MHCIIlow 
CD11b+, Ly-
6G-, NK1.1-, 
F4/80-, Ly-
6Clow and 
MHCIIlow 
CD11b+, 
Ly-6G-, 
NK1.1-, 
F4/80 
med/neg Ly-
6Clow and 
MHCIIlow 
CD11b+ Ly-
6G- F4/80low 
Ly-6Clow 
SSlow, 
CD11b+, 
Ly-6G-, 
NK1.1-, 
F4/80 
med/neg Ly-
6Clow 
CD11b+ 
Ly-6G- 
F4/80med 
Ly-6Clow 
Neutrophils SShigh 
CD11b+ 
Ly-6G+ 
CD11b+, Ly-
6G+ and 
NK1.1- 
CD11b+, 
Ly-6G+, 
NK1.1- 
CD11b+ Ly-
6G+ 
SSlow, 
CD11b+, 
Ly-6G+, 
NK1.1- 
CD11b+ 
Ly-6G+ 
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Macrophages       - (Interstitial 
Monocytes)  
CD11b+, Ly-
6G-, NK1.1-, 
F4/80-, Ly-
6Clow and 
MHCIIhigh 
       - CD11b+ Ly-
6G- F4/80high 
Ly-6Clow 
SShigh, 
CD11b+, 
Ly-6G-,  
NK1.1-
F4/80+ 
CD11b+ 
Ly-6G- 
F4/80high 
Ly-6Clow 
2.7 Cell density and counts calculations 
2.7.1 Cells/g Calculation 
= (Cell count/bead count) x (volume of beads µl /volume of cells µl) x Accucheck bead microspheres/μl 
x (1/weight) x volume cell suspension 
2.7.2 Cells/ml Calculation 
= (Cell count/bead count) x (volume of beads µl /volume of cells µl) x Accucheck bead microspheres/μl 
x 1000 
 
 
2.8 Quantitative RT-PCR Analysis 
Total RNA was extracted from tissue using RNeasy kit and Qiashredder (Qiagen Ltd, Hilden, Germany).  
The concentration of RNA in each sample was measured by NanoDrop (Thermo Scientific, Waltham, 
USA). RNA, standardised to a total of 1.0µg total per reaction was used for cDNA synthesis. Primer 
sets were designed and obtained from Invitrogen. Quantitative PCR was performed in the presence of 
SYBR Green (Roche) and amplicon yield was monitored by Rotor Gene R-G 3000 (Corbett Research, 
Hilden, Germany). Data for each gene of interest was fitted to a standard curve of known 
concentration (measured in pg/μl) using the Rotor Gene R-G 3000 software and the data normalised 
according to the mass of the amplicon. The PCR data for each gene of interest was then expressed as 
a ratio to the housekeeping genes Gapdh, Actb and Hprt. 
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Table 2.7. Mouse qPCR primers 
Mouse gene Forward (F) and Reverse (R) primer 
sequences (5’-3’) 
Genebank/EMBL 
Accession no. 
PCR product 
size (bp) 
Gapdh F:5’ACTCCACTCACGGCAAATTC-3’ 
R:5’TCTCCATGGTGGTGAAGACA-3’ 
NM_008084.3 171 
Actb F:5’ AGGCTGTGCTGTCCCTGTAT -3’ 
R:5’ GCTGTGGTGGTGAAGCTGTA -3’ 
NM_007393.4 202 
 
Hprt F:5’GCTTACCTCACTGCTTTCCG -3’ 
R:5’ CATCGCTAATCACGACGCTGG -3’ 
NM_013556 126 
Ccl2 F:5’CCCACTCACCTGCTGCTACT-3’ 
R:5’TCTGGACCCATTCCTTCTTG-3’ 
NM_011333 164 
Ccr2 F:5’GAGGGCATTGGATTCACCACA-3’ 
R:5’ GCCGTGGATGAACTGAGGTA -3’ 
NM_009915 108 
Ccl5 F:5’CCCTCACCATCATCCTCACT-3’ 
R:5’CCTTCGAGTGACAAACACGA-3’ 
NM_013653 185 
Ccl20 F:5’CGACTGTTGCCTCTCGTACA-3’ 
R:5’CACCCAGTTCTGCTTTGGAT-3’ 
NM_016960 157 
Cxcl1 F:5’GCCTATCGCCAATGAGCTG-3’ 
R:5’AAGGGAGCTTCAGGGTCAAG-3’ 
NM_008176 171 
Cxcl2 F:5’CTGACCTGGAAAGGAGGAGC -3’ 
R:5’ GGCACATCAGGTACGATCCA -3’ 
NM_009140 106 
 
Cx3cl1 F:5’CGGCATGACGAAATGCGAAA-3’ 
R:5’ TGTCGTCTCCAGGACAATGG -3’ 
NM_009142 124 
Cxcl5 F:5’CGCTAATTTGGAGGTGATCC-3’ NM_009141 167 
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R:5’GTGCATTCCGCTTAGCTTTC-3’ 
Il1b F:5’CAGGCAGGCAGTATCACTCA-3’ 
R:5’AGCTCATATGGGTCCGACAG-3’ 
NM_008361 250 
Tnf F:5’TATGGCTCAGGGTCCAACTC-3’ 
R:5’CTCCCTTTGCAGAACTCAGG-3’ 
 NM_013693 174 
Il6 F:5’CCGGAGAGGAGACTTCACAG-3’ 
R:5’TTCTGCAAGTGCATCATCGT-3’ 
NM_031168 166 
Ifng F:5’ACGGCACAGTCATTGAAAGC-3’ 
R:5’ TCACCATCCTTTTGCCAGTTC-3’ 
NM_008337 118 
Il1a F:5’TACTCGTCGGGAGGAGACGA -3’ 
R:5’ GGTGTTTCTGGCAACTCCTTC -3’ 
NM_010554 122 
Gja1 (Cx43) F:5’GCGTGAGGGAAGTACCCAAC-3’ 
R:5’ CTGGGCACCTCTCTTTCACTTA -3’ 
NM_010288 156 
Adgre1 (F4/80) F:5’CCATCCACTTCCAAGATGGGTTA-3’ 
R:5’TGCCATCAACTCATGATACCCT -3’ 
NM_010130 145 
Ly6c2 F:5’TGGACAGTACTCACGCTACA-3’ 
R:5’ TCCATAGCACTCGTAGCACTG -3’ 
NM_001099217 101 
Ngp F:5’GTCCTGCCCACATCAGTTCA -3’ 
R:5’ GGAGGCCCAGCTGTGAATAG -3’ 
NM_008694 101 
Csf1 F:5’TGGCTTGGCTTGGGATGATT -3’ 
R:5’ GTCTGTCCCCATGGTTTGGT -3’ 
NM_007778 161 
Csf1r F:5’ GCAGTACCACCATCCACTTGTA-3’ 
R:5’ GTGAGACACTGTCCTTCAGTGC -3’ 
NM_001037859 141 
Csf3 (G-CSF) 
 
F:5’ AGGTCTCCTGCAGGCTCTAT-3’ 
R:5’ CCCCTAGGTTTTCCATCTGCT-3’ 
NM_009971.1 119 
Ptgs2 (COX-2) F:5’TGCAGAATTGAAAGCCCTCT-3’ 
R:5’GCTCGGCTTTCCAAGTATTGAG-3’ 
NM_011198 
 
 
 
2.9 Protein analysis 
2.9.1 Multiplex Assay 
Tissue lysates were prepared using snap-frozen myometrium and lung samples in Bio-Plex Cell Lysis 
buffer (BIO-RAD, Hercules, USA) and a Precellys®24 (Stretton Scientific Ltd, Stretton, UK) homogeniser. 
Total protein concentrations were quantified using a Bradford assay (BIO-RAD). The Bio-Plex Pro 
Mouse Cytokine Assay was used to calculate cytokine concentrations in the samples (BIO-RAD). 
Cytokines measured included; IL-1α, IL-1β, IL-6, IL-10, IL-12p40, IL-12p70, G-CSF, IFN-γ, KC/CXCL1, 
MCP-1/CCL2, RANTES/CCL5 and TNF-α. 25µl of plasma and 250-500µg of total protein was added to 
the assay.   
2.9.2 Western blotting 
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Tissue lysates were prepared using snap frozen myometrium in Bio-Plex Cell Lysis buffer (BIO-RAD) 
and a Precellys®24 (Stretton Scientific Ltd) homogeniser. Total protein concentrations were quantified 
using a Bradford assay (BIO-RAD). Dithiothreitol (DTT) was added to the protein samples to a final 
concentration of 40mM. 20µg of protein samples were denatured in SDS loading buffer (Invitrogen) 
heated to 95°C for 10 minutes and added to each well on a pre-cast gel (Invitrogen). 
Electrophoretically-separated proteins were transferred onto a Hybond ECL nitrocellulose membrane 
(Amersham Pharmacia Biotech, Amersham, UK) using an electrophoresis transfer system (BIO-RAD). 
The membranes were activated in methanol and blocked in washing buffer (5M NaCl, Tris-HCl and 
Tween) containing 5% milk (Marvel) for 1 hour at room temperature. The membrane was incubated 
with the primary antibodies Cx43 (Cell Signalling Technologies, Massachusetts, USA cat#3512) or COX-
2  (Santa Cruz Biotechnology, cat#1745), overnight at 4°C, washed, and then incubated with secondary 
antibody for 1 hour at room temperature.  The protein was detected using SuperSignal West Pico 
Chemiluminescent Substrate (Pierce, Waltham, USA).  Band Intensity was analysed using ImageQuant 
7.0.(GE Healthcare Life Sciences, Amersham, UK). The band intensity of the proteins of interest were 
normalised against the band intensity of the housekeeping protein GAPDH.  
2.10 Statistical Analysis 
All data were tested for normality using a Kolmogorov-Smirnoff test. Normally distributed data were 
analysed using a Student t test for 2 groups or an analysis of variance (ANOVA) followed by a 
Bonferroni post hoc test for 3 groups or more. Data that were not normally distributed were analysed 
using a Mann Whitney test for unpaired data and when comparing 3 groups or more a Kruskal-Wallis 
test, with a Dunn’s Multiple Comparisons post hoc test. A p value of <0.05 was considered statistically 
significant. 
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Chapter 3 
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Local and Systemic Leukocyte Dynamics 
in Late Gestation and Labour 
 
 
 
 
 
 
 
 
 
3.1 Introduction 
The mononuclear phagocyte system (MPS) is comprised of monocytes, macrophages and dendritic 
cells linked by their common lineage. The original system described a simple cascade beginning with 
the bone marrow precursor cells and promonocytes developing into monocytes which circulate in the 
blood and contributed to tissue macrophage populations218. There is also evidence that resident tissue 
macrophages can proliferate in situ or be derived from embryonic precursors within the tissues219 122. 
MPS cells are highly plastic and adaptable. Depending on their milieu, their roles include maintaining 
homeostasis, by phagocytising apoptotic bodies, remodelling and repairing tissue as well as 
responding to pathogens by generating inflammatory or anti-inflammatory reactions. Their 
specialised nature often means these cells acquire tissue-specific nomenclature such as Kupffer cells 
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(liver), migroglia (brain), osteoclasts (bone), or Langerhans cells (skin). Furthermore, these specialised 
roles can be modified appropriately in response to infection or injury 220. 
Due to cyclic changes throughout the oestrous cycle and the dramatic expansion of the organ 
following conception, the MPS is likely to display a highly diverse repertoire of functions in the uterus. 
In addition to assisting with foetal growth, the MPS must ensure adequate responses to pathogens 
while avoiding an excessive inflammatory response that could harm the foetus. Moreover, the 
myometrium, which remains quiescent throughout pregnancy, undergoes a shift in activity at labour 
when it transforms into a contractile organ with enhanced inflammatory activity221. In the postnatal 
period, the uterus undergoes remodelling, during which macrophages contribute to collagen 
phagocytosis and degradation222.  
The uterine macrophage population has also been shown to increase in density during pregnancy 100, 
223, and, due to its abundance as a resident population and further expansion during labour, this 
population may have a central role in the regulation of labour97, 101, 128. As pregnancy advances the 
myometrium is also infiltrated by increasing numbers of monocytes, dendritic cells and neutrophils 
via distinct mechanisms. These cells, in addition to their immune roles, may modulate pregnancy 
outcome by influencing myometrial function 44.   The expansion of myeloid cells, not just in the uterus, 
but also in the cervix and foetal membranes around the time of labour with and without the presence 
of infection, has contributed to the concept that labour is an inflammatory process85, 86, 97, 100, 101, 224-226. 
Indeed, the increased levels of pro-inflammatory cytokines and matrix metalloproteinase in the 
uterus, cervix and foetal membranes have been suggested to be released by the macrophage and 
neutrophil populations26.  
Murine monocytes exists as at least two phenotypically and functionally distinct subsets, distinguished 
by levels of the surface marker Ly-6C. The Ly-6Chigh subset has been shown to be preferentially 
recruited to sites of inflammation in various models of infection and inflammation models113, 114, 227. It 
has been demonstrated that the uterus actively recruits the ‘inflammatory’ Ly-6Chigh subset rather 
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than the ‘resident’ Ly-6Clow subset with advancing gestation 130. Monocytes and macrophages have 
not been distinguished from one another in studies investigating leukocyte infiltration into the uterus 
around the time of labour. Discriminating between these populations in the pregnant uterus may lead 
to a clarification of their relative contributions to the regulation of pregnancy and/or labour.  
An increase in monocyte and neutrophil numbers have been reported in the circulation of labouring 
women compared to women at term, while the activation status of the systemic monocyte population 
has been found to increase during pregnancy 13, 14, 53, 54, 105. This enhanced systemic inflammatory state 
during pregnancy has been investigated in relation to pre-eclampsia, a condition which is associated 
with an exaggerated maternal inflammatory response 228. However the coordination between the 
uterine and systemic vascular pools of leukocytes has not been investigated prior to labour onset.  
The majority of studies that quantified leukocyte populations in tissues used histological analysis85, 97, 
224, and when flow cytometry has been used to determine the presence of leukocytes in the 
myometrium and cervix, the data have been expressed as a percentage of either live cells or CD45+ 
cells100, 225.  Quantifying cell populations in this way could be misleading as the numbers of CD45 
positive cells could fluctuate and expressing the data relative to the number of live cells does not take 
into account the growth of the uterus. Consequently, in this study, we aimed to develop a robust 
methodology to calculate cell density. Further, leukocyte trafficking dynamics systemically was 
assessed by measuring circulating numbers in the blood and marginated within the microvasculature 
in the lungs229. By investigating cell numbers systemically this addressed the question of how the 
vascular pool of leukocytes is modified during pregnancy. Examining how systemic responses may 
regulate monocyte recruitment mechanisms to the uterus in late gestation by measuring systemic and 
myometrial chemokine and cytokine levels is also of importance. The dynamics of leukocyte 
populations marginated within the systemic microvasculature has not yet been investigated during 
pregnancy and so using a murine model of pregnancy will provide a novel insight into the global 
changes in leukocyte numbers. 
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In this study, the leukocyte populations and subsets were analysed in late gestation in a murine model 
of pregnancy and labour, not only in the uterus, but also systemically, to gain a global understanding 
of the response to pregnancy and labour and to lay the foundation for future work. 
 
 
 
 
 
 
 
 
 
 
3.2 Hypothesis 
Ly-6Chigh monocyte recruitment in the uterus increases during late gestation in the CD-1 mouse in 
association with changes in the systemic distribution of inflammatory cells.   
 
3.3 Aims 
1) To identify and quantify leukocyte subsets systemically and locally to the uterus during late 
gestation in the CD-1 mouse.  
2) To investigate the inflammatory leukocyte kinetics in the myometrium, blood and marginated 
pools in late gestation. 
3) Evaluate local and systemic chemokine and cytokine levels in late gestation. 
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3.4 Methods 
The lungs, liver, blood and uterus of CD-1 mice were collected from naïve virgin non-pregnant mice 
and from time-mated mice (mated overnight with the following day termed E0). In the pregnant mice, 
myometrium, decidua and placentas were also collected. For pregnant mice, samples were collected 
during the morning of E16, 17 and 18 and after the spontaneous delivery of at least one pup for the 
labouring samples usually in the evening of E18. Postnatal samples were all collected on the morning 
following labour. Leukocyte cell numbers and density in the tissues and blood were analysed using 
flow cytometry. Intravascular staining is a method used to discriminate between vascular or tissue 
leukocytes   230 116 130. Using this method mice were given an intravascular injection of 2µg anti-
leukocyte CD45 antibody conjugated to Phycoerythrin (PE) and culled after 5 minutes. The tissues 
were collected and processed for flow cytometry, cell populations which stained positive for PE were 
deemed as intravascular. 100% of the leukocyte populations in the blood were positive for CD45. 
Serum and myometrial samples were analysed using RT-PCR and bead arrays to determine the mRNA 
and protein expression of chemokines and cytokines.  
3.5 Results 
3.5.1 Characterising the growth of the uterus in CD-1 mice in late gestation 
The CD-1 female mouse is capable of producing a litter of over 20 pups. The non-pregnant uterus is 
approximately 0.1g in weight, and during gestation the size increases in proportion to the litter 
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number and can be up to 20 times its original weight. In order to calculate the average increase in the 
size of the uterus, the total weight was divided by the number of pups (Fig. 3.1.). Figure 3.1.C. shows 
that the weight of the uterus has a trend to increase from E16-E18. The weight of the uterus tended 
to decrease (per pup) in labour and the decrease became significant (p<0.05) for the post-partum 
samples compared to E18 samples.  
Figure 3.1. The size and weight of the CD-1 uterus in late gestation.  A) The total weight of the uterus B) The 
number of pups in the litter C) The weight of the uterus divided by the number of pups it held to measure the 
growth of the uterus in late gestation and the post-partum period. Data in C) was analysed using a One way 
ANOVA and Kruskal-Wallis with Dunns post-test as at least two sets of data were not normally distributed. 
p<0.05 n=3-6  
 
 
 
3.5.2 Flow cytometric analysis of mononuclear phagocytes and neutrophil 
populations during pregnancy in CD-1 mice  
The standard method for tissue digestion is to use an enzymatic digestion technique such as 
collagenase. However, as the collection of tissues in these studies would depend on the time of labour, 
we required the integrity of tissue homogenates to be preserved for up to 12 hours between collection 
and analysis. Furthermore, fixation of tissues is compatible with intracellular staining231 which would 
enable us to measure intracellular antigens such as COX-2.  A mechanical method of tissue 
homogenisation with subsequent fixation has been reported previously217, 232. Using this technique, 
we compared cell yield and preservation over 48 hours to tissue dissociation using an enzymatic 
technique (Fig. 3.2.). Mechanical digestion with fixation consistently produced the highest yield (Fig. 
3.2.A.) using the macrophage cell population (CD11b+ Ly-6G- F4/80high Ly-6Clow population see ‘gating 
in myometrium’ below) as an indicator. It was possible that a fixation method might adversely affect 
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antigen-specific antibody binding while increasing non-specific background noise as compared to 
enzymatic digestion, making the cell populations difficult to define using surface phenotypic markers. 
However, leukocyte subpopulations could be easily distinguished in the fixed samples, consistent with 
the previous validation of this method using lung tissue217. For the purposes of standardising the cell 
preparation method for intracellular and surface staining we used a standard Saponin permeablisation 
technique. As well as producing a greater yield and a more uniform stain of cells, fixation of tissue also 
ensured the preservation of the single cell suspensions as shown in Figure 3.2B. In view of the 
advantage offered by combined dissociation and fixation of samples for preservation, we used this 
method for the calculating cell densities in all mouse studies.  
Figure 3.2. Macrophage counts in enzymatic digestion vs. mechanical digestion with fixative. A) Myometrium 
from three mice, two late gestation and one non-pregnant,  was collected and single cell suspensions prepared 
either using an enzymatic method (collagenase) or a mechanical method (GentleMACS homogeniser) with tissue 
fixation using 4% paraformaldehyde (IC fixation buffer). B) Half of the uterus from a non-pregnant mouse was 
mechanically disassociated and fixed for either 1, 5 or 10 minutes the other half was digested using collagenase. 
Cell counts of the macrophage population were measured immediately, 24 and 48 hours after digestion. Cells 
were gated on SSlow, CD11b+, Ly-6G-, F4/80+ and cell density was compared. 
 
In non-pregnant mice, a single uterine horn was taken and, in pregnant mice, the decidua and cervix 
were removed leaving the myometrium to prepare single cell suspensions for flow cytometric analysis. 
Neutrophils in the myometrium were identified as CD11b+ Ly-6G+. In the non-pregnant CD-1 uterus, 
60% of the neutrophil population was extravascular whereas on the final day of gestation, E18, 93% 
were extravascular. Figure 3.3. shows a CD11b+ Ly-6G- F4/80high Ly-6Clow population present in both the 
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non-pregnant uterus and pregnant myometrium (Fig. 3.3A-D. R2). Using CD45 vascular compartment 
staining this population was found to be 99% extravascular, therefore we identified it as the resident 
myometrial macrophage population (Fig. 3.3F.).  In certain samples a CD11b+ Ly-6G- F4/80med Ly-6Chigh 
population is observed in the uterus and myometrium (Fig. 3.3B. and D. R1). Figure 3.3E. shows the 
two monocyte subsets in a sample of blood which has been fixed and treated in a similar manner to 
the myometrial cell suspensions. The staining pattern of the CD11b+ Ly-6G- F4/80med Ly-6Chigh 
population in the myometrium in figure 3.3D. corresponded to the Ly-6Chigh monocyte population in 
the blood, suggesting that the Ly-6Chigh population observed in the myometrium and uterus were 
blood derived Ly-6Chigh monocytes (Fig. 3.3.R1). Further to this, in the non-pregnant uterus this 
population ranged from 14-58% positive for anti-CD45 intravascular staining, whereas in pregnant 
mice, intravascular Ly-6Chigh cells represented only ~ 12% of the total Ly-6Chigh cells in the myometrium, 
suggesting increased extravasation or in situ proliferation of this blood monocyte-like population 
during late gestation. As with the Ly-6Chigh population another population was identified in the non-
pregnant uterus and myometrium in certain conditions that does not express Ly-6C and has lower 
levels of F4/80 expression than the resident macrophage population (Fig. 3.3.R3). This CD11b+ Ly-6G- 
F4/80low Ly-6Clow population was found to be mainly extravascular in both non-pregnant and pregnant 
myometrial tissue. Further evaluation of this population (data not shown) revealed this population 
expressed varying levels of CD11c and MHCII indicating some of these cells were likely to be a CD11b+ 
dendritic cell population233. The phenotypic characterisation of this population was not investigated 
further in this study, herein it will be termed the CD11b+ F4/80low population.   
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Figure 3.3. Leukocyte populations identified using flow cytometry in the uterus and myometrium. All gated on 
SSlow CD11b+ Ly-6G-. A) The uterus from a non-pregnant untreated mouse B) The uterus from a second non-
pregnant untreated mouse C) The myometrium from an untreated pregnant mouse on gestation day 16 D) The 
myometrium from a pregnant mouse on gestation day 16, 6 hours after an i.p. LPS injection displaying an Ly-6C 
positive population E) Blood from untreated non-pregnant CD-1s was fixed and treated similarly as a myometrial 
single cell suspension showing the Ly-6Chigh monocyte population. R1-3 show the three distinct populations 
observed in the myometrium at various densities throughout gestation. F) Compartment localisation using CD45 
intravascular staining in the non-pregnant CD-1 uterus. The uterus was processed for flow cytometry, cell 
populations which showed positive staining in PE were deemed as intravascular. The values expressed are the 
mean percentages from 3 non-pregnant CD-1s. 
 
Siglec-1 is a type I transmembrane protein expressed on certain macrophage subpopulations, under 
normal conditions it is not expressed on circulating monocytes (Fig. 3.4A.). Figure 3.4B and C show the 
Siglec-1 expression of the macrophage and Ly-6Chigh population in the myometrium.  The majority of 
the resident macrophage population expressed Siglec-1 (Fig. 3.4B.). The percentage of the Ly-6Chigh 
population expressing Siglec-1 on E16, E17 and E18 and during labour was ~60% (Fig. 3.4C.).  
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Figure 3.4. Siglec-1 expression by the monocyte/macrophage population. A) Blood monocytes are negative for 
Siglec-1. B) Myometrial macrophages are predominantly Siglec-1 positive i) Two representative plots showing 
Siglec-1 expression on myometrial macrophage populations. C) Siglec-1 expression on the myometrial Ly-6Chigh 
population i) Two representative plots showing Siglec-1 expression Ly-6Chigh monocytes. Data are expressed as 
mean ±SD E16, E17, E18, labouring and postnatal cell densities were compared using a One-way ANOVA with 
Bonferroni post-test (*= p<0.05, **=p<0.01). n=5-6. 
3.5.3 Identification of blood and lung leukocyte subpopulations 
Leukocyte populations in the blood were identified using the antibody markers in Table 2.2. (Chapter 
2.6.1), forward and side scatter characteristics, and numbers quantified using AccuCheck counting 
beads. The gating strategy used is demonstrated in Figure 3.5. Neutrophil numbers were determined 
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based on their high side scatter and expression of the antigens CD11b and Ly-6G.  Monocytes were 
identified by their expression of CD11b, F4/80 and the absence of Ly-6G, NK1.1 and MHCII expression. 
The two monocyte subsets were identified using Ly-6C expression to differentiate between the Ly-
6Clow ‘resident’ and Ly-6Chigh “inflammatory” subsets108. Similarly, in the lungs the leukocyte 
populations could be identified based on their expression of the antibody markers in Table 2.2. 
(Chapter 2.6.1) the gating strategy used is demonstrated in Figure 3.6.  
 
 
Figure 3.5. Flow cytometry gating strategy used for the blood. A representative plot showing the neutrophil, 
NK cell and monocyte populations sorted using flow cytometry. Cell debris and platelets were excluded by 
forward and side scatter gating. 
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Three CD11b+, Ly-6G-, NK.1.1 -, F4/80+ populations were observed in the lungs of both pregnant and 
non-pregnant mice with varying levels of Ly-6C and MHCII (Fig. 3.6. R1-3). The location of these three 
populations was determined with the use of CD45 intravascular staining.  The neutrophil population 
in the non-pregnant lungs are mainly located in the vasculature as an average of 94% was positive for 
the CD45 antigen. The CD11b+, Ly-6G-, NK1.1-, F4/80-, Ly-6Chigh, MHCIIlow population shown in Figure 
3.6 R3 was 97% positive for the CD45 antigen, this population was identified as Ly-6Chigh monocytes 
which were marginated within the lungs microvasculature. The CD11b+, Ly-6G-, NK1.1-, F4/80-, Ly-
6Clow,MHCIIlow population  shown in Figure 3.6 R2  was identified as the Ly-6Clow monocyte subset  
slightly less of this population was intravascular compared to the Ly-6Chigh subset with 20% of the 
population not stained with intravascular CD45. Interestingly the CD11b+, Ly-6G-, NK1.1-, F4/80-, Ly-
6Clow and MHCIIhi subset (Fig. 3.6. R1) in the lungs was mainly an extravascular population and 
therefore will be termed the ‘interstitial population’. This population is not to be confused with the 
Alveolar Macrophage (AM) population, which is CD11b negative234. The AM population are not 
included in our analysis as our gating strategy was based on analysis of CD11b expressing cells in order 
to study the trafficking of cells from a myeloid lineage. 
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Figure 3.6. Flow cytometry gating strategy used for the lungs. A) The lungs from an untreated non-pregnant 
mouse B) The lungs from a pregnant untreated mouse on gestation day 16. Both lungs show 3 distinct 
populations when gated on SSlow CD11b+ Ly-6G- NK1.1- regions 1 to 3 (R1-3) C) Compartment localisation using 
CD45 intravascular staining in non-pregnant CD-1 mice lungs. Non-pregnant untreated mice were given an 
intravascular injection of 2µg anti-leukocyte CD45 antibody conjugated to PE and culled after 5 minutes. The 
lungs were processed for flow cytometry, cell populations which showed positive staining in PE were deemed 
as intravascular. The values expressed are the mean percentages from 3 non-pregnant CD-1s. 
3.5.4 Evaluation of mononuclear phagocyte dynamics during late gestation  
After identifying the cell populations in the mouse uterus, we next examined the mononuclear 
phagocyte population dynamics during late gestation. The macrophage population was the only 
leukocyte population that significantly increased in the myometrium on E16 compared to non-
pregnant cell densities (Fig. 3.7.). However, as the non-pregnant mice were at various stages of the 
oestrous cycle, this will have caused large variations in the cell densities of infiltrating leukocytes235 in 
the uterus, increasing the variability of the non-pregnant samples and so reducing any statistical 
significance. In Figure 3.7. it is important to note that macrophages are expressed per gram to account 
for the growing uterus during pregnancy. From these data in a non-pregnant uterus which weighs 
~0.1g there are ~3x105 macrophages while in an E16 uterus which weighs ~1.2g there are ~6x106 
macrophages. This significant increase in macrophage population size has been demonstrated in early 
pregnancy to be as a result of proliferation of resident macrophages and also by the recruitment of 
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monocytes to the growing myometrium130. In the blood, both Ly-6Chigh monocytes and neutrophils 
were increased on E16 compared to the non-pregnant values (Fig. 3.16.).  
 
Figure 3.7. Cell density of macrophages in the non-pregnant uterus and on E16 in the myometrium. Data are 
expressed as mean ±SD. Samples were analysed using an unpaired t-test. (*= p<0.05). n=10-14 
 
During late gestation, macrophages, Ly-6Chigh monocytes and neutrophils showed a tendency to 
increase in cell density in the myometrium prior to labour. Ly-6Chigh monocytes were significantly 
increased from E16 to E18 (p=<0.05) while neutrophils increased on E18 compared to E16 and E17 
(p=<0.001)(Fig. 3.8.). By contrast there appeared to be a decline in these three populations during 
labour compared to E18, which covered a period of 5-17 hours. This decrease was reversed in the 
postnatal period with the exception of the resident macrophage population which declined (Fig. 3.9.). 
Conversely the infiltrating leukocyte cell populations in the decidua were unchanged from E16 to 
labour (Fig. 3.10.) and during the postnatal period, the cell density of infiltrating myeloid leukocytes 
increased (Fig. 3.11.). This increased infiltration could be associated with a rapid remodelling of the 
decidua following labour. 
69 
 
 
 
Figure 3.8. Cell density of leukocytes in the myometrium of untreated pregnant mice in late gestation. Data 
are expressed as mean ±SD when normally distributed and when at least one data set was not normally 
distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers 
min to max). E16, E17 and E18 cell densities were compared using a One-way ANOVA with Bonferroni post-test 
when normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring samples 
were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. 
(*= p<0.05, **=p<0.01, *** = p<0.001). n=6-14 
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Figure 3.9. Cell density of leukocytes in the myometrium of untreated pregnant mice during labour and in the 
post-partum period. All data was normally distributed and expressed as mean ±SD. Labouring vs. post-natal 
samples were analysed using an unpaired t-test (*= p<0.05, **=p<0.01). n=6-14 
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Figure 3.10. Cell density of leukocytes in the decidua of untreated pregnant mice in late gestation. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
E16, E17 and E18 cell densities were compared using a One-way ANOVA with Bonferroni post-test when 
normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring samples were 
analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. n=6-
14 
72 
 
 
Figure 3.11. Cell density of leukocytes in the decidua of untreated pregnant mice during labour and in the 
post-partum period. Data are expressed as mean ±SD when normally distributed and when at least one data set 
was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Labouring vs. post natal samples were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when data was not. (*= p<0.05). n=6-14 
 We next investigated the possibility that increased levels of apoptosis were responsible for the 
decline in leukocyte cell density in the myometrium at labour, specifically in the macrophages as this 
is a resident population. Preliminary findings, using an APO-BrdU TUNEL assay kit (Invitrogen), 
suggested that the levels of apoptosis in the CD11b+ F4/80++ population in the myometrium fell from 
E18 to labour when the cell density of the macrophage population was decreased (Fig. 3.12.). This may 
mean that the process of apoptosis was on-going in the macrophages on day 18 and so may account 
for the decline in numbers observed on the day of labour (Fig. 3.8. and 3.12.). However these 
preliminary findings should be interpreted with caution as if 100% of myometrial macrophages were 
indeed in the process of apoptosis on E18 the macrophage cells at labour would be almost 
undetectable. 
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Figure 3.12. TUNEL staining on the CD11b+, F4/80++ population in the myometrium of untreated pregnant mice 
in late gestation. A) Data are expressed as scatter plots with mean ±SD. E18 vs. labouring samples were analysed 
using a Mann Whitney test as the data was not normally distributed. (*= p<0.05). B) E18 and C) labouring 
samples, histograms demonstrating the positive TUNEL stain of myometrial CD11b+, F4/80++ cells (Red histogram 
no anti-BrdU control, black with anti-BrdU demonstrating TUNEL staining) n=5-7 
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To determine if the reduction in macrophage cell density at labour was an anomaly related to our 
fixation methodology, we duplicated sample analysis to digest half the myometrium enzymatically 
using Liberase and half using the mechanical homogenisation with the fixation method used 
throughout the study.  There was a reduction in CD11b+ cells, albeit non-significant, from E18 to 
labour, which was not apparent in liberase prepared cell suspensions. This difference was also evident 
in the total cells recovered suggesting that the labouring myometrium may be more difficult to 
disaggregate cells from than in the non-labouring myometrium. However, numbers of cells recovered 
by the fix method still exceeded those from the liberase method by a factor of ~4. 
There was a trend in the myometrial samples that were fixed for cell density to decrease during labour, 
which was not observed in the Liberase treated sample (Fig. 3.13.). The ratio of CD11b+ cells to total 
cell counts (data not shown) remained constant from E16 through to the postnatal collection 
myometrial samples. Suggesting that the drop in cell density observed during labour may be a 
technique-related phenomenon associated with a physiological change in myometrium at labour. 
Importantly though there is certainly no increase in cell density of CD11b+ cells in the myometrium at 
labour.  
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Figure 3.13. Analysis of myometrial tissue disassociation on E18 and during labour. Data are expressed as 
scatter plots with mean ±SD. A and B) Total myometrial cell counts on E18 and during labour in A)fixed and 
homogenised samples B) enzymatically disassociated samples. C and D) All CD11b+ cells in the myometrium on 
E18 and during labour in C) fixed and homogenised samples D) enzymatically disassociated samples. n=5,4. 
 
To assess responses of the myometrial macrophage population we measured the relatively stable and 
functionally relevant markers MHCII, CD86 and COX-2.  Expression of all the myometrial macrophage 
activation markers was increased in the myometrium of mice on gestation day 16 compared to non-
pregnant values (Fig. 3.14.).  
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Figure 3.14. Macrophage expression of activation markers in the non-pregnant uterus and on E16 in 
the myometrium. Data are expressed as mean ±SD. Samples were analysed using an unpaired t-test. 
(**=p<0.01, *** = p<0.001). n=10-14 
 
The majority of resident macrophages in the non-pregnant uterus were found not to express the 
MHCII antigen (Fig. 3.14.), however there was a significant increase by E16 which remained constant 
until E18 with ~20-30% of the population expressing MHCII (p=<0.001,Fig. 3.14. and 3.15.). There was 
no increase in markers of activation with advancing gestation or the onset of labour, indeed, if 
anything there was a progressive decline.  
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Figure 3.15. Markers of activation by macrophages in the myometrium of untreated pregnant mice in late 
gestation. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). E16, E17 and E18 geometric mean values and the percentage of macrophages expressing 
MHCII were compared using a One-way ANOVA with Bonferroni post-test when normally distributed and a 
Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring samples were analysed using an unpaired 
t-test when normally distributed and a Mann Whitney test when data was not. (*= p<0.05, **=p<0.01). n=6-14 
78 
 
Having determined leukocyte trafficking to the myometrium and decidua during late gestation we 
next wanted to assess systemic mononuclear phagocyte population dynamics during late gestation. 
Ly-6Chigh monocytes and neutrophil numbers were increased in the circulation of mice on E16 
compared to the levels observed in non-pregnant mice (Fig. 3.16.). These results are similar to that 
described in human blood and are consistent with an up regulation of the innate immune responses 
during pregnancy.  
Figure 3.16. Cell numbers of leukocytes in the blood in non-pregnant and E16 pregnant mice. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
Samples were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data 
was not. (**=p<0.01). n=6-11 
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Figure 3.17. Cell numbers and density of leukocytes in the blood of untreated pregnant mice in late gestation. 
At least one data set was not normally distributed data in each graph so data were expressed as a box and 
whiskers plot (box 25th to 75th percentile with median, whiskers min to max). E16, E17 and E18 cell densities 
were compared using a One-way ANOVA with Bonferroni post-test when normally distributed and a Kruskal-
Wallis with Dunns post-test when it was not. E18 vs. labouring samples were analysed using an unpaired t-test 
when normally distributed and a Mann Whitney test when data was not. (*= p<0.05,). n=6-14 
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Figure 3.18. Cell counts of leukocytes in the circulation of untreated pregnant mice during labour and in the 
postnatal period. Data are expressed as mean ±SD when normally distributed and when at least one data set 
was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Labouring vs. post natal samples were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when the data were not. n=6-12 
 
In the days preceding delivery however there was no change in leukocyte numbers in the circulation 
of pregnant CD-1s (Fig. 3.17.). Likewise leukocyte cells counts in the circulation did not change from 
labour to the postnatal period (Fig. 3.18). Before the cell numbers could be ascertained, the location 
of the leukocyte populations in the tissues needed to be established using the same intravascular 
labelling method used in the myometrium. Examination of anti-CD45 antibody staining of blood 
leukocytes after i.v. injection confirmed the validity of this method for staining all cells in the 
intravascular compartment as 100% of circulating leukocytes were positive for the CD45 antibody (Fig. 
3.19.). We determined that the macrophage population in the placenta was mainly extravascular, this 
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population showed a steady increase in cell density in the placenta from E16 to E18 (p=<0.05) as did 
the mainly intravascular neutrophil population (Fig. 3.19. and 3.20.). 
 
Figure 3.19. Compartment localisation of the leukocyte populations on E18 in the myometrium, placenta, 
lungs and liver using CD45 i.v. staining. Histogram A) shows 100% blood monocyte population positive for CD45 
B) 0% of the resident myometrial macrophage population stained positively for CD45 C) a representative plot 
showing 12% of the Ly-6Chigh monocyte population in the myometrium is positive for CD45. Bar charts showing 
the mean percentage of CD45 positive and negative leukocytes in the myometrium, placenta, lungs and liver. All 
tissues collected 5 minutes post i.v. CD45 injection. n=3  
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Figure 3.20. Cell density of leukocytes in the placenta of untreated pregnant mice in late gestation. All data 
were normally distributed and so expressed as mean ±SD. E16, E17 and E18 cell densities were compared using 
a One-way ANOVA with Bonferroni post-test. E18 vs. labouring samples were analysed using an unpaired t-test. 
(*= p<0.05). n=6-14 
 
Numbers of leukocytes in the lungs and liver were not increased on E16 from the non-pregnant levels 
however in the days preceding labour our data suggest the numbers of leukocytes which were 
marginated within the major organs increased. Both the marginated monocyte populations in the 
lungs increased on E18 while neutrophil numbers peaked in the lungs and liver on E17 (Fig. 3.21. and 
3.24.). The increasing leukocyte cell numbers in the lungs and liver demonstrate that these organs are 
fundamental in the investigation of leukocyte trafficking dynamics systemically. The blood populations 
are variable and transient however the lungs and liver are likely to act as a substantial reservoir for 
the circulating leukocytes could be significant in understanding altered sensitivity or susceptibility to 
infection during pregnancy. Furthermore, the levels of the co-stimulatory molecule CD86 were 
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increased by both the marginated Ly-6Clow monocytes and interstitial population in the lungs of E16 
mice (Fig. 3.23.).  
Figure 3.21. Cell numbers of leukocytes in the lungs of untreated pregnant mice in late gestation. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
E16, E17 and E18 cell densities were compared using a One-way ANOVA with Bonferroni post-test when 
normally distributed and a Kruskal-Wallis with Dunn’s post- test when it was not. E18 vs. labouring samples were 
analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= 
p<0.05, **=p<0.01). n=6-14 
 
Interestingly the interstitial lung population decreased in size as did the cell density of Ly-6Chigh 
monocytes in the postnatal period compared to levels during labour (Fig. 3.22. and 3.25).  
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Figure 3.22. Cell numbers of leukocytes in the lungs of untreated pregnant mice during labour and in the 
postnatal period. Data are expressed as mean ±SD when normally distributed and when at least one data set 
was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Labouring vs. post natal samples were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when the data were not. (*= p<0.05).  n=6-11 
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Figure 3.23. Expression of CD86 by lung leukocyte populations in non-pregnant and E16 pregnant mice. Data 
are expressed as mean ±SD when normally distributed and when at least one data set was not normally 
distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers 
min to max). Samples were analysed using an unpaired t-test when normally distributed and a Mann Whitney 
test when data was not. (*= p<0.05). n=6-11 
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Figure 3.24. Cell density of leukocytes in the liver of untreated pregnant mice in late gestation. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
E16, E17 and E18 cell densities were compared using a One-way ANOVA with Bonferroni post-test when 
normally distributed and a Kruskal-Wallis with Dunn’s post- test when it was not. E18 vs. labouring samples were 
analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= 
p<0.05, **=p<0.01). n=6-14 
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Figure 3.25. Cell density of leukocytes in the liver of untreated pregnant mice during labour and in the 
postnatal period. Data are expressed as mean ±SD when normally distributed and when at least one data set 
was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Labouring vs. post natal samples were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when the data were not. (*= p<0.05).  n=6-11 
 
3.5.5 Evaluation of inflammatory response kinetics during late gestation  
To address the regulatory mechanisms underlying changes in the local and systemic trafficking during 
pregnancy, we determined levels of tissue-associated and plasma levels of chemokines and cytokines. 
The quality of normalised data are only as good as the quality of the housekeeper the data are being 
normalised to. To assess which housekeeper gene all the myometrial tissue should be normalised to 
we selected three of the most commonly used housekeeper genes for mouse myometrial tissue, 
Gapdh, Actb (β-actin) and Hprt (Fig. 3.26.). We selected Gapdh as the most stable housekeeping gene 
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in the myometrial samples. As levels of Hprt and Actb were variable throughout gestation and labour, 
normalising the data to these genes would skew relative expression levels of the genes of interest. 
Selecting an appropriate housekeeper gene is of the up most importance, especially in a tissue such 
as the myometrium which is continually changing throughout pregnancy. The 22 genes were selected 
for mRNA analysis based on previous studies demonstrating pro-labour functions of the proteins they 
encode (COX-2, TNFα, Cx43, IL-6, IL-1β), changes in the levels of the proteins throughout pregnancy 
(IL-10, IL-4, IFNγ, IL-1α) or for their possible role in leukocyte trafficking (CCR2, CCL2, CXCL1, CXCL2, 
CXCL5, CCL5, CCL20, CX3CL1, Ly-6C, G-CSF, NGP, M-CSF and M-CSFR)  90, 130, 192-194, 210, 236.  Of the 22 
genes analysed in the uterus and myometrium of non-pregnant and pregnant mice on E16 only 2 
genes had increased expression during pregnancy, Ccl2 and Ngp.  Conversely the expression of 10 
genes significantly decreased on E16 compared to non-pregnant levels, Cxcl5, Tnf, Il4, Cx3cl1, Cxcl1, 
Ccr2, Ccl20, Csf1, Csf1r and Csf3 while 10 genes remained unchanged (Fig. 3.27.).   
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Figure 3.26. Copy number of three housekeeping genes in the myometrium. Data are expressed as mean ±SD, 
non-pregnant, E14, E16, E17, E18 and labouring levels of housekeeping genes were compared using a One-
way ANOVA with Bonferroni post-test. (*= p<0.05, **=p<0.01, *** = p<0.001) n=6 
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Figure 3.27. Gene expression of selected genes in the uterus of non-pregnant mice and the myometrium of 
mice on gestation day 16. NP vs. E16 cell density and counts analysed using an unpaired t-test when normally 
distributed and a Mann Whitney test when data was not. n=6 
  
As the leukocyte cell densities increase in the myometrium during late gestation it was expected that 
chemokines responsible for the recruitment of monocytes and neutrophils would also steadily 
increase in late gestation. The mRNA levels of the majority of genes measured in the myometrium did 
not increase from E16 levels prior to labour. The genes which showed an increase in mRNA levels prior 
to labour were Cx3cl1, Cxcl2, Il6 and Gja1 (Fig. 3.28. and 3.29.). Expression of the chemokine ligand 
mRNAs, Ccl2, Cxcl5, and Cxcl1 were not significantly increased in the myometrium from E16 to E18 
and only increased at labour (Fig. 3.28.).  As demonstrated previously in other labs, mRNA of the pro-
inflammatory cytokines Tnf and Il1b were upregulated during labour as was Ptgs2100, 237. Ccr2 mRNA 
expression increases in the myometrium during labour, paradoxically however, our flow cytometry 
data shows this was when cell density of Ly-6Chigh monocytes was reduced. Ccr2 is also expressed by 
T cells and so it may be that this population is contributing to the increased expression shown during 
labour238. Ngp mRNA levels significantly decreased during labour compared to values on E18 which is 
consistent with the drop in neutrophil cell density in the myometrium during labour (Fig. 3.30. and 
Fig. 3.8.). 
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Figure 3.28. mRNA expression of chemokines in the myometrium of untreated mice in late gestation. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
E16, E17 and E18 data sets were analysed using a One-way ANOVA with Bonferroni post-test when normally 
distributed and a Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring mRNA levels were 
analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= 
p<0.05, **=p<0.01, *** = p<0.001). n=6  
 
 
Figure 3.29. mRNA expression of cytokines in the myometrium of untreated mice in late gestation. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
E16, E17 and E18 data sets were analysed using a One-way ANOVA with Bonferroni post-test when normally 
distributed and a Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring mRNA levels were 
analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= 
p<0.05, **=p<0.01). n=6  
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Figure 3.30. mRNA expression of pro-inflammatory factors in the myometrium of untreated mice in late 
gestation. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). E16, E17 and E18 data sets were analysed using a One-way ANOVA with Bonferroni post-
test when normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. E18 vs. labouring 
mRNA levels were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when 
data was not. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6  
 
Levels of mRNA are indicative of protein generation, however, direct extrapolation should be avoided 
as factors such as translation, degradation and modification of mRNA cannot be estimated and will 
effect mRNA translation to protein. Therefore we measured chemokine and cytokine proteins levels 
using a bead array assay to test protein levels in myometrial tissue homogenate (0.5mg per test). Of 
the chemokines measured, CXCL1, CCL3 and CCL4 levels were significantly increased during labour 
and CCL2, CCL5 and G-CSF levels showed a non-significant trend to peak during labour (Fig.3.31.). The 
increase in CCL3 and CCL4 levels during labour may have implications in the recruitment of monocytes 
to the myometrium during labour as these are ligands for CCR5, a chemokine receptor expressed on 
monocytes and macrophages. Conversely, IL-10 protein levels showed a decrease, albeit not 
statistically significant, at labour (Fig. 3.31.). The pro-labour proteins Cx43 and COX-2 were measured 
using Western blotting (Fig. 3.32.). For both proteins levels increased dramatically during labour but 
with no change before. Determining which proteins are upregulated prior to labour would provide 
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evidence of possible mechanisms involved in labour onset, however, when proteins levels are 
increased during labour it is not possible to determine if this is a consequence of the labour process 
and associated tissue/cellular stresses, or contributes to the onset of labour. 
Circulating chemokine levels in the serum were also analysed. Levels of CCL2 significantly increased 
during labour compared to E18. Levels of CXCL1 were greater on day 17 of pregnancy compared to 16 
and 18, while CCL5 levels remained comparatively stable throughout late gestation. IL-1α and IL-5 
were the only pro-inflammatory cytokines measured to increase in the serum with labour. The protein 
levels of G-CSF, which has an essential role in neutrophil mobilisation, were highest on day 17 and 
significantly greater than the values observed on day 16 and 18 (Fig. 3.33.).  
 
 
Figure 3.31. Protein levels of chemokines and cytokines in the myometrium of untreated mice in late 
gestation. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). E16, E17 and E18 data sets were analysed using a One-way ANOVA with Bonferroni post-
test when normally distributed and a Kruskal-Wallis with Dunns post-test when data was not. E18 vs. labouring 
protein levels were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when 
data was not. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6  
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Figure 3.32. Protein levels of Cx43 and COX-2 in the myometrium of untreated mice in late gestation analysed 
using Western blotting. Data are expressed as mean ±SD all data are normally distributed. E16, E17 and E18 
data sets were analysed using a One-way ANOVA with Bonferroni post-test. E18 vs. labouring protein levels were 
analysed using an unpaired t-test .(*= p<0.05, *** = p<0.001). n=6 
 
 
Figure 3.33. Protein levels of chemokines and cytokines in the serum of untreated mice in late gestation. Data 
are expressed as mean ±SD when normally distributed and when at least one data set was not normally 
distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers 
min to max). E16, E17 and E18 data sets were analysed using a One-way ANOVA with Bonferroni post-test when 
normally distributed and a Kruskal-Wallis with Dunn’s post- test when data was not. E18 vs. labouring protein 
levels were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data 
was not. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6 
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3.6 Discussion  
Understanding the cellular and molecular mechanisms that regulate labour is an essential step in the 
process of developing effective interventions to prevent PTB which is responsible for 1 million deaths 
per year globally1. Leukocyte trafficking to the uterus and systemically may be critical in the regulation 
of term labour; however the precise regulatory mechanisms involved are unclear. In this study, we 
performed a detailed flow cytometry-based analysis of mononuclear phagocyte and neutrophil 
dynamics with direct comparison to chemokine and cytokine kinetics to establish to the basic 
characteristics of the model for future mechanistic studies. Our results were consistent with previous 
studies showing an increase in leukocyte density and infiltration to the uterus around the time of 
labour; we found a steady increase in macrophage and neutrophil numbers in the myometrium from 
day 16 of pregnancy up to day 18 100, 101, 128, 134, 225, 226.  Unlike many previous studies which did not 
distinguish between resident macrophages and infiltrating monocytes, here we were able to compare 
the kinetics of a Ly-6Chigh monocyte-like subset to resident macrophages in the myometrium and found 
some differences in the kinetic profiles prior to and after labour. Concomitant with these changes, we 
observed increased levels of key chemokines suggestive of a relationship between altered local and 
systemic cell trafficking. 
The resident macrophage population in the myometrium was identified based primarily on the high 
F4/80 expression. Using CD45 intravascular labelling the location of this population was determined 
as almost entirely extravascular. Further investigation, using the Siglec-1 antibody, which identifies 
tissue macrophages, supported the identification of CD11b+ Ly-6G- Ly-6Clow F4/80++ cells as a resident 
macrophage population. Tagliani et al. demonstrated that there were two macrophage subsets in the 
early gestation myometrium, an MHCIIlow macrophage subset, with an anti-inflammatory phenotype, 
which matures into a MHCIIhigh macrophage130.  They suggested that the MHCIIlow macrophage 
expansion in the myometrium was due to several effects: monocyte (MHCIIlow) recruitment, in situ 
proliferation and blockade of maturation to the MHCIIhigh subset through the action of M-CSF. In this 
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study in both non-pregnant and pregnant mice the majority of myometrial macrophages were 
MHCIIlow however we found the percentage of MHCIIhigh macrophages in the myometrium increased 
significantly on E16 compared to the non-pregnant macrophage population. MHCII expression on 
macrophages is associated with an activated M1 like phenotype this result suggests that during late 
gestation the phenotype of the myometrial macrophages is altered to a more inflammatory profile 
with increased antigen presentation potential 110, 239. However the murine placental tissue does not 
express MHCII to ensure that the foetus is not rejected by the maternal immune response240, 241. This 
suggests the macrophages in the myometrium during late gestation perform a unique immunological 
role which may not be involved in the maternal immune response to the foetus.  Further to this 
increase in MHCII expression in the myometrial macrophage, COX-2 and CD86 expression was also 
upregulated on E16 compared to levels found in the non-pregnant myometrium which also suggests 
that during late gestation the activation state of the myometrial macrophage population was 
upregulated. CD86 expression on macrophages is associated with a pro-inflammatory M1 
phenotype242, 243. The resident myometrial macrophage showed highest CD86 expression on E17 which 
would suggest the M1 like activity of myometrial macrophages is not associated with the progression 
of labour.  
It has previously been shown that during early gestation the uterus preferentially recruits the Ly-6Chigh 
monocyte subset from the blood130. Here we identified a CD11b
+
 Ly-6G
- 
F4/80
+
 Ly-6C
high population 
which varied in cell density depending on gestation. Using CD45 intravascular staining we identified 
that the majority of this population was an interstitial population within the myometrium. When the 
blood was processed and stained in a similar manner to the myometrium, the location of the Ly-6Chigh 
monocyte population in the blood corresponded to the Ly-6Chigh population in the myometrium 
suggesting it was blood derived. When Siglec-1 expression was measured in this population in late 
gestation >60% were positive. This may indicate maturation of recruited Ly-6Chigh monocytes within 
the myometrium to a distinct macrophage like subpopulation or even a transition step between 
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monocytes and the main resident macrophage population. Further investigation into the origin of 
these cells will be described in Chapters 4 and 5.  
Systemically, circulating neutrophils and Ly-6Chigh monocytes were increased on E16 compared to non-
pregnant controls which is consistent with a study in humans showing that neutrophils and monocyte 
numbers are gradually increased in the circulation throughout pregnancy. Further to this absolute 
leukocyte counts were reaching levels nearly twice those of non-pregnant levels 244. Using CD45 
intravascular staining three CD11b+ Ly-6G- NK1.1- populations were identified in the lung based on 
their expression of MHCII and Ly-6C. Interestingly the two Ly-6Clow populations had increased 
expression of CD86 on E16 compared to untreated non-pregnant controls. This supports other findings 
that the activation of systemic leukocytes is upregulated during pregnancy14, 53, 54, 105 and potentially 
of greater significance because of the larger reservoir of monocytes and neutrophils than in the 
circulating pool. 
Increases in CD86 and MHCII expression are associated with the ability of monocytes to acquire 
antigen presenting activity. Due to the association between a maternal autoimmune dysfunction and 
PTB, labour onset is thought to be initiated by a shift in the maternal autoimmune responses from 
immune tolerance throughout pregnancy to a ‘graft-versus- host’ like response at term245.  Evidence 
at the maternal-foetal interface of leukocytes interacting with T cells to produce a microenvironment 
conducive to labour onset246 suggests an important link between the two arms of the immune 
response system in the initiation of labour.  Our evidence of an increase in MHCII and CD86 expression 
by monocytes located in the lung microvasculature suggests increased antigen presenting ability of 
these cells. This could indicate that the lung is an important site of innate and adaptive immune 
integration during late gestation. To test this, these cells could be isolated to perform in vitro studies 
to assess their antigen presenting abilities following treatment with an antigen247. 
The increasing cell density of leukocytes in the myometrium during late gestation is suggestive of a 
causative role in the onset of labour. However, contrary to expectations during labour neutrophil, Ly-
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6Chigh monocyte and macrophage cell densities decreased within the myometrium compared to values 
on E18. We investigated this phenomenon, reassessing the methodology for cell harvest, changes in 
tissue water content and rates of apoptosis during this period. To see if the homogenisation and 
fixation methodology was responsible for reducing cell yield during labour, we also digested 
myometrial tissue enzymatically, and found that in the enzymatically digested samples did not show 
a significant decrease in cell density from E18 to labour. As our cell density incorporated the weight 
of the tissue into the calculations we considered if a change in the physiology of the myometrium, 
such as an oedema, around the time labour was affecting the cell counts. Therefore we determined 
the wet: dry ratio of the myometrial tissue throughout late gestation and at labour. No significant 
changes in the myometrial wet: dry ratio were observed prior to, during or post labour.  Using TUNEL 
staining, high levels of apoptosis were observed in the myometrial CD11b+ F4/80+ populations on E18 
however on this day of pregnancy the myometrial macrophages were still detectable by flow 
cytometry and were found at their highest cell density which is not consistent with high levels of cell 
death.  In the human myometrium, prior to labour myometrial fibres were also shown be undergoing 
apoptosis248 highlighting the complexity of the myometrium around the time of labour. 
 A reduction in the macrophage cell density in the myometrium may actually be crucial in the onset of 
labour, as  hypothesised by Mackler et al. the fluctuating myometrial macrophage populations may 
be an important factor in regulating uterine contractions based on an association of high macrophage 
levels and a reduced ability to produce high amplitude contractions 226. Mechanistically, this may be 
related to the muscle relaxant effects of macrophage iNOS derived NO 249. However there is 
controversy about whether human macrophages even produce NO due to the inability of researchers 
to stimulate NO production in human monocytes in vitro250-256. This conclusion is based on in vitro 
studies and is not supported by studies in vivo; it is therefore probable that human macrophages do 
produce NO. 
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In order to decipher whether inflammatory leukocytes play a role in the onset or progression of labour, 
further work in determining the activation status of the macrophage populations in the myometrium 
is necessary. The role of Ly-6Chigh monocytes as modulators or precursors of the resident macrophage 
population and the maturation of MHCIIlow to high may all be determinants in the activation of the 
myometrial macrophages prior to labour. 
Although none of the chemokines measured in the myometrium increased significantly from E16 to 
E18, CCL2 and CXCL1 protein levels showed a tendency to increase during late gestation which 
coincides with the observed increase in Ly-6Chigh monocytes and neutrophils in this period. Ly-6Chigh 
monocyte extravasion into tissues under certain conditions has been demonstrated to be a CCR2 
mediated mechanism108, 113, 257 and these data give some support that the Ly-6Chigh monocyte 
trafficking to the myometrium during late gestation is CCR2 mediated. To further asses the role of 
CCR2 on monocyte trafficking to the myometrium during pregnancy the two other CCR2 ligands, CCL7 
and CCL12 should also be investigated. By only investigating CCL2 levels a large part of the CCR2 
mediated trafficking mechanism has been omitted from the analysis of monocyte trafficking dynamics 
during pregnancy. 
In the postnatal myometrium and decidua, the number of infiltrating leukocytes significantly increased 
compared to labouring levels, suggesting a second phase of leukocyte recruitment following labour. 
These increased levels of leukocytes suggest that in the postpartum period myeloid derived leukocytes 
have a reparative role in the uterus. Female mice experience a postpartum oestrus 14-28 hours after 
parturition and so are capable of becoming pregnant immediately post-delivery258. It may be, 
therefore, that the observed increase in leukocyte density in the myometrium prior to labour is 
necessary for the preparation of the uterus for a subsequent pregnancy100, 210. In the post-partum 
period, the weight of the uterus significantly decreased compared to the weight measured 
approximately 24 hours previously on E18, these rapid changes in the physiology of the uterus also 
suggest that there is a requirement for the uterus to return to its pre-pregnancy state.  Therefore in 
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future work it may be advantageous to investigate the postpartum uterus 48 hours post-delivery to 
determine if the second phase of leukocyte recruitment is associated with the rapid occurrence of 
oestrus.  
These data provide a basis for future chapters in which we manipulate the onset of labour to 
investigate the leukocyte trafficking dynamics involved.     
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Chapter 4 
 
Progesterone Regulation of Ly-6Chigh 
Monocyte Trafficking and Recruitment to 
the Myometrium 
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4.1 Introduction 
There is strong link between female steroid hormones and the regulation and trafficking of leukocytes 
to the tissues of the female reproductive tract. This relationship has been clearly identified by the 
investigation of leukocyte dynamics during menstruation in humans and the oestrous cycle in the 
mouse235, 259-261. During the female menstrual cycle, changing levels of the steroid hormones P4 and E2 
regulate the proliferation, differentiation, breakdown and repair of the endometrial lining of the 
uterus. P4 withdrawal prior to menstruation is associated with an influx of leukocytes in the 
endometrium that coincides with an increase in chemokines259, 261. These leukocytes are suggested to 
be involved in both the breakdown and the repair of the endometrial tissue via their release of 
proteases, cytokines and growth factors259.  Although leukocyte levels in the endometrium are 
modified by E2 and P4, there is conflicting evidence on whether leukocyte levels in the circulation 
fluctuate throughout the menstrual cycle262, 263. However, importantly, leukocytes located within the 
endometrium are functionally and phenotypically distinct from circulating leukocytes264, 265. 
In mice, the oestrous cycle differs considerably from the menstrual cycle in humans. As opposed to a 
monthly cycle the rodent oestrous last from 4-5 days and the endometrium is not shed as it is in 
humans. The distribution of leukocytes in the mouse reproductive tract varies depending on the stage 
of the oestrous cycle235 260. In studies which control circulating levels of P4 and E2 by hormone 
supplementation or withdrawal the distribution and function of leukocytes in the murine uterus can 
be altered. When levels of P4 and E2 are increased macrophage numbers increase and the distribution 
of the cells is altered so that macrophages are concentrated in the subepithelial stroma266. P4 has also 
been demonstrated to inhibit cytokine secretion of uterine dendritic cells while E2 treatment has been 
shown to result in increased neutrophil infiltration into the uterus267, 268. 
Currently there is controversy as to whether human leukocytes express P4 and E2 receptors (PR, ER)269-
271. Alternatively, steroid hormones may act indirectly to influence leukocytes dynamics. However, 
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experiments performed in vitro have shown that P4 and E2 alter the expression of adhesion molecules 
on human leukocytes, suggesting that they do have a direct effect272-274.  
P4 is essential for the maintenance of both human and murine pregnancy. High P4 levels throughout 
pregnancy promote uterine quiescence162. In murine pregnancy plasma P4 levels decline prior to 
parturition170 . However in humans plasma levels remain high and it is thought that there is a 
functional P4 withdrawal within the myometrium that promotes the onset of contractions166. The 
effect of the P4 withdrawal on leukocyte trafficking dynamics to the uterus could be central in 
regulating the onset of parturition.  
Exogenous P4 and its antagonists are used in patients and animal models to delay or advance labour. 
Thus, administration of the progesterone and glucocorticoid receptor antagonist, mifepristone, prior 
to 7 weeks gestation in humans173 and day 16 of pregnancy in mice induces abortion and labour 
respectively100. Conversely, P4 supplementation in the mouse delays parturition275, 276. For women that 
have experienced a spontaneous preterm singleton birth or have a short cervix, P4 supplementation 
has been found to reduce the rate of subsequent preterm labour by a third277-279. The mechanisms by 
which P4 exerts control over the uterus at the molecular level has been an area of focus in recent years 
162, 280-283 however how P4 acts to regulate leukocyte  trafficking to the myometrium prior to labour is 
still an area which requires investigation. 
Gene expression of Ccl2 in the myometrium of pregnant rats in late gestation is increased by P4 
withdrawal and decreased following P4 supplementation208. As CCL2 is a major monocyte 
chemoattractant, high levels in the myometrium would suggest an enhanced chemotactic gradient for 
monocytes. However, the percentage of F4/80+ mononuclear phagocyte cells did not increase in the 
myometrium during PTL induced by P4 withdrawal100, this may be because the histological analysis 
used detected the more abundant F4/80+ high-expressing resident macrophage only, and a more 
precise approach may be required to assess monocyte infiltration following P4 withdrawal.   
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In this study, P4 levels were manipulated by P4 supplementation or RU486 (P4 receptor antagonist) 
administration in the pregnant mouse to investigate how P4 modulates leukocyte trafficking to the 
myometrium around the time of labour. We aimed to extend previous work by investigating how P4 
supplementation and withdrawal affects monocyte subset trafficking to the myometrium by using a 
more precise approach. Further, the role of CCL2/CCR2 in the trafficking of Ly-6Chigh monocytes to the 
myometrium following P4 withdrawal was investigated.   
 
4.2 Hypothesis 
Progesterone regulates Ly-6Chigh monocyte trafficking to the myometrium in a CCR2-mediated 
process. 
 
4.3 Aims 
1) Investigate the hormonal regulation of the myeloid leukocyte populations using progesterone 
supplementation and withdrawal during late gestation in the CD-1 mouse. 
 
2) Define the process whereby Ly-6Chigh monocytes are trafficked to the myometrium in late 
gestation.  
 
 
4.4 Method 
The lungs, liver, blood and uterus of CD-1 mice were collected from naïve virgin non-pregnant mice 
and mice given sub-cutaneous injections of P4 for 5 days prior to collection on the morning of day 6. 
For the P4 supplementation experiments mice on E14 were given daily subcutaneous injections of 2mg 
P4 dissolved in a total volume of 40µl peanut oil, or vehicle alone, prior to the day of tissue collection. 
P4 withdrawal was induced by s.c. injection of 150µg RU486 in 20µl DMSO on E16 and tissue samples 
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obtained by sacrificing mice at different time points prior to PTL. Myometrial samples were analysed 
using bead arrays to determine the protein expression of chemokines and cytokines.  
We used in vivo BrdU cell labelling of dividing cells in the bone marrow Ly-6Chigh monocyte precursor 
pool to investigate the origin of Ly-6Chigh monocytes in the myometrium following RU486 treatment. 
BrdU (100µl 10mg/ml) was administered by i.p. injection 6 hours before RU486. Blood and myometrial 
samples were collected at labour or 24 hours post BrdU injection and processed according to 
manufacturer’s instructions (BD Pharmingen).  
To investigate the role of CCR2 in Ly-6Chigh monocyte trafficking to the myometrium following RU486 
the CCR2 antagonist (RS504393 2mg/kg) was administered by oral gavage 8 hours after 150µg RU486 
administration. Blood, lung and myometrial samples were collected at labour or 12 hours after 
RS504393 oral gavage.  Leukocyte cell numbers and density in the tissues and blood were analysed 
using flow cytometry.  
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4.5 Results  
4.5.1 Progesterone supplementation 
The changing P4 levels throughout the mouse oestrous cycle cause cell densities of leukocytes within 
the uterus to fluctuate235, 260. Supplementing with P4 for 5 days induces a diestrus-like state in non-
pregnant mice. Of all the organs collected (uterus, lungs, liver and blood) only the uterus showed 
significant changes in leukocyte cell density after P4 supplementation (Fig.4.1., 4.2., 4.3.  and 4.4.). Ly-
6Chigh monocyte and macrophage numbers in the uterus were lower and more uniform following P4 
supplementation, while neutrophils numbers were significantly decreased (p=<0.05 Fig.4.1.). In 
contrast, P4 treatment increased the variation and cell density of the CD11b+ F4/80low cells in the 
uterine tissue cell suspensions (p=<0.05 Fig.4.1.). 
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Figure 4.1. Cell density of leukocytes in the uterus of untreated and P4 supplemented non-pregnant mice. 
Leukocyte cell density in the uteri of naïve non-pregnant controls were compared to non-pregnant mice 
supplemented with 2mg of P4 in 40µl peanut oil via a subcutaneous injection daily for 5 days. Scatter plot of data 
showing mean ±SEM and analysed using an unpaired t-test when data was normally distributed and a Mann 
Whitney test when it was not. (*= p<0.05). n=10,8 
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Figure 4.2. Cell numbers of leukocytes in the circulation of untreated and P4 supplemented non-pregnant mice. 
Leukocyte numbers in the circulation of naïve non-pregnant controls were compared to non-pregnant mice 
supplemented with 2mg of P4 in 40µl peanut oil via a subcutaneous injection daily for 5 days. Scatter plot of data 
showing mean ±SEM and analysed using an unpaired t-test when data was normally distributed and a Mann 
Whitney test when it was not. n=8-10 
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Figure 4.3. Cell numbers of leukocytes in the lungs of untreated and P4 supplemented non-pregnant mice. 
Leukocyte numbers in the lungs of naïve non-pregnant controls were compared to non-pregnant mice 
supplemented with 2mg of P4 in 40µl peanut oil via a subcutaneous injection daily for 5 days. Scatter plot of data 
showing mean ±SEM and analysed using an unpaired t-test when data was normally distributed and a Mann 
Whitney test when it was not. n=8-10 
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Figure 4.4. Cell density of leukocytes in the liver of untreated and P4 supplemented non-pregnant mice. 
Leukocyte cell density in the liver of naïve non-pregnant controls were compared to non-pregnant mice 
supplemented with 2mg of P4 in 40µl peanut oil via a subcutaneous injection daily for 5 days. Scatter plot of data 
showing mean ±SEM and analysed using an unpaired t-test when data was normally distributed and a Mann 
Whitney test when it was not. n=8-10 
 
Supplementation with P4 from E14 prevents parturition on E18/19. Pregnancy can be artificially 
prolonged until E20, at which point Dams are culled on welfare grounds. To investigate the role P4 has 
on regulating leukocyte dynamics prior to labour onset, we measured leukocyte densities in the 
myometrium, circulation, placenta and lungs in mice supplemented with P4 from E14 and in vehicle 
controls. Ly-6Chigh monocytes in the myometrium were the only leukocyte population in all of the 
organs investigated to significantly change, being reduced following P4 supplementation (Fig.4.5.). 
Presumably this myometrium-specific change indicates P4 effects on local recruitment as opposed to 
any changes in systemic trafficking or in turnover of the bone marrow reservoir. In vehicle controls, 
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Ly-6Chigh monocyte cell density in the myometrium gradually increased from E16-E18 as seen in naïve 
pregnant mice in chapter 3.5.4 (Fig.3.8.). Whereas P4 treatment resulted in the Ly-6Chigh monocyte cell 
densities remaining at the levels seen on E16. In the circulation, lungs and placenta P4 
supplementation had no significant effect on leukocyte numbers (Fig.4.7., 4.8. and 4.9.). 
 
Figure 4.5. Cell density of leukocytes in the myometrium of vehicle controls and P4 supplemented mice in late 
gestation. Leukocyte cell density of mice on E16, E17 and E18 following either 2mg P4 or 40µl peanut oil 
subcutaneous injections from E14. Data are expressed as mean ±SD. All data was normally distributed, on each 
gestation day the cell density of leukocytes in the myometrium in vehicle controls was compared to P4 treated 
mice using an unpaired t-test. (**=p<0.01, *** = p<0.001). n=6-9 
 
We next measured chemokine protein levels in the myometrium to determine if a reduction in 
monocyte chemoattractants were responsible for the maintained Ly-6Chigh monocyte cell density in P4 
treated mice. CCL2 levels were not significantly lower in P4 treated mice compared to vehicle controls 
in late gestation although there was a trend for vehicle control CCL2 levels to increase on E18 which 
was not seen in the P4 treated mice (Fig.4.6.). CCL5 was the only chemokine or cytokine that we 
measured that showed a significant difference between vehicle controls and P4 treated levels (Fig.4.6). 
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On E17 CCL5 levels were significantly increased in vehicle controls (Fig.4.6) whereas CCL5 levels were 
maintained in P4 treated mice from E16 to E18 (Fig.4.11.). 
 
Figure 4.6. Protein levels of chemokines and cytokines in the myometrium of vehicle control and P4 
supplemented mice in late gestation. Protein levels in the myometrium of mice on E16, E17 and E18 following 
either 2mg P4 or 40µl peanut oil subcutaneous injections from E14. Data are expressed as mean ±SD when 
normally distributed and when at least one data set was not normally distributed data were expressed as a box 
and whiskers plot (box 25th to 75th percentile with median, whiskers min to max).  Protein levels of vehicle 
controls compared to P4 treated mice were compared on each gestation day using an unpaired t-test when the 
data was normally distributed and a Mann Whitney test when it was not.( *=p<0.05). n=6 
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Figure 4.7. Cell numbers of leukocytes in the circulation of vehicle controls and P4 supplemented mice in late 
gestation. Leukocyte cell numbers and density of mice on E16, E17 and E18 following either 2mg P4 or 40µl 
peanut oil subcutaneous injections from E14. Data are expressed as mean ±SD when normally distributed and 
when at least one data set was not normally distributed data were expressed as a box and whiskers plot (box 
25th to 75th percentile with median, whiskers min to max).  Cell counts of vehicle controls compared to P4 
treated mice were compared on each gestation day using an unpaired t-test when the data was normally 
distributed and a Mann Whitney test when it was not. n=6-9 
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Figure 4.8. Cell numbers of leukocytes in the lungs of vehicle controls and P4 supplemented mice in late 
gestation. Leukocyte cell numbers of mice on E16, E17 and E18 following either 2mg P4 or 40µl peanut oil 
subcutaneous injections from E14. Data are expressed as mean ±SD when as all data were normally distributed.  
Cell counts of vehicle controls compared to P4 treated mice were compared on each gestation day using an 
unpaired t-test. n=6-9 
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Figure 4.9. Cell density of leukocytes in the placenta of vehicle controls and P4 supplemented mice in late 
gestation. Leukocyte density of mice on E16, E17 and E18 following either 2mg P4 or 40µl peanut oil 
subcutaneous injections from E14. Data are expressed as mean ±SD as all data were normally distributed.  Cell 
densities of vehicle controls compared to P4 treated mice were compared on each gestation day using an 
unpaired t-test. n=6-9 
 
P4 supplementation was associated with an increase of leukocyte numbers and density in the 
myometrium and systemically on days 19 and 20 of gestation (Fig.4.10). Myometrial Ly-6Chigh 
monocytes and neutrophils increased significantly on days 19 and 20 (Fig.4.10.). Levels of CCL2 in the 
myometrium also began to increase on E18 with a significant rise on E19 and E20 suggesting that P4 
supplementation per se does not significantly inhibit CCL2 expression (Fig.4.11.). The peak in 
neutrophils on E19 did not coincide with CXCL1 and CXCL2 levels in the myometrium which were only 
significantly increased on E20 (Fig.4.10. and 4.11.), although a more gradual increase was apparent 
from E17 for CXCL1 and E18 for CXCL2. Of note the myometrial macrophage population decreased in 
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cell density from E19 to E20 to levels that were comparable to E16 vehicle controls (Fig.4.10.). High 
numbers of leukocytes combined with high levels of IL-6, IL-10, IFN γ and IL-12 on E20 suggest that the 
prolonged gestation is causing inflammation in the myometrium (Fig.4.11.). This inflammation is also 
demonstrated by high systemic levels of monocytes and neutrophils on E19 (Fig.4.12., 4.13. and 4.14.). 
Delaying parturition with P4 supplementation does not inhibit the viability of the pups in utero on E19, 
but by E20 the majority of pups were dead. 
 
Figure 4.10. Cell density of leukocytes in the myometrium of mice supplemented with 2mg of P4 
subcutaneously daily from E14. Data are expressed as mean ±SD when normally distributed and when at least 
one data set was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th 
percentile with median, whiskers min to max). Cell densities were compared using a One-way ANOVA with 
Bonferroni post-test when normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. (*= 
p<0.05, **=p<0.01, *** = p<0.001). n=6-10 
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Figure 4.11. Protein levels of chemokines and cytokines in the myometrium of mice supplemented with 2mg 
P4 subcutaneously daily from E14. Data are expressed as mean ±SD when normally distributed and when at 
least one data set was not normally distributed data were expressed as a box and whiskers plot (box 25th to 
75th percentile with median, whiskers min to max). Protein levels were compared using a One-way ANOVA with 
Bonferroni post-test when normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. (*= 
p<0.05, **=p<0.01, *** = p<0.001). n=6 
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Figure 4.12. Cell numbers of leukocytes in the circulation of mice supplemented with 2mg of P4 subcutaneously 
daily from E14. Data are expressed as mean ±SD when normally distributed and when at least one data set was 
not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Cell numbers were compared using a One-way ANOVA with Bonferroni post-test 
when normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. (*= p<0.05, **=p<0.01,). 
n=6-10 
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Figure 4.13. Cell numbers of leukocytes in the lungs of mice supplemented with 2mg of P4 subcutaneously 
daily from E14. Data are expressed as mean ±SD as all data were normally distributed. Cell numbers were 
compared using a One-way ANOVA with Bonferroni post-test. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6-10 
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Figure 4.14. Cell density of leukocytes in the placenta of mice supplemented with 2mg of P4 subcutaneously 
daily from E14. Data are expressed as mean ±SD as all data were normally distributed. Cell densities were 
compared using a One-way ANOVA with Bonferroni post-test. (*** = p<0.001). n=6-10 
 
4.5.2 Progesterone withdrawal 
In mouse pregnancy, P4 levels drop gradually prior to labour, but by administering the progesterone 
and glucocorticoid receptor antagonist, RU486 on E16, P4 activity can be more abruptly curtailed 
resulting in PTL within 17±1 hours (Fig.4.15.). We determined the leukocyte trafficking dynamics 
locally in the myometrium and also systemically at 3 intermediate time points (4.5, 9 and 13.5 hours 
post RU486) and during labour. 
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Figure 4.15. Delivery time after administration of progesterone receptor antagonist.  Delivery time was 
recorded when at least one pup had been delivered.  For naïve mice in spontaneous labour, time to delivery was 
recorded from 9am on E16. For the mice given 150µg RU486 delivery time was counted in hours from the time 
of the subcutaneous injection. Data are expressed as mean ±SEM. Data were all normally distributed and 
analysed using an unpaired t-test. (***= p<0.0001) n=13,7 
 
Cell densities of leukocytes within the myometrium showed a trend to increase following RU486 
administration (Fig.4.16.). Ly-6Chigh monocytes showed a trend to increase at 13.5 hours, with a 
further, significant, rise in density at labour (p<0.001 Fig.4.16.). The increase in Ly-6Chigh monocyte cell 
density coincided with an increase in the F4/80++ Ly-6Clow ‘macrophage’ cell density during labour 
(Fig.4.16.). The neutrophil cell density in the myometrium was not significantly increased after RU486 
administration at the time points prior to labour however during labour neutrophil cell density 
increased compared to E16 values (p<0.01 Fig.4.16.).  
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Figure 4.16. Cell density of leukocytes in the myometrium of mice following treatment with RU486. Data are 
expressed as mean ±SD and all data was normally distributed. Cell densities were compared using a One-way 
ANOVA with Bonferroni post-test . (*= p<0.05, **=p<0.01, *** = p<0.001). n=6-9 
 
Chemokine levels in the myometrium increased relatively early following RU486, with CCL2, CXCL1 
and CXCL2 levels peaking at 9 hours (Fig.4.17.). Although CXCL1 and CXCL2 significantly increased at 9 
hours (both p<0.01, Fig.4.17.), neutrophil density did not significantly increase prior to parturition. The 
rise in the cytokines IL-10, IL-1α, IL-12p70 and IFN-γ in the myometrium preceded the rise in 
chemokines at 9 hours, with levels significantly increased at 4.5 hours (Fig.4.17). Hence, it appears 
that withdrawal of P4 signalling provokes a detectable inflammatory response within the myometrium 
prior to a significant leukocyte infiltration. 
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Figure 4.17. Protein levels of chemokines and cytokines in the myometrium of mice following treatment with 
RU486. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). Protein levels were compared using a One-way ANOVA with Bonferroni post-test when 
normally distributed and a Kruskal-Wallis with Dunns post-test when it was not. (*= p<0.05, **=p<0.01, *** = 
p<0.001). n=6-9 
 
To determine the origin of Ly-6Chigh monocytes in the myometrium following RU486 treatment we 
used BrdU cell labelling (Fig.4.18.). BrdU is incorporated into the DNA of proliferating cells that include 
precursor Ly-6Chigh monocytes within 24 hours of egress from the bone marrow. Due to its relatively 
short-half life in vivo (~2hours) labelling is restricted to cells that are dividing at the time of 
administration and therefore can be used to pulse label and track Ly-6Chigh monocytes. We initially 
injected BrdU i.p. to untreated mice and collected blood and myometrial samples. After 24 hours 
51±3% of the Ly-6Chigh monocytes in the blood were positive for BrdU whereas less than 2% of the Ly-
6Clow monocyte populations were BrdU positive (1 ±1%). This positive labelling demonstrates that the 
circulating Ly-6Chigh monocytes have been released from the bone marrow into the circulation. In the 
myometrium, the Ly-6Chigh monocyte population was 37±17% positive 24 hours after BrdU injection, 
while the macrophage population was only 3±3%. This demonstrates either high rates of Ly-6Chigh 
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monocyte proliferation in situ at the time of BrdU injection, or more likely, their derivation from the 
recently divided bone marrow precursor population. 
In the BrdU and RU486 treated mice 24 hours after BrdU and 18 hours after RU486 administration, 
when Ly-6Chigh monocyte population density was at its highest in the myometrium, 41±2% of Ly-6Chigh 
monocytes were positive for BrdU in both the blood and myometrium while 4±3% of the macrophage 
population was positive for BrdU (Fig.4.18.).  These results suggest that the substantial increase in Ly-
6Chigh population seen in the myometrium 18 hours after RU486 is derived from the bone marrow cells 
labelled 24 hours previously and not as a result of in situ proliferation after RU486 administration. 
 
Figure 4.18. BrdU proliferation staining on Ly-6Chigh monocytes in the blood and myometrium 18 hours after 
subcutaneous injection of 150µg RU486. RU486 was administered 6 hours after an i.p. injection of 100µl 
10mg/ml BrdU in sterile 1x DPBS. Blood and myometrial samples were collected at labour or 24 hours post BrdU 
injection. Two representative histograms showing the percentage of Ly-6Chigh monocytes in the blood and 
myometrium positive for BrdU incorporation. n=3 
 
Next we used CD45 vascular compartment staining to confirm that the increase in leukocyte cell 
density in the myometrium following RU486 was due to infiltration of cells into the myometrium and 
not the high numbers in residual blood or adherent to capillary walls in the myometrium. The anti-
CD45 antibody was injected i.v. during RU486 induced PTL. Only ~15% of the Ly-6Chigh monocyte 
population in the myometrium was CD45 positive, demonstrating that the majority of this population 
had migrated from the circulation into the tissue (Fig.4.19.). The macrophage population was only ~1% 
positive confirming this as the tissue resident macrophage population (Fig.4.19.). The percentage of 
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neutrophils in the myometrium positive for CD45 was ~55% indicating that ~1x105 neutrophils were 
located within the blood vessels of the myometrium and had not infiltrated into the tissue during 
labour (Fig.4.19.).  
                            
Figure 4.19. Compartment localisation of the myometrial leukocyte populations in RU486 induced PTL using 
CD45 i.v. staining. Bar chart showing the mean percentage of CD45 positive and negative leukocytes in the 
myometrium during labour following RU486. i.v. injection of CD45 was given 5 minutes before collections of the 
myometrial tissue. n=2  
 
Systemically, circulating monocyte populations remained stable in the blood but neutrophil numbers 
significantly increased 9 hours after RU486 injection (Fig.4.20.). In the lung, all leukocyte cells 
populations measured were significantly increased during labour compared to E16 naïve controls 
(Fig.4.21.). Ly-6Chigh monocyte cell density increased substantially in the placenta at 13.5 hours post 
RU486 and during labour (Fig.4.22.).  
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Figure 4.20. Cell numbers of leukocytes in the circulation of mice following treatment with RU486. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
Cell numbers were compared using a One-way ANOVA with Bonferroni post-test when normally distributed and 
a Kruskal-Wallis with Dunns post-test when it was not. (*= p<0.05). n=6-9 
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Figure 4.21. Cell numbers of leukocytes in the lungs of mice following treatment with RU486. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
Cell numbers were compared using a One-way ANOVA with Bonferroni post-test when normally distributed and 
a Kruskal-Wallis with Dunns post-test when it was not. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6-9 
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Figure 4.22. Cell density of leukocytes in the placenta of mice following treatment with RU486. Data are 
expressed as mean ±SD when normally distributed and when at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
Cell densities were compared using a One-way ANOVA with Bonferroni post-test when normally distributed and 
a Kruskal-Wallis with Dunns post-test when it was not. (*= p<0.05, **=p<0.01, *** = p<0.001). n=6-9 
 
4.5.3 Acute CCR2 antagonism 
P4 supplementation and withdrawal specifically altered the trafficking of Ly-6Chigh monocytes to the 
myometrium, to determine if this trafficking is an integral process in the onset of labour we aimed to 
inhibit this infiltration using a CCR2 antagonist (RS504393). As RU486 administration resulted in PTL 
and a sharp increase in Ly-6Chigh monocyte infiltration, both within a narrowly defined time-point, we 
reasoned that this would be an ideal model to investigate the effects of an acute CCR2 antagonism on 
PTL.  
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Ly-6Chigh monocyte cell density in the myometrium was increased at 13.5 hours following RU486 
administration (E16 vs 13.5 hours t-test p=0.0076), therefore an oral gavage of CCR2 antagonist 
(RS504393 2mg/kg) was given 8 hours after RU486 before the rise (administration of the CCR2 
antagonist RS504393 is recommended every 12 hours, therefore the collection of tissues was either 
at labour or 12 hours post oral gavage). Delivery time was not affected by CCR2 antagonist 
administration (Fig.4.23.).  
                                     
Figure 4.23. Delivery time after PTL induced by RU486 in vehicle controls and mice given the CCR2 antagonist 
RS504393. 150µg of RU486 was given on the morning of E16 via a subcutaneous injection. 8 hours after RU486 
administration mice were either given an oral gavage of 5%DMSO in PBS or 2mg/kg RS504393 in a maximum 
volume of 650µl. Delivery time was recorded when at least one pup had been delivered. Time to delivery was 
recorded from the time of RU486 injection. Data are expressed as mean ±SEM. Data were all normally distributed 
and analysed using an unpaired t-test. n=6 
 
Cell counts and densities were measured in the myometrium, circulation and lungs following RU486 
and combined with either vehicle control or RS504393 oral gavage. In the circulation cell counts of Ly-
6Chigh monocytes were reduced following RS504393 confirming the action of the CCR2 antagonist in 
preventing mobilisation of monocytes from the bone marrow (Fig.4.25.). Although there was a trend 
for the Ly-6Chigh monocyte cell density to decrease in the myometrium of mice treated with the CCR2 
antagonist this was not significant (Fig.4.24.). Unexpectedly, neutrophil cell density in the 
myometrium decreased following treatment with a CCR2 antagonist (Fig.4.24). Leukocyte cell counts 
in the lungs were comparable in both control and CCR2 antagonist treated mice (Fig.4.26). 
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Figure 4.24. Cell density of leukocytes in the myometrium of mice in RU486 induced PTL treated with either 
vehicle or the CCR2 antagonist RS504393. Data are expressed as mean ±SEM. Cell density were analysed using 
an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= p<0.05). n=6 
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Figure 4.25. Cell numbers of leukocytes in the circulation of mice in RU486 induced PTL treated with either 
vehicle or the CCR2 antagonist RS504393. Data are expressed as mean ±SEM. Cell numbers were analysed using 
an unpaired t-test when normally distributed and a Mann Whitney test when data was not. (*= p<0.05). n=6 
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Figure 4.26. Cell numbers of leukocytes in the lungs of mice in RU486 induced PTL treated with either vehicle 
or the CCR2 antagonist RS504393. Data are expressed as mean ±SEM. Cell numbers were analysed using an 
unpaired t-test when normally distributed and a Mann Whitney test when data was not. n=6 
 
 
 
 
 
 
 
133 
 
4.6 Discussion  
The effect of P4 on leukocyte trafficking dynamics specifically to the uterus is demonstrated by the 
supplementation of P4 daily in non-pregnant mice. The uterus was the only tissue to show significant 
changes in the leukocyte populations following P4 supplementation. In naïve non-pregnant mice, the 
variation within the data set of Ly-6Chigh monocytes, macrophages and neutrophils in the uterus, 
suggests variability related to the stage of oestrous. This finding is supported by previous research235, 
260, 266, 267 but these data, reporting leukocyte numbers in the peripheral tissues, highlight the 
importance of P4 in leukocyte trafficking specifically to the uterus. 
In normal murine pregnancy, the decline in systemic P4 levels is initiated by the degradation of the 
corpus luteum by prostaglandins, as demonstrated in mice that are deficient in genes encoding the 
receptor for prostaglandin F2alpha, where delivery is prevented and gestation extended until an 
ovariectomy is performed284.  Supplementation with P4 also has the effect of delaying delivery275, 276, 
however, the effect of maintaining high P4 levels has on leukocyte trafficking has not been reported.  
In this study, P4 supplementation maintained the E16 population densities of Ly-6Chigh monocytes in 
the myometrium, preventing their continued expansion toward E18. This effect of P4 on leukocyte 
populations was specific to the myometrium and to the Ly-6Chigh monocyte subset. How P4 regulates 
this specific leukocyte subset is unclear. Currently, there is no evidence to suggest mouse Ly-6Chigh 
monocytes express the PR, although bone marrow derived and immature splenic DCs do express the 
PR29, 267. The shared common lineage between immature DC and Ly-6Chigh monocytes means that there 
is a strong possibility that P4 acts directly on the Ly-6Chigh monocyte subset. The investigation of the 
mechanisms of P4 action have focussed on the role of the classical nuclear PR, however a 7-
transmembrane protein has been identified to act as a progestin receptor on cells which do not 
express PR285. Alternatively, in humans, it has been argued that circulating monocytes do not express 
the classical PR and that P4 is actually acting through the GR receptor286, 287.   
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Whether P4 is able to exert direct effects on leukocytes in still unknown, however its indirect effects 
on leukocyte trafficking are well documented. P4 has been found to suppress CXCL1 and CXCL2 in the 
endothelium via PR 288, in this study the myometrial levels of CXCL1 and CXCL2 were comparable in 
vehicle and P4 treated mice. The increase in CXCL1 and CXCL2 levels on E18 despite P4 treatment may 
be in part due to the increasing stretch exerted on the myometrium by the growing pups 147. Stretch 
has been shown to induce the myocytes in the myometrium to produce cytokines which promote 
leukocyte infiltration into the myometrium289. The multiple pathways involved in leukocyte trafficking 
to the myometrium highlight the complexity of the mechanisms in the regulation of labour. 
The administration of RU486 to the mouse on E16 is a non-infectious model of PTL.  Following an acute 
PR/GR blockade levels of monocyte and neutrophil chemoattractants; CCL2, CXCL1 and CXCL2, 
increase in the myometrium. During labour, the cell density of Ly-6Chigh monocytes and neutrophils is 
significantly increased in the myometrium. Coinciding with the increase in Ly-6Chigh monocytes, 
myometrial macrophages also increased in cell density which is further evidence to support that Ly-
6Chigh monocytes contribute to myometrial macrophage expansion130. RU486 administration induced 
a neutrophilia and increased margination in the lungs suggesting mobilisation from the bone marrow 
into the circulation, however neutrophil cell counts in the circulation were not altered by P4 
supplementation. This suggests that the effect RU486 has on neutrophil trafficking dynamics may not 
be a direct effect of P4 withdrawal, but perhaps of the GR antagonism. The anti-inflammatory 
properties of glucocorticoids have meant that they are one of the most widely used drugs to treat 
inflammatory and auto-immune diseases. Blocking the GR on neutrophils has been shown to increase 
rolling and adherence to post capillary venules290. Further to this, long-term exposure of RU486 in rats 
resulted in higher circulating neutrophil numbers291. Compartment staining performed during RU486 
induced labour demonstrated that ~50% of the neutrophil population measured in the myometrium 
was located within the vasculature. The observed increase in the percentage of neutrophils located in 
the blood vessels of the myometrium compared to E18 could be as a direct result of GR blockade. 
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As well as affecting neutrophil trafficking, antagonism of the GR could also have resulted in the high 
numbers of Ly-6Chigh monocytes migrating to the myometrium following RU486 administration. 
Deletion of GR in myeloid cells has been shown to result in persistent leukocyte infiltration into 
inflamed areas while also promoting IL-1β, MCP-1 and MIP-2 secretion by tissue macrophages292.  
Tagliani et al. demonstrated that in early pregnancy the trafficking of Ly-6Chigh monocytes to the uterus 
was CCR2 mediated130. P4 withdrawal initiated by antagonism of the PR and GR receptors by RU486, 
induced a rise in CCL2 protein levels in the myometrium at 9 hours, preceding the increase in Ly-6Chigh 
monocytes in the myometrium. To determine if the mechanism via which Ly-6Chigh monocytes were 
recruited to the myometrium following P4 withdrawal was CCR2 mediated and if blocking this 
recruitment would delay labour, the CCR2 antagonist, RS504393, was administered. Labour time was 
not affected following RS504393 administration, however the decrease in Ly-6Chigh monocyte number 
in the blood confirmed antagonism of the CCR2 receptor. Although Ly-6Chigh monocytes did not 
significantly decrease in the myometrium there was a trend for a decreased cell density after CCR2 
antagonism. It may be that due to the complexity of pregnancy and labour that CCR2 is not the only 
mechanism by which Ly-6Chigh monocytes are recruited to the myometrium and therefore Ly-6Chigh 
monocyte trafficking was not significantly reduced. There is evidence to suggest that CCR5, CX3CR1 
and CCR6 may all be involved in Ly-6Chigh monocyte function or migration in inflamed tissues293-295. 
Indeed, in a CCR2 deficient mouse model labour time is comparable to that of WT mice210. 
CCR2 is a receptor mainly expressed on monocytes296-299; it has not been detected on the surface of 
human, rat or mouse neutrophils in resting conditions300-302. Furthermore in CCR2 deficient mice, 
monocyte recruitment to areas of inflammation has been demonstrated to be impaired whereas 
neutrophil recruitment is unaffected303, 304. Interestingly our data demonstrated that neutrophil cell 
density in the myometrium was significantly reduced following CCR2 antagonism. This reduction in 
neutrophil migration to the myometrium may be linked to the trend for a reduction in the density of 
Ly-6Chigh monocytes in the myometrium. During lung inflammation monocytes and neutrophils have 
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been demonstrated to show a coordinated migration whereby neutrophil accumulation in the lungs 
is accelerated by the presence of monocytes305. However in cases of chronic inflammation circulating 
neutrophils have been shown to express CCR2 and exhibit an enhanced ability to migrate towards 
CCR2 chemokines142, 301, 302. Therefore CCR2 antagonism may be acting both indirectly via monocyte 
interactions and directly on neutrophils to reduce the trafficking to the myometrium following RU486. 
It is possible that the altered inflammatory environment during pregnancy and labour can modify the 
previously characterised trafficking dynamics of leukocytes. 
Overall, these data suggest that P4 levels alone are not the only factor influencing leukocyte trafficking 
to the myometrium.  
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Chapter 5 
 
Local and Systemic Leukocyte Trafficking 
in LPS-induced Models of PTL 
 
 
 
 
 
 
 
 
 
5.1 Introduction 
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Normal labour in the absence of infection is thought to be an inflammatory process with many studies 
showing an increased infiltration of myeloid leukocytes to the uterus around the time of labour85, 86, 
97, 100, 101, 226. Excessive inflammation as a result of infection during pregnancy has been proposed to 
initiate the pathologic activation of the common terminal pathway involved in parturition306. High 
rates of PTL are seen in women who suffer from systemic infections such as pneumonia, periodontal 
disease, typhoid fever, pyelonephritis and malaria during pregnancy307. Further to this, enhanced or 
excessive local inflammation is also associated with a greater incidence of PTL159, 177, 308, 309. 
In further support of an infection-derived inflammatory trigger capable of initiating the onset of PTL, 
multiple animal models have been developed which reliably result in PTL following the administration 
of micro-organisms or endotoxin either systemically or locally to the uterus178. The mouse is a useful 
model to investigate infection induced PTL as labour occurs over a short time window on the evening 
of E18 in the untreated dam. Therefore, the impact of an inflammatory insult on labour timing can be 
easily investigated. Additionally, the mouse model can be genetically modified to perform mechanistic 
studies far more easily than other lab animals.  
It has been almost 20 years since the intrauterine (i.u.) administration of Escherichia coli was used as 
a model for the induction of PTL in the mouse197. This model was later adapted by Elovitz et al. in 2003 
using high dose i.u. LPS (250 µg), which resulted in 100% pup mortality and PTB within 24 hours179. 
Using this model of local infection induced PTL it has been possible to investigate leukocyte infiltration 
and chemokine levels in the uterus prior to and during PTL. Infection induced PTL following i.u 
administration of LPS has been shown to cause an exaggerated increase in chemokine and cytokine 
levels in the uterus compared to normal term labour or non-infection induced PTL100, 135.   
 
The ripening of the murine cervix has been demonstrated to have distinct mechanistic pathways at 
term and following infection induced PTL, involving the activation of specific gene pathways and an 
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altered pro-inflammatory profile 310, 311. Further to this P4 levels in the serum of mice following 
intravaginal administration of LPS do not decline during labour as they do at term312. In the previous 
chapters, Ly-6Chigh monocytes subset trafficking has been demonstrated in late gestation and the role 
of P4 in the regulation of Ly-6Chigh monocyte recruitment to the myometrium in a model of non-
infectious induced PTL studied. As mechanistic pathways involved in labour onset have been shown 
to vary between spontaneous term labour and PTL, here Ly-6Chigh monocyte trafficking dynamics 
during infection-induced PTL have been studied. The Ly-6Chigh monocyte subset has been shown in 
various infection and inflammation models to be preferentially recruited to sites of inflammation130, 
257, 313, 314. This process appears to be regulated primarily by the higher expression of the chemokine 
receptor CCR2 on Ly-6Chigh monocytes, which regulates both their egress from their bone marrow and 
their extravasation into tissue115, 315.  We wanted to assess if CCR2 is required for Ly-6Chigh monocyte 
recruitment to the myometrium following infection induced PTL. As CCR2 knockout mice deliver 
healthy pups at term210 we used this as a suitable model to assess how the local administration of LPS 
affected inflammatory monocyte subset dynamics. 
A systematic investigation into leukocyte kinetics locally, in the uterus, and systemically in the murine 
model of LPS-induced PTL have been studied, to dissect out the remote as well as local effects of 
inflammation on monocyte trafficking in this model. To directly assess the effects of systemic 
inflammation with the traditional i.u. route, we also investigated LPS challenge via the i.v. and i.p. 
routes, determining their effects on monocyte trafficking and labour time. 
 
 
5.2 Hypothesis 
Localised administration of i.u. LPS induces inflammatory subset Ly-6Chigh monocyte infiltration into 
the myometrium, which contributes to early labour onset.  
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5.3 Aims 
1) To investigate the myeloid leukocyte kinetics in the myometrium, blood and marginated pools in 
LPS-induced PTL.   
2) To determine if and how CCR2 regulates leukocyte trafficking to the myometrium in i.u. LPS induced 
PTL. 
3) Compare leukocyte trafficking following localised vs. systemic LPS administration. 
 
5.4 Methods 
PTL was induced by administration of 10µg of LPS serotype 0111:B4. Three routes of LPS 
administration, i.u., i.p. and i.v., were used on E16 to induce PTL. For intrauterine (i.u.) administration 
of LPS, a laparotomy was performed and the uterine horns exteriorised. i.u. injections were performed 
on the right uterine horn. 10µg in a total volume of 25µl of LPS or sterile PBS (25 µl) were injected to 
form a bleb. For intraperitoneal (i.p.) and intravascular (i.v.) injections, 10µg of LPS in a total volume 
of 100µl PBS or PBS alone were also given on the morning of E16. Labour time was calculated from 
the time of injection to the delivery of one or more pups. When an average delivery time was 
established for each route of administration, an intermediate time-point was calculated halfway 
between LPS administration and labour.  
Cell counts and density in the myometrium, blood, placenta, lungs and liver were determined using 
flow cytometry based on the gating strategy defined in chapter 3.5.2 (Fig.3.3, 3.5. and 3.6.). Plasma, 
lung and myometrial samples were analysed using bead arrays to determine protein levels of 
inflammatory chemokines and cytokines.  
141 
 
 
5.5 Results 
5.5.1 Investigating Leukocyte Trafficking in the intrauterine LPS Model of Preterm 
Labour  
Laparotomy and intrauterine injection of LPS on E16 induced preterm labour within 10±4 hours 
whereas, in the surgical sham control group, labour was significantly delayed compared to 
spontaneous labouring naïve controls (Fig. 5.1.). At 7 hours post LPS injection, densities of Ly-6Chigh 
monocytes were unchanged compared to E16 controls, whereas a substantial increase in this 
population was found in sham PBS injected mice. These unexpected results were mirrored by 
neutrophils, where again levels increased considerably in sham mice compared to LPS-treated mice, 
albeit at higher levels than in E16 untreated controls (Fig. 5.2.).  During labour in LPS-treated mice 
neutrophil cell density in the myometrium was higher compared to labour in the sham group however, 
comparing these two groups at labour is difficult taking into account on average there was ~65 hours’ 
time difference between labour time and when surgery was performed (Fig. 5.2. and 5.1.). Although 
macrophage cell densities remained relatively constant expression of the co-stimulatory marker, 
CD86, was significantly increased during LPS induced labour compared to vehicle controls while levels 
of COX-2 expression in the myometrial macrophage population were unchanged (Fig. 5.3.). 
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Figure 5.1. Delivery time after intrauterine injection.  Delivery time was recorded when at least one pup had 
been delivered.  For naïve mice in spontaneous labour, time to delivery was recorded from 9am on E16. For the 
mice given an intrauterine injection delivery time was counted in hours from the time of the laparotomy. 10µg 
in a total volume of 25µl of Escherichia coli LPS serotype 0111:B4 or sterile PBS (25 µl) were injected to form a 
bleb in the myometrium of the right uterine horn. Data are expressed as  mean ±SD. Data were all normally 
distributed and analysed using a One-way ANOVA with Bonferroni post-test. (***= p<0.0001) n=7. 
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Figure 5.2. Cell density of leukocytes in the myometrium from untreated mice on E16, during labour, and 
following a laparotomy and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD when normally 
distributed and when at least one data set was not normally distributed data were expressed as a box and 
whiskers plot (box 25th to 75th percentile with median, whiskers min to max). Cell densities of PBS vs. LPS data 
at each time point were analysed using an unpaired t-test when normally distributed and a Mann Whitney test 
when data was not. Statistical significance was expressed with a * following an unpaired t-test or a # following 
a Mann-Whitney test.  E16 untreated and spontaneously labouring data was included as a guide (**/##=p<0.01, 
*** = p<0.001) n=5-6. 
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Figure 5.3. Activation status of myometrial macrophages in the myometrium from untreated mice on E16, 
during labour, and following a laparotomy and i.u. injection of either PBS or LPS. Data are expressed as mean 
±SD when normally distributed and when at least one data set was not normally distributed data were expressed 
as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). Geometric mean of 
PBS vs. LPS data at each time point were analysed using an unpaired t-test when normally distributed and a 
Mann Whitney test when data was not. Statistical significance was expressed with a * following an unpaired t-
test or a # following a Mann-Whitney test.  E16 untreated and spontaneously labouring data was included as a 
guide (*/#=p<0.05) n=5-6. 
 
 
In view of the large numbers of Ly-6Chigh cells associated with myometrial tissue at 7 hours post-
surgery and PBS injection, we wanted to confirm if these cells were derived from blood Ly-6Chigh  
monocytes or instead represented a resident population undergoing  proliferation or phenotypic 
alteration. Previous kinetic studies have demonstrated that at 18 hours following BrdU injection a 
peak of ~50% of the Ly-6Chigh monocytes in the circulation are BrdU positive by 24 hours this is 
decreased to ~10%130 To coincide with this peak at 18 hours we timed the PBS i.u. laparotomy to be 
performed 17 hours post BrdU i.p. and collected tissues 24 hours post BrdU injection, at the 7 hour 
post i.u. sampling point.  
Large numbers of Ly-6Chigh monocytes were seen in the myometrium 7 hours post-surgery  (Fig. 5.4B.), 
of which 40% were BrdU positive suggesting these cells were derived from the circulating Ly-6Chigh 
monocyte pool and have migrated from the circulation into the myometrium (Fig. 5.4B. and C). The 
myometrial macrophage population had very low levels of cells that had incorporated BrdU; there was 
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a trend for an increase in the percentage of BrdU positive macrophages following i.u. PBS compared 
to E16 levels suggesting some in situ BrdU incorporation and proliferation (Fig. 5.4D.). 
 
Figure 5.4. BrdU proliferation staining of Ly-6Chigh monocytes and macrophages in the myometrium. An i.p. 
injection of 100µl 10mg/ml BrdU was injected approximately 24 hours prior to collection of tissues. At this time 
point ~50% of Ly-6Chigh monocytes in the circulation were positive for BrdU. A and B are representative FACs 
images showing  Ly-6Chigh monocytes in the myometrium A) E16 plus 7 hours and B) 7 hours following i.u. 
injection of PBS with the corresponding histograms showing the percentage of BrdU positively labelled cells.  
Graphs C and D are scatter plots showing the percentage of BrdU positive C) Ly-6Chigh monocytes and D) 
macrophages in the myometrium. n=3-5 no statistical analysis.     
 
The leukocyte profiles in the blood of both i.u. PBS and LPS injected mice 7 hours post laparotomy 
were consistent with a systemic inflammation (Fig. 5.5.), with indications of monocytopenia 
concomitant with a neutrophilia116. However, levels of leukocytes in the placenta did not appear to be 
significantly altered by surgery and/or LPS treatment (Fig. 5.6.). 
146 
 
Figure 5.5. Cell counts of leukocytes in the circulation of untreated mice on E16, during labour, and following 
a laparotomy and i.u. injection of either PBS or LPS. When at least one data set was not normally distributed 
data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers min to max). 
Cell counts of PBS vs. LPS data at each time point were analysed using a Mann Whitney test. Statistical 
significance was expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. E16 
untreated and spontaneously labouring data was included as a guide (#=p<0.05, ##=p<0.01) n=5-6. 
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Figure 5.6. Cell density of leukocytes in the placenta of untreated mice on E16, during labour, and following a 
laparotomy and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD as all data were normally 
distributed. Cell densities of PBS vs. LPS data at each time point were analysed using an unpaired t-test. Statistical 
significance was expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. E16 
untreated and spontaneously labouring data was included as a guide (**=p<0.01, *** = p<0.001) n=5-6. 
 
Clearer cut evidence of a systemic response to LPS was indicated by the marked increase in Ly-6Chigh 
monocyte and neutrophil numbers in the lungs and liver of dams at 7 hours (Fig. 5.7. and 
5.8.).Although cell numbers of the interstitial lung population did not increase, the expression of CD86 
was significantly increased in LPS-treated mice (Fig. 5.9.).Therefore it appears that although i.u. LPS 
produces limited leukocyte infiltration into the uterus its effects in remote organs are very apparent, 
while the local effects of surgery and PBS injection much less evident at the systemic level as might be 
expected for an aseptic surgical procedure.  
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Figure 5.7. Cell counts of leukocytes in the lungs of untreated mice on E16, during labour, and following a 
laparotomy and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD when normally distributed 
and when at least one data set was not normally distributed data were expressed as a box and whiskers plot 
(box 25th to 75th percentile with median, whiskers min to max). Cell counts of PBS vs. LPS data at each time 
point were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data 
was not. Statistical significance was expressed with a * following an unpaired t-test or a # following a Mann-
Whitney test. E16 untreated and spontaneously labouring data was included as a guide (**=p<0.01, *** = 
p<0.001) n=6. 
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Figure 5.8. Cell density of leukocytes in the liver of untreated mice on E16, during labour, and following a 
laparotomy and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD when normally distributed 
and when at least one data set was not normally distributed data were expressed as a box and whiskers plot 
(box 25th to 75th percentile with median, whiskers min to max). Cell densities of PBS vs. LPS data at each time 
point were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data 
was not. Statistical significance was expressed with a * following an unpaired t-test or a # following a Mann-
Whitney test. E16 untreated and spontaneously labouring data was included as a guide (*=p<0.05, *** = 
p<0.001) n=6. 
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Figure 5.9. Activation status of Interstitial cells in the lungs of untreated mice on E16,  at 7 hours post 
laparotomy with i.u. PBS, and 7 hours post laparotomy with i.u. LPS. Data are expressed as mean ±SD all data 
were normally distributed. Cell densities and geometric mean were compared using a One-way ANOVA with 
Bonferroni post-test. ( *** = p<0.001). n=6. 
 
 
In order to investigate the mechanisms regulating  leukocyte trafficking in the LPS induced PTL model, 
we measured the myometrial levels of chemokines and cytokines at 3 and 7 hours post LPS and during 
labour. At 3 and 7 hours post-LPS injection all the chemokines measured, were increased compared 
to PBS controls (Fig. 5.10.). Laparotomy and PBS injection alone increased CCL2, IL-6 and IL-1β levels 
in the myometrium at 3 hours (<0.0001, 0.0050, <0.0001 respectively using an Unpaired t-test or Mann 
Whitney) , but by 7 hours post PBS chemokine and cytokine levels were comparable to naïve controls 
(Fig. 5.10. and 5.11.). During LPS induced PTL levels of CCL2, CCL5, G-CSF, TNFα, IL-6, IL-1β and IL-10 
protein in the myometrium were significantly higher than in PBS controls (Fig. 5.10. and 5.11.) Thus, 
despite lower levels of leukocyte infiltration at 7 hours, the local inflammatory response produced by 
LPS injection was more prolonged than in mice undergoing surgery and PBS injection. 
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Figure 5.10. Chemokine protein levels in the myometrium following a laparotomy and i.u. injection of either 
PBS or LPS. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). Protein levels of PBS vs. LPS at each time point were analysed using an unpaired t-test 
when normally distributed and a Mann Whitney test when data was not. Statistical significance was expressed 
with a * following an unpaired t-test or a # following a Mann-Whitney test.  E16 untreated data was included as 
a guide (*=p<0.05, **=p<0.01, *** = p<0.001) n=6. 
 
 
 
 
 
 
Figure 5.11. Cytokine protein levels in the myometrium following a laparotomy and i.u. injection of either PBS 
or LPS. Data are expressed as mean ±SD when normally distributed and when at least one data set was not 
normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, 
whiskers min to max). Protein levels of PBS vs. LPS at each time point were analysed using an unpaired t-test 
when normally distributed and a Mann Whitney test when data was not. Statistical significance was expressed 
with a * following an unpaired t-test or a # following a Mann-Whitney test. E16 untreated data was included as 
a guide (*/#=p<0.05, **/##=p<0.01, *** = p<0.001) n=6. 
 
 
To further evaluate the systemic component of inflammation induced PTL we measured soluble 
inflammatory mediators in the circulation. As with myometrial chemokine and cytokine protein levels, 
plasma protein levels were increased substantially in LPS-treated mice at 3 and 7 hours compared to 
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naïve and PBS injected controls (Fig. 5.12. and 5.13.). During LPS-induced PTL all chemokines measured 
in the plasma were increased compared to PBS controls (Fig. 5.12.), while IL-1α, IL-10 and IL-12p40 
were the only cytokines to be significantly increased during LPS induced PTL (Fig. 5.13.). 
 
 
Figure 5.12. Chemokine protein levels in the plasma following a laparotomy and i.u. injection of either PBS or 
LPS. Data are expressed as mean ±SD when normally distributed and when at least one data set was not normally 
distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers 
min to max). Protein levels of PBS vs. LPS at each time point were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when data was not. Statistical significance was expressed with a 
* following an unpaired t-test or a # following a Mann-Whitney test. E16 untreated data was included as a guide 
(*/#=p<0.05, **/##=p<0.01) n=6. 
 
 
Figure 5.13. Cytokine protein levels in the plasma following a laparotomy and i.u. injection of either PBS or 
LPS. Data are expressed as mean ±SD when normally distributed and when at least one data set was not normally 
distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with median, whiskers 
min to max). Protein levels of PBS vs. LPS at each time point were analysed using an unpaired t-test when 
normally distributed and a Mann Whitney test when data was not. Statistical significance were expressed with 
a * following an unpaired t-test or a # following a Mann-Whitney test. E16 untreated data was included as a 
guide (*=p<0.05, **=p<0.01, *** = p<0.001) n=6. 
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Pulmonary tissue  levels of CCL2, IL-1α, IL-1β, IFN γ, IL-6, G-CSF and IL-12p40 protein levels were all 
significantly increased in the LPS-treated dams compared to PBS controls, the CCL2 specifically 
perhaps accounting for the increased monocyte cell numbers (Fig. 5.14.). Surgery alone increased 
CCL2, CXCL1, G-CSF, IL-6 and IL-12p40 protein levels in the lungs of PBS treated mice compared to 
naïve controls (Fig. 5.14.), but presumably not enough to promote significant leukocyte recruitment 
(Fig. 5.7.). This increase cannot be attributed to residual blood in the lungs as in 250µg of lung 
homogenate there would be 0.05µl of plasma.  
 
Figure 5.14. Chemokine and cytokine protein levels in the lungs of mice on E16, or 7 hours after laparotomy 
and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD when normally distributed and when at 
least one data set was not normally distributed data were expressed as a box and whiskers plot (box 25th to 
75th percentile with median, whiskers min to max). E16 vs. PBS and PBS vs. LPS cell densities were compared 
using an unpaired t-test when normally distributed and a Mann Whitney when they were not. (*=p<0.05 
**=p<0.01, *** = p<0.001). n=5-6 
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5.5.2 Determining the Role of the Chemokine Receptor 2 on Leukocyte Trafficking 
in the intrauterine LPS Model of PTL 
Prior to determining the effect of i.u. LPS on a CCR2 knockout mouse model, we wanted to determine 
leukocyte levels in the untreated pregnant KO mice (mated with CD-1 males) compared to the CD-1 
“wild-type” on E16. Leukocyte densities were measured in the myometrium, circulation, placenta, 
lungs and liver.  Ly-6Chigh monocytes were significantly lower in the myometrium, circulation, lungs 
and liver of CCR2 KO mice compared to CD-1s. Similar to Ly-6Chigh monocyte levels, Ly-6Clow monocytes 
were also reduced in the placenta, lungs and liver of CCR2 KO mice (Fig.5.15., 5.16. and 5.17.)  In the 
myometrium cell density of the resident macrophage population was lower in CCR2 KO mice 
compared to CD-1s however expression of COX-2 and CD86 was significantly increased by the 
macrophages of CCR2 KO mice (Fig.5.15.). Neutrophils were significantly increased in the 
myometrium, circulation and placenta of CCR2 KO mice (Fig.5.15. and 5.16.).  
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Figure 5.15. Cell density of leukocytes and activation status of myometrial macrophages in the myometrium 
from untreated CD-1 mice and CCR2 KO mice on E16. Data are expressed as mean ±SD all data were normally 
distributed. Cell densities and geometric mean were compared using an unpaired t-test. (*=p<0.05, **=p<0.01, 
*** = p<0.001). n=5-6. 
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Figure 5.16. Cell counts and density of leukocytes in the circulation and placenta from untreated CD-1 mice 
and CCR2 KO mice on E16. Data are expressed as mean ±SD when normally distributed and when at least one 
data set was not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th 
percentile with median, whiskers min to max). Cell counts and densities were analysed using an unpaired t-test 
when normally distributed and a Mann Whitney test when data was not. Statistical significance were expressed 
with a * following an unpaired t-test or a # following a Mann-Whitney test. (#=p<0.05, **/##=p<0.01, *** = 
p<0.001) n=5-6 
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Figure 5.17. Cell counts and density of leukocytes in the lungs and liver from untreated CD-1 mice and CCR2 
KO mice on E16. Data are expressed as mean ±SD when normally distributed and when at least one data set was 
not normally distributed data were expressed as a box and whiskers plot (box 25th to 75th percentile with 
median, whiskers min to max). Cell counts and densities were analysed using an unpaired t-test when normally 
distributed and a Mann Whitney test when data was not. Statistical significance were expressed with a * 
following an unpaired t-test or a # following a Mann-Whitney test.(*=p<0.05, ##=p<0.01, *** = p<0.001).n=5-6 
 
Next, we wanted to determine whether CCR2 plays a role in labour time and if this is related to 
leukocyte trafficking, to the myometrium or globally after i.u. injection of LPS. Labour time following 
i.u LPS was comparable for CD-1s and CCR KO mice however in the surgical i.u. PBS control group, time 
to labour was significantly decreased in CCR2 KOs (Fig. 5.18.).  
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Figure 5.18. Delivery time after intrauterine injection in CD-1 and CCR2 knockout mice. Delivery time was 
counted in hours from the laparotomy to the delivery of one pup. 10µg in a total volume of 25µl of Escherichia 
coli LPS serotype 0111:B4 or sterile PBS (25 µl) were injected to form a bleb in the myometrium of the right 
uterine horn. Data are expressed as mean ±SD. Data was all normally distributed. Wild types (WT) mice were 
compared to CCR2 knockout (KO) mice using an unpaired t-test (*=p<0.05) n=7-8. 
 
In the myometrium, the increase in Ly-6Chigh monocytes seen at 7 hours following i.u. PBS was 
abolished in the CCR2 KO mice, indicating the recruitment of monocytes as a result of surgery and 
injection alone is CCR2-dependent. In the i.u. LPS mice, the lack of any monocyte recruitment into the 
myometrium (as shown earlier in Fig. 5.2.) was confirmed, with numbers remaining similar in the CD-
1 and CCR2 KO groups. The macrophages and CD11b+ F4/80low cells remained reduced in CCR2 KO 
mice and irrespective of the treatments given; however, by labour macrophages densities were 
comparable in WT and KOs (Fig. 5.19.). During labour following i.u. PBS neutrophils in the CCR2 KO 
myometrium were increased compared to CD-1s (Fig. 5.19.).  
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Figure 5.19. Cell density of leukocytes in the myometrium of CD-1 and CCR2 KO mice following a laparotomy 
and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD. Cell densities were analysed using an 
unpaired t-test when normally distributed and a Mann Whitney test when data was not. Statistical significance 
were expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. (*/#=p<0.05, 
**=p<0.01, *** = p<0.001). n=5-6. 
 
In circulating blood, WT and KO leukocyte cell numbers were similar following surgery and i.u. injection 
with the exception of the Ly-6Clow monocyte population which was significantly higher in the WT blood 
compared to KOs at 7 hours post i.u. PBS (Fig. 5.20.). Cell densities of macrophages in the placenta 
were significantly decreased in all CCR2 KO groups (Fig.5.21.).  In the lungs and liver, the increases in 
Ly-6Chigh monocytes were greater in the WT compared to CCR2 KO, but the increase in neutrophils 
seen with i.u. LPS were largely unaffected by CCR2 deficiency (Fig.5.22., and 5.23.). In the lungs only, 
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the Ly-6Chigh monocytes numbers were greater at baseline and 7 hours, but similar in labour in the two 
groups of mice (Fig.5.22.). 
Figure 5.20. Cell counts of leukocytes in the circulation of CD-1 and CCR2 KO mice following a laparotomy and 
i.u. injection of either PBS or LPS. Data are expressed as mean ±SD. Cell counts were analysed using an unpaired 
t-test when normally distributed and a Mann Whitney test when data was not. Statistical significance was 
expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. (*/#=p<0.05, ##=p<0.01). 
n=5-6 
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Figure 5.21. Cell density of leukocytes in the placenta from CD-1 and CCR2 KO mice following a laparotomy 
and i.u. injection of either PBS or LPS. Data are expressed as mean ±SD. Cell densities were analysed using an 
unpaired t-test when normally distributed and a Mann Whitney test when data was not. Statistical significance 
was expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. (*/#=p<0.05, 
**/##=p<0.01, ***= p<0.001). n=5-6 
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Figure 5.22. Cell counts of leukocytes in the lungs from CD-1 and CCR2 KO mice following a laparotomy and 
i.u. injection of either PBS or LPS. Data are expressed as mean ±SD. Cell counts were analysed using an unpaired 
t-test when normally distributed and a Mann Whitney test when data was not. Statistical significance was 
expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. (*=p<0.05, **/##=p<0.01, 
***= p<0.001). n=5-6 
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Figure 5.23. Cell density of leukocytes in the liver from CD-1 and CCR2 KO mice following a laparotomy and 
i.u. injection of either PBS or LPS. Data are expressed as mean ±SD. Cell densities were analysed using an 
unpaired t-test when normally distributed and a Mann Whitney test when data was not. Statistical significance 
was expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. (*=p<0.05, ***= 
p<0.001). n=5-6 
 
5.5.3 Comparison of the i.u. LPS model of PTL to systemic routes (i.p. and i.v.) LPS 
administration  
We found that LPS administered systemically via i.p. and i.v. injection resulted in labour on average 
23±4 hours post injection, much later than LPS administered i.u. with surgery (10±4 hours post -
injection) but still premature compared to spontaneous labour at 59±3 hours (Fig. 5.24. Spontaneous 
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labour vs. i.p. LPS p= <0.0001 using an unpaired t-test). These results suggest that a large part of the 
i.u. LPS effect on PTL could be through the excessive inflammation occurring simultaneously in the 
systemic compartments. Therefore we examined the leukocyte trafficking dynamics prior to and 
during labour following both an i.p. and i.u. LPS challenge. 
                                   
Figure 5.24. Delivery time following i.u. injection combined with a laparotomy and i.p. injection of either LPS 
or PBS with i.v. LPS injection only.  Delivery time was recorded when at least one pup had been delivered.  For 
naïve mice in spontaneous labour, time to delivery was recorded from 9am on E16. For the mice given an 
intrauterine intraperitoneal or intravenous injection delivery time was counted in hours from the time of the 
injection. 10µg in a total volume of 100µl of Escherichia coli LPS serotype 0111:B4 or sterile PBS (100 µl) were 
injected into either the uterus, peritoneum or tail vein. Data are expressed as median with interquartile range. 
Data was all normally distributed and labour time following i.u. injection was compared to i.p. injection using an 
unpaired t-test. Spontaneous labour and i.v. LPS data were included as a guide. (***= p<0.001) n=7-11. 
 
Intermediate time-points of 7 hours for the i.u. model of LPS induced PTL and 12 hours for the i.p. 
model were selected based on average labour time from preliminary experiments. Regardless of the 
route of LPS administration, leukocyte cell densities in the myometrium were comparable except for 
the CD11b+ F4/80low population which during labour following i.u. LPS had significantly more cells 
compared to labour induced by i.p. LPS administration (Fig. 5.25.). Although macrophage cell densities 
were comparable the activation status, as shown by CD86 expression levels, of macrophages in the 
myometrium in the LPS i.u. group, were significantly increased at both the intermediate time-point 
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and at labour compared to mice injected i.p. while COX-2 was only significantly increased during 
labour in the i.u. LPS treated mice (Fig. 5.25.).    
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Figure 5.25. Cell density of leukocytes and activation status of myometrial macrophages in the myometrium 
of CD-1 mice given either i.u. or i.p. injection of LPS. Data are expressed as mean ±SD. i.u. vs. i.p. intermediate 
time points (7 hours i.u.,12 hours i.p.) and labouring data were analysed using an unpaired t-test when normally 
distributed and a Mann Whitney test when data was not. Statistical significance were expressed with a * 
following an unpaired t-test or a # following a Mann-Whitney test. (*=p<0.05, **/##=p<0.01, ***/### = 
p<0.001). n=5-9. 
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In the placenta cell density of the leukocytes measured were comparable following i.u. or i.p. LPS 
(Fig.5.26). Circulating numbers of monocytes and neutrophils were higher during i.u. LPS labour 
compared to i.p. LPS labour (Fig.5.27.). The substantial increase in lung monocytes and neutrophils 
(Fig. 5.7.) with i.u. LPS treatment was less apparent in the i.p. LPS group (Fig. 5.28.). This difference 
may relate to the later sampling time point in the i.p. LPS mice or other factors such as reduced 
mobilisation of monocytes from the bone marrow seen with higher systemic LPS doses316, although 
circulating levels of all leukocyte subsets were higher with the i.p. route in labour suggesting that 
mobilisation was not reduced. In the liver of i.p. injected mice, Ly-6Clow monocytes were increased as 
compared to mice injected via the i.u. route (Fig.5.29.). 
 
Figure 5.26. Cell density of leukocytes in the placenta of CD-1 mice given either i.u. or i.p. injection of LPS. 
Data are expressed as mean ±SD. i.u. vs. i.p. intermediate time points (7 hours i.u.,12 hours i.p.) and labouring 
data were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was 
not. Statistical significance was expressed with a * following an unpaired t-test or a # following a Mann-Whitney 
test.n=5-9 
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Figure 5.27. Cell counts of leukocytes in the circulation of CD-1 mice given either i.u. or i.p. injection of LPS. 
Data are expressed as mean ±SD. i.u. vs. i.p. intermediate time points (7 hours i.u.,12 hours i.p.) and labouring 
data were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was 
not. Statistical significance was expressed with a * following an unpaired t-test or a # following a Mann-Whitney 
test. (*/#=p<0.05, **p<0.01). n=5-9. 
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Figure 5.28. Cell counts of leukocytes in the lungs of CD-1 mice given either i.u. or i.p. injection of LPS. Data 
are expressed as mean ±SD. i.u. vs. i.p. intermediate time points (7 hours i.u.,12 hours i.p.) and labouring data 
were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. 
Statistical significance was expressed with a * following an unpaired t-test or a # following a Mann-Whitney test. 
(*=p<0.05, **=p<0.01).  n=5-9. 
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Figure 5.29. Cell density of leukocytes in the liver of CD-1 mice given either i.u. or i.p. injection of LPS. Data 
are expressed as mean ±SD. i.u. vs. i.p. intermediate time points (7 hours i.u.,12 hours i.p.) and labouring data 
were analysed using an unpaired t-test when normally distributed and a Mann Whitney test when data was not. 
Statistical significance were expressed with a * following an unpaired t-test or a # following a Mann-Whitney 
test. (*=p<0.05, ##=p<0.01).  n=5-9. 
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5.6 Discussion 
This study set out to investigate the mechanisms responsible for inflammation induced PTL following 
the administration of LPS via the i.u. route. Administration of LPS consistently resulted in PTL, however 
the underlying dynamics between the local and systemic responses responsible for early onset of 
labour have not yet been determined.  Specifically we compared local and systemic inflammatory 
leukocyte trafficking and mediator production prior to and during LPS induced PTL. 
Administration of i.u. LPS consistently resulted in PTL within 16 hours however contrary to 
expectation, control i.u. PBS was found to produce greater inflammatory leukocyte trafficking to the 
uterus than i.u. LPS.  Surgery and injection of PBS into the right uterine horn alone was sufficient to 
cause inflammation in the myometrium as shown by an increase in CCL2, IL-6 and IL-1β at 3 hours post 
injection, this increase had subsided by 7 hours however there was a marked increase in leukocyte 
density to the myometrium at this time-point. The number of neutrophils and Ly-6Chigh monocytes 
migrating to the myometrium after PBS injection was far higher than after LPS injection despite the 
local chemokine levels in favour of the latter. These data suggest that abdominal surgery, with a 
manipulation of the uterus, and injection of PBS are adequate stimuli to induce a localised 
inflammation with significant leukocyte recruitment to the myometrium, yet this was  not sufficient 
to induce PTL or have a detrimental effect on pup survival.  
Using BrdU proliferation staining we were able to determine that the increase in Ly-6Chigh monocyte 
density in the myometrium at 7 hours following i.u. PBS was as a result of circulating Ly-6Chigh 
monocytes infiltrating the myometrium, rather than in situ expansion of this population. This increase 
in infiltration to myometrium 7 hours after i.u. PBS was abolished in the CCR2 KO mouse model 
indicating a CCR2 mediated mechanism. Notably time to labour following i.u. PBS was reduced in CCR2 
KO mice compared to WT controls, suggesting that the increased Ly-6Chigh monocyte density in the 
myometrium of i.u. PBS WT mice was responsible for the delayed  labour onset. However it is 
important to note the different genetic backgrounds of these mice, as it has been demonstrated that 
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different strains can respond very differently to the same stimulus317, 318. CCR2 KO mice were derived 
from mice with a C57BL/6 background while the control mice were pure CD-1s. The difference in the 
genetic background of the mice could have had an effect on labour times and leukocyte trafficking 
dynamics. This should be controlled for in future experiments by determining time to labour and 
monocyte trafficking dynamics following i.u. LPS injection in the C57BL/6 strain of mouse and 
comparing to CD-1 values. 
Taken together these results of i.u. PBS and LPS with surgery suggests that the infiltration of leukocytes 
into the myometrium per se is not crucial to the onset of inflammation induced PTL. This conclusion is 
supported by studies from Rinaldi and Timmons et al. in which the depletion of both circulating 
neutrophils and Ly-6Chigh monocytes using Gr1 antibodies did not delay LPS induced PTL or term labour 
respectively135, 136.  
The lower numbers of infiltrating neutrophils and Ly-6Chigh monocytes to the myometrium in LPS-
treated compared to PBS-treated mice appeared to indicate that other factors apart from local 
inflammation may be involved in this model of infection-induced PTL. These data strongly imply that 
leukocyte infiltration to the myometrium is not a crucial component of the infection induced PTL 
pathway. 
At 3 hours after LPS injection systemic inflammation was significantly increased as demonstrated by 
plasma chemokine and cytokine protein levels. These high levels observed in the plasma at 3 hours 
were maintained at 7 hours indicating a sustained systemic inflammation after LPS i.u injection. The 
high levels of chemokines in the circulation of i.u. LPS treated mice may have acted to skew the 
chemokine gradient restricting leukocyte migration into the myometrium. In lung tissue there were 
also significant increases in some cytokines and chemokines including CCL2 at 7 hours post i.u LPS 
challenge and large numbers of neutrophils and Ly-6Chigh monocytes providing further evidence of a 
significant  systemic inflammatory response to i.u. LPS. It has been previously shown that a subclinical 
endotoxemia is also sufficient to induce monocyte mobilisation from the bone marrow and a 
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prolonged margination of these monocytes in the lung microvasculature116.  O’Dea et al. further 
demonstrated the subclinical endotoxemia was capable of priming the inflammatory marginated 
monocytes to a secondary LPS challenge. The high numbers of leukocytes sequestered to the lungs 
and liver following LPS may be a limiting factor in their recruitment to the myometrium. This has been 
previously reported in a paper by Andonegui et al., who demonstrated that when neutrophils are 
sequestered in lungs, this may reduce entry into other sites of infection319.  
Given the potentially pro-pregnancy effect of the Ly-6Chigh monocyte infiltration to the myometrium 
demonstrated by the delay in labour onset in the i.u. PBS group. The failure of leukocyte infiltration 
into the myometrium may shorten the interval to parturition and possibly exacerbate the myometrial 
inflammation and the expression of chemotactic factors. These data suggest that LPS induced PTL 
could either be as a result of local inflammation in the uterus without the need for amplification via 
the infiltration of non-residents cells and/or as a result of the systemic inflammation evidenced by 
successful initiation of PTL following both i.p. and i.v. LPS. 
Shynlova et al. demonstrated that the systemic administration of a broad spectrum chemokine 
inhibitor (BSCI) significantly delayed LPS induced PTL following an i.p. injection and pre-treatment with 
a BSCI reduced the LPS induced increase in chemokine and cytokine gene expression in the 
myometrium200. It could therefore be speculated that the LPS-induced increase in chemokines may be 
promoting the contraction of uterine myocytes directly. In studies where human myometrial smooth 
muscle cells have been incubated with IL-1β, a significant increase in Ptgs2/COX-2 mRNA and protein 
expression has been found320, 321, supporting the concept of a cytokine-induced contractile effect, 
perhaps through the production of pro-contractile prostaglandins. However the direct stimulation of 
cultured myocytes with LPS has also been demonstrated to promote contractions independently of 
prostaglandin synthesis and cytokine activation322.  
Although large numbers of infiltrating leukocytes are observed in the intermediate time-point 
following LPS, the activity of the local resident leukocytes could be responsible for driving the 
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inflammation seen during infection-induced PTL. Macrophages are the most abundant leukocyte 
population in the myometrium and therefore are an important cell type to investigate their role in 
infection induced PTL. To assess macrophage activity we considered CD86 a co-stimulatory molecule 
found on the surface of APCs. In this study, CD86 expression by myometrial macrophages increased 
approximately threefold in LPS induced PTL compared to PBS labour; however no increase was seen 
prior to labour at the 7 hour time-point.  
Taken together these data suggest that both systemic and local factors may be important in regulating 
parturition following both localised and systemic LPS administration. Increased expression of 
activation factors by myometrial macrophages following i.u. injection of LPS compared to a systemic 
injection may suggest an increased localised inflammatory response following local administration and 
may account for the reduced time until labour onset. However although activation of macrophages in 
the myometrium appears to be reduced following systemic administration of LPS, PTL still occurs. 
When administrating LPS systemically to mice often far less is required to initiate PTB (~10µg)  
compared to the models of localised administration which often require higher doses (~250µg) 178. 
Considering that even a very small dose of LPS in comparison (1-10ng) is enough to induce high levels 
of cytokine production via the activation of TLR-4 in both male and non-pregnant female mice323 250µg 
is an extremely high dose needed to induce PTB. The systemic response to i.p. LPS is exaggerated 
compared to i.u LPS and indicates an important systemic component to infection-induced PTB. 
Therefore, it is important to understand the mechanisms whereby both systemic and localised 
inflammation regulates parturition as they may be distinct and amenable to different therapeutic 
approaches. 
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6.1 Discussion 
Preterm birth is responsible for the death of over 1 million neonates globally per year, while those 
that do survive are often affected by a permanent neurodevelopmental disability.  Our understanding 
of the processes and mechanisms involved in the regulation of parturition are limited. Currently the 
two major mechanisms thought to induce preterm parturition are the pro-inflammatory actions of the 
immune response and a reduction in the levels or functional activity of progesterone.  Many studies 
have demonstrated that labour is associated with an increase in the numbers of leukocytes in the 
uterus and foetal membranes and propose that leukocyte trafficking may be a prerequisite to labour 
onset.  In this thesis, leukocyte trafficking dynamics locally, to the uterus, and systemically, prior to 
and around preterm and term labour in the mouse, were investigated to determine their role in the 
onset or progression of labour. By using quantitative flow cytometry combined with other allied 
techniques and measurements, the source, behaviour and tissue infiltration of individual 
subpopulations of cells of the mononuclear phagocyte system (MPS) during late gestation were 
elucidated.  More specifically, the Ly-6Chigh monocyte subset trafficking and the underlying 
mechanisms involved using a range of models were studied, that included delaying labour using 
exogenous P4 supplementation  and inducing PTL using either a progesterone receptor antagonist or 
LPS injection. Previous studies, investigating leukocyte densities in the myometrium at parturition, 
have tended to approach the phenotypically and functionally heterogeneous cells of the MPS as a 
single population and therefore these results may help to clarify some of the cell-mediated 
mechanisms of normal and dysfunctional labour processes. 
Firstly, a longitudinal study to establish the baseline for leukocyte subset kinetics both locally, to the 
myometrium, and systemically was performed. A robust method of simultaneous fixation and 
homogenisation to generate single cell suspensions from myometrial, decidual, placental, lung and 
liver tissue was developed. This technique enabled the leukocyte cell densities and trafficking 
dynamics of the various leukocyte subsets, including the Ly-6Chigh monocyte subset, to be determined. 
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Using a variety of in vivo cell labelling techniques, the tissue location and origin of leukocytes 
specifically in the myometrium, but also systemically, in late murine gestation were deciphered. This 
detailed pre-labour analysis allowed us to characterise the leukocyte subsets to form a basis for 
further studies to investigate the mechanisms by which these cells entered the myometrium. 
This is the first study to show that the Ly-6Chigh monocyte subset density increases in the myometrium 
prior to labour onset. Intravascular compartment staining to determine their location within the 
myometrium and phenotypic profiling of the population using Siglec-1 expression to assess their in 
situ differentiation was used. In a paper published during the course of this study, Shynlova and 
colleagues also used flow cytometry to identify monocytes, macrophages and neutrophils in the 
murine myometrium in the period surrounding parturition100. They demonstrated a trend for 
macrophage and total monocyte numbers to increase from E15 to E18. They also showed that 
monocyte and neutrophil levels in the myometrium were significantly increased post-partum 
compared to the day prior to E18, while macrophage numbers decreased at labour and post-partum. 
The data presented in this thesis are consistent with these findings, although the approach and 
analysis was somewhat different. Here absolute cells counts were quantified more precisely in the 
infiltrating and resident populations.   
Further, to characterising leukocyte cell subsets in the myometrium during late gestation, the systemic 
leukocyte profile was studied. This approach was taken to obtain a complete picture of leukocyte 
trafficking, as local effects occurring in the myometrium may be related to changes that are occurring 
systemically. An increase in the intravascular lung-marginated monocyte populations from E16 to E18 
was identified, which was not mirrored in the circulation. The increased number of marginated cells 
within the lungs prior to labour suggests that there is an enhanced level of systemic activation prior 
to delivery.  
Next, the role of P4 in the regulation of leukocyte trafficking and proliferation in the myometrium and 
systemically during pregnancy was determined. Monocyte and neutrophil densities in the uterus of 
178 
 
non-pregnant naïve mice were found to fluctuate considerably and the variability in numbers was 
reduced by exogenous P4, suggesting P4 plays a role in regulating these cells which may be important 
in the process of uterine remodelling and immunity during the oestrous cycle. Furthermore, during 
late gestation P4 treatment significantly altered Ly-6Chigh monocyte densities in the myometrium, this 
effect was specific to these cells in the myometrium and was not observed in any of the other systemic 
organs, implying a specialised role in hormonal regulation of labour. 
 It has previously been demonstrated in rats that Ccl2 mRNA expression in the myometrium increases 
prior to labour with a further increase during labour208. This rise was associated with increasing stretch 
of the uterus and can be prevented by exogenous administration of P4. Conversely the administration 
of RU486, the progesterone receptor antagonist, caused a rise in Ccl2 expression208.  Here, we also 
demonstrated that CCL2 protein levels show a trend to increase on E18 in untreated mice  and 
following RU486 administration on E16, but not in mice given exogenous P4, suggesting that P4 
downregulates CCL2 levels in the myometrium. The variation in CCL2 levels in response to P4 
corresponded with Ly-6Chigh monocyte trafficking to the myometrium. However, when pregnancy was 
artificially extended beyond E18 by supplementation with exogenous P4, there were increases in both 
CCL2 levels and Ly-6Chigh monocyte cell density in the myometrium on E19 and E20. This suggests that 
P4 is unable to constrain stretch-induced monocyte recruitment, but that this was not sufficient to 
allow normal labour.   
In other mouse models of tissue inflammation, numbers of infiltrating Ly-6Chigh monocytes are often 
relatively small compared the resident macrophage population, but they are still capable of 
orchestrating or augmenting local responses324. An important consideration in understanding the 
function of infiltrating myometrial Ly-6Chigh monocytes in the different phases of gestation, is the role 
played  by  P4 as it not only suppresses their migration prior to labour, but also could potentially  alter 
their pro-inflammatory activity.  The activation status of CD11c+ dendritic cells has been demonstrated 
to be directly regulated by P4 in the murine uterus throughout the oestrous cycle267. Therefore, it will 
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be important to assess if P4 treatment could alter the functionality of Ly-6Chigh monocytes directly and 
if this then has down-stream effects on pro-labour mechanisms in the myometrium. Although there 
is debate as to whether human monocytes express PRs, it has been demonstrated that dendritic cells 
do express PR, and female mice express higher levels than males 267, 325. The common lineage may 
suggest that Ly-6Chigh monocytes also express PR and that P4  has a direct effect on their activation 
status 
The administration of a CCR2 antagonist following P4 withdrawal-induced PTB was not sufficient to 
delay labour and only partially inhibited the increase of Ly-6Chigh monocyte densities in the 
myometrium. In the chronic knockout model of CCR2 deficiency where Ly-6Chigh monocyte infiltration 
is substantially lower, labour time is indistinguishable from that of controls326. The significant increase 
in Ly-6Chigh monocytes and neutrophils combined with a decrease in macrophages in the myometrium 
from labour to the postpartum period of untreated mice suggests infiltrating leukocytes are important 
to post-partum events. This theory, based on various pieces of observational data, is shared by others 
in the field that leukocytes are critical for successful healing and/or remodelling of the uterus in the 
post-partum period99, 100, 167, 210. This is particularly of importance in the mouse model of pregnancy in 
which a post-partum oestrus occurs within 28 hours of delivery. Therefore, extrapolation of the 
findings from murine studies to humans should be made with caution.  A different role for monocytes 
and neutrophils prior to labour and post labour in the uterus should be considered and would be 
consistent with their known roles in orchestrating repair and remodelling of injured tissues 119.  
Finally, we investigated leukocyte trafficking dynamics prior to and during labour in a mouse model of 
infection-induced PTB. The high levels of Ly-6Chigh monocytes infiltrating the myometrium appeared 
to delay labour onset in mice following surgery and vehicle injection. This suggests strongly that 
leukocyte infiltration per se is not sufficient for the induction of labour and may actually delay the 
onset of labour in some circumstances.  When anti-Gr1 antibody was used to deplete neutrophils and 
probably Ly-6Chigh monocytes327 prior to administration of i.u. LPS, labour time was not delayed135, 
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which is further evidence that leukocyte migration to the uterus is not required for successful 
parturition following an inflammatory stimulus. The activity of the resident macrophage population 
may be an important factor in the outcome of myometrial inflammation. This may be as a direct result 
of the localised administration of LPS to the myometrium as systemic administration of LPS still 
induces PTL without the associated increase in markers of activation by the myometrial macrophages.  
However, in a study using broad spectrum chemokine inhibitors in a model of infection-induced PTB 
in mice, myometrium neutrophil densities were reduced modestly and labour delayed to term in 36% 
of BSCI treated mice200 suggesting that attenuation of inflammation in uterine tissues by reducing 
leukocyte infiltration could have some impact on labour onset. 
The analysis of circulating and marginated leukocyte populations following LPS challenge 
demonstrated an increase in the numbers of leukocytes sequestered within the lungs and liver. This 
response was unaffected in CCR2 deficient mice, suggesting that in these mice, which display normal 
labour onset times, the systemic response, including that of monocytes, is still intact and functional.  
At the intermediate time-point prior to labour following intrauterine LPS, chemokines and cytokines 
were increased in the lungs while the activation status of the interstitial leukocyte population was also 
increased. This systemic activation may be an integral mechanism in the onset of labour and an area 
which needs to be further investigated. Indeed in the study described above by Shynlova and 
colleagues , the delay in labour induced by BSCI administration could have resulted from a dampening 
of systemic response as evidenced by substantial reductions in plasma cytokine levels200. 
Using CCR2 deficient mice, it was possible to determine that the Ly-6Chigh monocyte trafficking to the 
myometrium following a vehicle i.u. injection was CCR2 mediated. This reduction in Ly-6Chigh monocyte 
trafficking to the myometrium coincided with a reduction in time to labour compared to CD-1 controls, 
suggesting that high levels of Ly-6Chigh monocyte trafficking to the myometrium may actually be 
associated with a delay in labour time, perhaps consistent with a role for myometrial monocytes and 
macrophages in maintaining a uterine quiescence during gestation via the production of NO.  
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However, we also observed that expression of COX-2 and CD86, and neutrophil densities were higher 
in CCR2-deficient mice than those in CD-1 mice on E16, suggesting CCR2 deficiency may produce a 
compensatory inflammatory response that could mask any effect that monocyte depletion has on 
labour. Such scenarios, where blocking or depleting cells could lead to unwanted effects such as 
inflammation, illustrate the difficulty in interpretation of findings related to labour time as an 
endpoint. Redundancy of cellular function may be particularly pronounced within the same cell 
lineage, as may be the case of infiltrating monocytes and resident macrophages, where one could 
compensate for the absence of the other.  
When this project began, the aim was to determine if and how monocytes were involved in the 
regulation of parturition. Using hormonal and infection-induced PTB models in the mouse, Ly-6Chigh 
monocyte trafficking to the myometrium was shown to be a significant and highly regulated process, 
controlled by integrated hormonal and inflammatory responses.  However, no clear evidence that 
these cells play a critical role in promoting the onset of labour was found, which is in agreement with 
other studies published prior to and during the course of this study.  As stated above, interventions 
designed to remove the effects of a pathway or cell population involved in labour may themselves 
contribute to the inflammatory mechanisms of labour and may therefore require caution in their 
interpretation.  However, based on the kinetic data obtained in this study and the crucial roles of Ly-
6Chigh monocytes in tissue injury, their recruitment to the myometrium strongly suggests that they are 
involved in the rapid remodelling and repair of the uterus following delivery. Instead of demonstrating 
a new cell-mediated inflammatory pathway of labour, evidence was obtained in the different LPS-
based models of PTB that systemic inflammation may be a very significant contributor in the regulation 
of parturition and this merits further investigation. 
6.2 Future work 
The work in this thesis identified the following areas of future research that should next be addressed.  
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Firstly based on my findings in Chapter 4, future work would involve determining if Ly-6Chigh monocyte 
migration to the myometrium following RU486 administration is significantly reduced in CCR2-/- mice 
and consequently determine if this has any effect on timing of PTB. Combining an acute P4 antagonist 
treatment with a model of CCR2 knockout may highlight the role of CCR2 in the onset and progression 
of labour. 
Further to this, profiling of the monocyte and macrophage phenotypes in the myometrium is 
necessary to identify their possible roles throughout gestation, at labour and in the postpartum 
period. This could be investigated by cell isolation using a FACS machine capable of isolating each of 
the monocyte and macrophage subsets and analysing these subsets with quantitative mRNA analysis. 
Isolating and analysing the monocyte and macrophage subsets in the myometrium could lead to 
insights into their regulatory roles in situ without the need for blockade or cell depletion treatments. 
Also by isolating the monocyte/macrophage subsets it will be possible to discriminate between 
leukocyte versus myocyte cell responses. 
To determine the mechanisms which regulate trafficking dynamics of the Ly-6Chigh monocyte 
population, future work should investigate the potential effects P4 on this population. This would 
include determining whether this subset does express a PR and if not how does P4 regulate the 
trafficking dynamics of this population? 
To assess the role of the circulating and marginated leukocyte populations in the lungs prior to and 
during labour the pro-inflammatory phenotype of monocytes and neutrophils should be determined. 
This could be performed by measuring the kinase activation and TNFα expression in the lungs of mice 
prior to and during labour. Characterising the inflammatory phenotype of these cells populations in 
late gestation and during labour would lead to a more complete picture of the innate immune system 
at this time and also suggest if there is a systemic component involved in the labour process.  
Finally to evaluate the contribution of the systemic vascular responses in infection induced PTB the 
models used in Chapter 5 could be adapted in order to measure the response to infection without the 
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presence of the inflammation initiated as a result of labour itself. LPS would be administered via both 
the i.p. and i.v. routes at a reduced dose so as not to induce PTL. Following this mRNA analysis and 
adhesion molecule expression of the leukocyte populations in the lungs and blood would be assessed 
to determine their pro-inflammatory phenotype. With this information the role of the systemic innate 
immune response during infection induced PTL could be identified. 
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